BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Seppälä-Lindroos A, Vehkavaara S, Häkkinen AM, Goto T, Westerbacka J, Sovijärvi A, Halavaara J, Yki-Järvinen H. Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. J Clin Endocrinol Metab. 2002;87:3023-3028. [PMID: 12107194 DOI: 10.1210/jcem.87.7.8638] [Cited by in Crossref: 471] [Cited by in F6Publishing: 524] [Article Influence: 24.8] [Reference Citation Analysis]
Number Citing Articles
1 Yang J, Zhang LJ, Wang F, Hong T, Liu Z. Molecular imaging of diabetes and diabetic complications: Beyond pancreatic β-cell targeting. Adv Drug Deliv Rev 2019;139:32-50. [PMID: 30529307 DOI: 10.1016/j.addr.2018.11.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
2 Larson-Meyer DE, Newcomer BR, Heilbronn LK, Volaufova J, Smith SR, Alfonso AJ, Lefevre M, Rood JC, Williamson DA, Ravussin E; Pennington CALERIE Team. Effect of 6-month calorie restriction and exercise on serum and liver lipids and markers of liver function. Obesity (Silver Spring). 2008;16:1355-1362. [PMID: 18421281 DOI: 10.1038/oby.2008.201] [Cited by in Crossref: 143] [Cited by in F6Publishing: 125] [Article Influence: 11.0] [Reference Citation Analysis]
3 Chang Y, Jung H, Yun KE, Cho J, Cho YK, Ryu S. Cohort Study of Non-alcoholic Fatty Liver Disease, NAFLD fibrosis score, and the Risk of Incident Diabetes in a Korean population. American Journal of Gastroenterology 2013;108:1861-8. [DOI: 10.1038/ajg.2013.349] [Cited by in Crossref: 103] [Cited by in F6Publishing: 89] [Article Influence: 12.9] [Reference Citation Analysis]
4 Weyrich P, Staiger H, Stančáková A, Machicao F, Machann J, Schick F, Stefan N, Kuusisto J, Laakso M, Schäfer S, Fritsche A, Häring HU. The D299G/T399I Toll-like receptor 4 variant associates with body and liver fat: results from the TULIP and METSIM Studies. PLoS One 2010;5:e13980. [PMID: 21125016 DOI: 10.1371/journal.pone.0013980] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
5 Stanhope KL, Havel PJ. Fructose consumption: recent results and their potential implications. Ann N Y Acad Sci 2010;1190:15-24. [PMID: 20388133 DOI: 10.1111/j.1749-6632.2009.05266.x] [Cited by in Crossref: 90] [Cited by in F6Publishing: 70] [Article Influence: 8.2] [Reference Citation Analysis]
6 Visser ME, Lammers NM, Nederveen AJ, van der Graaf M, Heerschap A, Ackermans MT, Sauerwein HP, Stroes ES, Serlie MJ. Hepatic steatosis does not cause insulin resistance in people with familial hypobetalipoproteinaemia. Diabetologia 2011;54:2113-21. [PMID: 21547498 DOI: 10.1007/s00125-011-2157-x] [Cited by in Crossref: 52] [Cited by in F6Publishing: 48] [Article Influence: 5.2] [Reference Citation Analysis]
7 Tay J, Goss AM, Garvey WT, Lockhart ME, Bush NC, Quon MJ, Fisher G, Gower BA. Race affects the association of obesity measures with insulin sensitivity. Am J Clin Nutr 2020;111:515-25. [PMID: 31879755 DOI: 10.1093/ajcn/nqz309] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 10.0] [Reference Citation Analysis]
8 Harada PH, Bensenõr IJM, Drager LF, Goulart AC, Mill JG, Lotufo PA. Non-alcoholic fatty liver disease presence and severity are associated with aortic stiffness beyond abdominal obesity: The ELSA-Brasil. Atherosclerosis 2019;284:59-65. [PMID: 30875494 DOI: 10.1016/j.atherosclerosis.2019.02.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
9 Knudsen SH, Hansen LS, Pedersen M, Dejgaard T, Hansen J, Hall GV, Thomsen C, Solomon TP, Pedersen BK, Krogh-Madsen R. Changes in insulin sensitivity precede changes in body composition during 14 days of step reduction combined with overfeeding in healthy young men. J Appl Physiol (1985) 2012;113:7-15. [PMID: 22556394 DOI: 10.1152/japplphysiol.00189.2011] [Cited by in Crossref: 66] [Cited by in F6Publishing: 56] [Article Influence: 7.3] [Reference Citation Analysis]
10 Power ML, Schulkin J. Sex differences in fat storage, fat metabolism, and the health risks from obesity: possible evolutionary origins. Br J Nutr. 2008;99:931-940. [PMID: 17977473 DOI: 10.1017/s0007114507853347] [Cited by in Crossref: 255] [Cited by in F6Publishing: 126] [Article Influence: 18.2] [Reference Citation Analysis]
11 Iizuka T, Iemitsu K, Takihata M, Takai M, Nakajima S, Minami N, Umezawa S, Kanamori A, Takeda H, Kawata T, Ito S, Kikuchi T, Amemiya H, Kaneshiro M, Mokubo A, Takuma T, Machimura H, Tanaka K, Asakura T, Kubota A, Aoyagi S, Hoshino K, Ishikawa M, Matsuzawa Y, Obana M, Sasai N, Kaneshige H, Minagawa F, Saito T, Shinoda K, Miyakawa M, Tanaka Y, Terauchi Y, Matsuba I. Efficacy and Safety of Ipragliflozin in Japanese Patients With Type 2 Diabetes: Interim Outcome of the ASSIGN-K Study. J Clin Med Res 2016;8:116-25. [PMID: 26767080 DOI: 10.14740/jocmr2417w] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
12 Patel R, Patel M, Tsai R, Lin V, Bookout AL, Zhang Y, Magomedova L, Li T, Chan JF, Budd C, Mangelsdorf DJ, Cummins CL. LXRβ is required for glucocorticoid-induced hyperglycemia and hepatosteatosis in mice. J Clin Invest 2011;121:431-41. [PMID: 21123945 DOI: 10.1172/JCI41681] [Cited by in Crossref: 75] [Cited by in F6Publishing: 43] [Article Influence: 6.8] [Reference Citation Analysis]
13 García-galiano D, Sánchez-garrido MA, Espejo I, Montero JL, Costán G, Marchal T, Membrives A, Gallardo-valverde JM, Muñoz-castañeda JR, Arévalo E, De la Mata M, Muntané J. IL-6 and IGF-1 are Independent Prognostic Factors of Liver Steatosis and Non-Alcoholic Steatohepatitis in Morbidly Obese Patients. OBES SURG 2007;17:493-503. [DOI: 10.1007/s11695-007-9087-1] [Cited by in Crossref: 66] [Cited by in F6Publishing: 65] [Article Influence: 4.7] [Reference Citation Analysis]
14 Regnell SE, Lernmark Å. Hepatic steatosis in type 1 diabetes. Rev Diabet Stud 2011;8:454-67. [PMID: 22580727 DOI: 10.1900/RDS.2011.8.454] [Cited by in Crossref: 59] [Cited by in F6Publishing: 20] [Article Influence: 6.6] [Reference Citation Analysis]
15 Burger KS, Shearrer GE, Gilbert JR. Brain, Environment, Hormone-Based Appetite, Ingestive Behavior, and Body Weight. In: Nillni EA, editor. Textbook of Energy Balance, Neuropeptide Hormones, and Neuroendocrine Function. Cham: Springer International Publishing; 2018. pp. 347-69. [DOI: 10.1007/978-3-319-89506-2_13] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
16 Shaharyar S, Roberson LL, Jamal O, Younus A, Blaha MJ, Ali SS, Zide K, Agatston AA, Blumenthal RS, Conceição RD, Santos RD, Nasir K. Obesity and metabolic phenotypes (metabolically healthy and unhealthy variants) are significantly associated with prevalence of elevated C-reactive protein and hepatic steatosis in a large healthy Brazilian population. J Obes 2015;2015:178526. [PMID: 25838943 DOI: 10.1155/2015/178526] [Cited by in Crossref: 28] [Cited by in F6Publishing: 17] [Article Influence: 4.7] [Reference Citation Analysis]
17 Singh P, Garg R, Goand UK, Riyazuddin M, Reza MI, Syed AA, Gupta AP, Husain A, Gayen JR. Combination of Pancreastatin inhibitor PSTi8 with metformin inhibits Fetuin-A in type 2 diabetic mice. Heliyon 2020;6:e05133. [PMID: 33033766 DOI: 10.1016/j.heliyon.2020.e05133] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
18 Cintra DE, Pauli JR, Araújo EP, Moraes JC, de Souza CT, Milanski M, Morari J, Gambero A, Saad MJ, Velloso LA. Interleukin-10 is a protective factor against diet-induced insulin resistance in liver. J Hepatol. 2008;48:628-637. [PMID: 18267346 DOI: 10.1016/j.jhep.2007.12.017] [Cited by in Crossref: 108] [Cited by in F6Publishing: 101] [Article Influence: 8.3] [Reference Citation Analysis]
19 Misra A, Anoop S, Gulati S, Mani K, Bhatt SP, Pandey RM. Body Fat Patterning, Hepatic Fat and Pancreatic Volume of Non-Obese Asian Indians with Type 2 Diabetes in North India: A Case-Control Study. PLoS One 2015;10:e0140447. [PMID: 26474415 DOI: 10.1371/journal.pone.0140447] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 4.8] [Reference Citation Analysis]
20 Bays H, Mandarino L, DeFronzo RA. Role of the adipocyte, free fatty acids, and ectopic fat in pathogenesis of type 2 diabetes mellitus: peroxisomal proliferator-activated receptor agonists provide a rational therapeutic approach. J Clin Endocrinol Metab. 2004;89:463-478. [PMID: 14764748 DOI: 10.1210/jc.2003-030723] [Cited by in Crossref: 437] [Cited by in F6Publishing: 366] [Article Influence: 25.7] [Reference Citation Analysis]
21 Eickhoff H, Guimarães A, Louro TM, Seiça RM, Castro E Sousa F. Insulin resistance and beta cell function before and after sleeve gastrectomy in obese patients with impaired fasting glucose or type 2 diabetes. Surg Endosc 2015;29:438-43. [PMID: 24993174 DOI: 10.1007/s00464-014-3675-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
22 Heilbronn L, Smith SR, Ravussin E. Failure of fat cell proliferation, mitochondrial function and fat oxidation results in ectopic fat storage, insulin resistance and type II diabetes mellitus. Int J Obes Relat Metab Disord. 2004;28 Suppl 4:S12-S21. [PMID: 15592481 DOI: 10.1038/sj.ijo.0802853] [Cited by in Crossref: 273] [Cited by in F6Publishing: 243] [Article Influence: 17.1] [Reference Citation Analysis]
23 Lang AL, Beier JI. Interaction of volatile organic compounds and underlying liver disease: a new paradigm for risk. Biol Chem. 2018;399:1237-1248. [PMID: 29924722 DOI: 10.1515/hsz-2017-0324] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 7.5] [Reference Citation Analysis]
24 Weickert MO, Pfeiffer AFH. Signalling mechanisms linking hepatic glucose and lipid metabolism. Diabetologia 2006;49:1732-41. [DOI: 10.1007/s00125-006-0295-3] [Cited by in Crossref: 72] [Cited by in F6Publishing: 60] [Article Influence: 4.8] [Reference Citation Analysis]
25 Schwenger KJ, Fischer SE, Jackson T, Okrainec A, Allard JP. In nonalcoholic fatty liver disease, Roux-en-Y gastric bypass improves liver histology while persistent disease is associated with lower improvements in waist circumference and glycemic control. Surgery for Obesity and Related Diseases 2018;14:1233-9. [DOI: 10.1016/j.soard.2018.06.007] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
26 Zadjali F, Santana-Farre R, Vesterlund M, Carow B, Mirecki-Garrido M, Hernandez-Hernandez I, Flodström-Tullberg M, Parini P, Rottenberg M, Norstedt G. SOCS2 deletion protects against hepatic steatosis but worsens insulin resistance in high-fat-diet-fed mice. FASEB J. 2012;26:3282-3291. [PMID: 22562833 DOI: 10.1096/fj.12-205583] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 4.6] [Reference Citation Analysis]
27 Denechaud PD, Dentin R, Girard J, Postic C. Role of ChREBP in hepatic steatosis and insulin resistance. FEBS Lett. 2008;582:68-73. [PMID: 17716660 DOI: 10.1016/j.febslet.2007.07.084] [Cited by in Crossref: 85] [Cited by in F6Publishing: 79] [Article Influence: 6.1] [Reference Citation Analysis]
28 Zhang L, Ma X, Jiang Z, Zhang K, Zhang M, Li Y, Zhao X, Xiong H. Liver enzymes and metabolic syndrome: a large-scale case-control study. Oncotarget 2015;6:26782-8. [PMID: 26449189 DOI: 10.18632/oncotarget.5792] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
29 Magkos F. Exercise and fat accumulation in the human liver: . Current Opinion in Lipidology 2010;21:507-17. [DOI: 10.1097/mol.0b013e32833ea912] [Cited by in Crossref: 34] [Cited by in F6Publishing: 14] [Article Influence: 3.1] [Reference Citation Analysis]
30 Fischbach F, Thormann M, Ricke J. 1H-Magnetresonanzspektroskopie (MRS) der Leber und von Lebermalignomen bei 3,0�Tesla. Radiologe 2004;44:1192-6. [DOI: 10.1007/s00117-004-1136-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
31 Deivanayagam S, Mohammed BS, Vitola BE, Naguib GH, Keshen TH, Kirk EP, Klein S. Nonalcoholic fatty liver disease is associated with hepatic and skeletal muscle insulin resistance in overweight adolescents. Am J Clin Nutr 2008;88:257-62. [PMID: 18689359 DOI: 10.1093/ajcn/88.2.257] [Cited by in Crossref: 82] [Cited by in F6Publishing: 72] [Article Influence: 6.3] [Reference Citation Analysis]
32 Bozzetto L, Prinster A, Mancini M, Giacco R, De Natale C, Salvatore M, Riccardi G, Rivellese AA, Annuzzi G. Liver fat in obesity: role of type 2 diabetes mellitus and adipose tissue distribution. Eur J Clin Invest 2011;41:39-44. [PMID: 20825466 DOI: 10.1111/j.1365-2362.2010.02372.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
33 Makkonen J, Pietiläinen KH, Rissanen A, Kaprio J, Yki-Järvinen H. Genetic factors contribute to variation in serum alanine aminotransferase activity independent of obesity and alcohol: a study in monozygotic and dizygotic twins. J Hepatol. 2009;50:1035-1042. [PMID: 19303161 DOI: 10.1016/j.jhep.2008.12.025] [Cited by in Crossref: 86] [Cited by in F6Publishing: 78] [Article Influence: 7.2] [Reference Citation Analysis]
34 Tokita Y, Maejima Y, Shimomura K, Takenoshita S, Ishiyama N, Akuzawa M, Shimomura Y, Nakajima K. Non-alcoholic Fatty Liver Disease Is a Risk Factor for Type 2 Diabetes in Middle-aged Japanese Men and Women. Intern Med 2017;56:763-71. [PMID: 28381741 DOI: 10.2169/internalmedicine.56.7115] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
35 Ruhl CE, Everhart JE. Trunk fat is associated with increased serum levels of alanine aminotransferase in the United States. Gastroenterology 2010;138:1346-56, 1356.e1-3. [PMID: 20060831 DOI: 10.1053/j.gastro.2009.12.053] [Cited by in Crossref: 45] [Cited by in F6Publishing: 37] [Article Influence: 4.1] [Reference Citation Analysis]
36 Kozlitina J, Boerwinkle E, Cohen JC, Hobbs HH. Dissociation between APOC3 variants, hepatic triglyceride content and insulin resistance. Hepatology. 2011;53:467-474. [PMID: 21274868 DOI: 10.1002/hep.24072] [Cited by in Crossref: 90] [Cited by in F6Publishing: 84] [Article Influence: 8.2] [Reference Citation Analysis]
37 Meneses MJ, Silvestre R, Sousa-Lima I, Macedo MP. Paraoxonase-1 as a Regulator of Glucose and Lipid Homeostasis: Impact on the Onset and Progression of Metabolic Disorders. Int J Mol Sci 2019;20:E4049. [PMID: 31430977 DOI: 10.3390/ijms20164049] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 10.5] [Reference Citation Analysis]
38 Garbow J, Lin X, Sakata N, Chen Z, Koh D, Schonfeld G. In vivo MRS measurement of liver lipid levels in mice. Journal of Lipid Research 2004;45:1364-71. [DOI: 10.1194/jlr.d400001-jlr200] [Cited by in Crossref: 32] [Cited by in F6Publishing: 9] [Article Influence: 1.9] [Reference Citation Analysis]
39 Taylor R. Type 2 diabetes: etiology and reversibility. Diabetes Care. 2013;36:1047-1055. [PMID: 23520370 DOI: 10.2337/dc12-1805] [Cited by in Crossref: 172] [Cited by in F6Publishing: 121] [Article Influence: 21.5] [Reference Citation Analysis]
40 Kotronen A, Seppänen-Laakso T, Westerbacka J, Kiviluoto T, Arola J, Ruskeepää AL, Oresic M, Yki-Järvinen H. Hepatic stearoyl-CoA desaturase (SCD)-1 activity and diacylglycerol but not ceramide concentrations are increased in the nonalcoholic human fatty liver. Diabetes. 2009;58:203-208. [PMID: 18952834 DOI: 10.2337/db08-1074] [Cited by in Crossref: 155] [Cited by in F6Publishing: 143] [Article Influence: 11.9] [Reference Citation Analysis]
41 Kim K, Park SM. Association of muscle mass and fat mass with insulin resistance and the prevalence of metabolic syndrome in Korean adults: a cross-sectional study. Sci Rep. 2018;8:2703. [PMID: 29426839 DOI: 10.1038/s41598-018-21168-5] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 11.7] [Reference Citation Analysis]
42 Fang L, Guo F, Zhou L, Stahl R, Grams J. The cell size and distribution of adipocytes from subcutaneous and visceral fat is associated with type 2 diabetes mellitus in humans. Adipocyte. 2015;4:273-279. [PMID: 26451283 DOI: 10.1080/21623945.2015.1034920] [Cited by in Crossref: 54] [Cited by in F6Publishing: 45] [Article Influence: 9.0] [Reference Citation Analysis]
43 Higashiura Y, Furuhashi M, Tanaka M, Takahashi S, Koyama M, Ohnishi H, Numata K, Hisasue T, Hanawa N, Moniwa N, Tsuchihashi K, Miura T. High level of fatty liver index predicts new onset of diabetes mellitus during a 10-year period in healthy subjects. Sci Rep 2021;11:12830. [PMID: 34145341 DOI: 10.1038/s41598-021-92292-y] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 Yoon D, Lee SH, Park HS, Lee JH, Park JS, Cho KH, Kim SM. Hypoadiponectinemia and insulin resistance are associated with nonalcoholic fatty liver disease. J Korean Med Sci. 2005;20:421-426. [PMID: 15953863 DOI: 10.3346/jkms.2005.20.3.421] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 0.9] [Reference Citation Analysis]
45 Rembeck K, Maglio C, Lagging M, Christensen PB, Färkkilä M, Langeland N, Buhl MR, Pedersen C, Mørch K, Norkrans G. PNPLA 3 I148M genetic variant associates with insulin resistance and baseline viral load in HCV genotype 2 but not in genotype 3 infection. BMC Med Genet. 2012;13:82. [PMID: 22978414 DOI: 10.1186/1471-2350-13-82] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
46 Liu Z, Que S, Ning H, Wang L, Peng T. Elevated alanine aminotransferase is strongly associated with incident metabolic syndrome: a meta-analysis of prospective studies. PLoS One 2013;8:e80596. [PMID: 24324614 DOI: 10.1371/journal.pone.0080596] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
47 Qu S, Su D, Altomonte J, Kamagate A, He J, Perdomo G, Tse T, Jiang Y, Dong HH. PPAR{alpha} mediates the hypolipidemic action of fibrates by antagonizing FoxO1. Am J Physiol Endocrinol Metab 2007;292:E421-34. [PMID: 16985262 DOI: 10.1152/ajpendo.00157.2006] [Cited by in Crossref: 70] [Cited by in F6Publishing: 66] [Article Influence: 4.7] [Reference Citation Analysis]
48 Doi Y, Kubo M, Yonemoto K, Ninomiya T, Iwase M, Tanizaki Y, Shikata K, Iida M, Kiyohara Y. Liver Enzymes as a Predictor for Incident Diabetes in a Japanese Population: The Hisayama Study*. Obesity 2007;15:1841-50. [DOI: 10.1038/oby.2007.218] [Cited by in Crossref: 77] [Cited by in F6Publishing: 60] [Article Influence: 5.5] [Reference Citation Analysis]
49 Fabbrini E, Mohammed BS, Korenblat KM, Magkos F, McCrea J, Patterson BW, Klein S. Effect of fenofibrate and niacin on intrahepatic triglyceride content, very low-density lipoprotein kinetics, and insulin action in obese subjects with nonalcoholic fatty liver disease. J Clin Endocrinol Metab 2010;95:2727-35. [PMID: 20371660 DOI: 10.1210/jc.2009-2622] [Cited by in Crossref: 102] [Cited by in F6Publishing: 92] [Article Influence: 9.3] [Reference Citation Analysis]
50 Ferre T, Riu E, Franckhauser S, Agudo J, Bosch F. Long-term overexpression of glucokinase in the liver of transgenic mice leads to insulin resistance. Diabetologia 2003;46:1662-8. [PMID: 14614559 DOI: 10.1007/s00125-003-1244-z] [Cited by in Crossref: 72] [Cited by in F6Publishing: 59] [Article Influence: 4.0] [Reference Citation Analysis]
51 Santini F, Giannetti M, Mazzeo S, Fierabracci P, Scartabelli G, Marsili A, Valeriano R, Pucci A, Anselmino M, Zampa V, Vitti P, Pinchera A. Ultrasonographic evaluation of liver volume and the metabolic syndrome in obese women. J Endocrinol Invest 2007;30:104-10. [DOI: 10.1007/bf03347407] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
52 Lesmana CR, Pakasi LS, Inggriani S, Aidawati ML, Lesmana LA. Development of non-alcoholic fatty liver disease scoring system among adult medical check-up patients: a large cross-sectional and prospective validation study. Diabetes Metab Syndr Obes 2015;8:213-8. [PMID: 25960672 DOI: 10.2147/DMSO.S80364] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
53 Lund MT, Kristensen M, Hansen M, Tveskov L, Floyd AK, Støckel M, Vainer B, Poulsen SS, Helge JW, Prats C, Dela F. Hepatic mitochondrial oxidative phosphorylation is normal in obese patients with and without type 2 diabetes. J Physiol 2016;594:4351-8. [PMID: 27060482 DOI: 10.1113/JP272105] [Cited by in Crossref: 15] [Cited by in F6Publishing: 4] [Article Influence: 3.8] [Reference Citation Analysis]
54 Kalinovich A, Dehvari N, Åslund A, van Beek S, Halleskog C, Olsen J, Forsberg E, Zacharewicz E, Schaart G, Rinde M, Sandström A, Berlin R, Östenson CG, Hoeks J, Bengtsson T. Treatment with a β-2-adrenoceptor agonist stimulates glucose uptake in skeletal muscle and improves glucose homeostasis, insulin resistance and hepatic steatosis in mice with diet-induced obesity. Diabetologia 2020;63:1603-15. [PMID: 32472192 DOI: 10.1007/s00125-020-05171-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
55 Machann J, Thamer C, Schnoedt B, Haap M, Haring H, Claussen CD, Stumvoll M, Fritsche A, Schick F. Standardized assessment of whole body adipose tissue topography by MRI. J Magn Reson Imaging 2005;21:455-62. [DOI: 10.1002/jmri.20292] [Cited by in Crossref: 173] [Cited by in F6Publishing: 160] [Article Influence: 10.8] [Reference Citation Analysis]
56 Kwak M, Kim D, Chung GE, Kim W, Kim YJ, Yoon J. Role of physical activity in nonalcoholic fatty liver disease in terms of visceral obesity and insulin resistance. Liver Int 2015;35:944-52. [DOI: 10.1111/liv.12552] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 4.1] [Reference Citation Analysis]
57 Macauley M, Smith FE, Thelwall PE, Hollingsworth KG, Taylor R. Diurnal variation in skeletal muscle and liver glycogen in humans with normal health and Type 2 diabetes. Clin Sci (Lond) 2015;128:707-13. [PMID: 25583442 DOI: 10.1042/CS20140681] [Cited by in Crossref: 22] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
58 Choi YH, Park S, Hockman S, Zmuda-Trzebiatowska E, Svennelid F, Haluzik M, Gavrilova O, Ahmad F, Pepin L, Napolitano M, Taira M, Sundler F, Stenson Holst L, Degerman E, Manganiello VC. Alterations in regulation of energy homeostasis in cyclic nucleotide phosphodiesterase 3B-null mice. J Clin Invest 2006;116:3240-51. [PMID: 17143332 DOI: 10.1172/JCI24867] [Cited by in Crossref: 119] [Cited by in F6Publishing: 70] [Article Influence: 8.5] [Reference Citation Analysis]
59 Skytte MJ, Samkani A, Petersen AD, Thomsen MN, Astrup A, Chabanova E, Frystyk J, Holst JJ, Thomsen HS, Madsbad S, Larsen TM, Haugaard SB, Krarup T. A carbohydrate-reduced high-protein diet improves HbA1c and liver fat content in weight stable participants with type 2 diabetes: a randomised controlled trial. Diabetologia 2019;62:2066-78. [DOI: 10.1007/s00125-019-4956-4] [Cited by in Crossref: 38] [Cited by in F6Publishing: 30] [Article Influence: 19.0] [Reference Citation Analysis]
60 Bugianesi E, McCullough AJ, Marchesini G. Insulin resistance: a metabolic pathway to chronic liver disease. Hepatology. 2005;42:987-1000. [PMID: 16250043 DOI: 10.1002/hep.20920] [Cited by in Crossref: 512] [Cited by in F6Publishing: 439] [Article Influence: 32.0] [Reference Citation Analysis]
61 Roncero-Ramos I, Gutierrez-Mariscal FM, Gomez-Delgado F, Villasanta-Gonzalez A, Torres-Peña JD, Cruz-Ares S, Rangel-Zuñiga OA, Luque RM, Ordovas JM, Delgado-Lista J, Perez-Martinez P, Camargo A, Alcalá-Diaz JF, Lopez-Miranda J. Beta cell functionality and hepatic insulin resistance are major contributors to type 2 diabetes remission and starting pharmacological therapy: from CORDIOPREV randomized controlled trial. Transl Res 2021:S1931-5244(21)00158-4. [PMID: 34298148 DOI: 10.1016/j.trsl.2021.07.001] [Reference Citation Analysis]
62 Tamura Y, Watada H, Sato F, Kumashiro N, Sakurai Y, Hirose T, Tanaka Y, Kawamori R. Effects of metformin on peripheral insulin sensitivity and intracellular lipid contents in muscle and liver of overweight Japanese subjects. Diabetes, Obesity and Metabolism 2008;10:733-8. [DOI: 10.1111/j.1463-1326.2007.00801.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
63 Brouwers B, Schrauwen-hinderling V, Jelenik T, Gemmink A, Havekes B, Bruls Y, Dahlmans D, Roden M, Hesselink M, Schrauwen P. Metabolic disturbances of non-alcoholic fatty liver resemble the alterations typical for type 2 diabetes. Clinical Science 2017;131:1905-17. [DOI: 10.1042/cs20170261] [Cited by in Crossref: 22] [Cited by in F6Publishing: 4] [Article Influence: 5.5] [Reference Citation Analysis]
64 Gormsen LC, Nellemann B, Sørensen LP, Jensen MD, Christiansen JS, Nielsen S. Impact of body composition on very-low-density lipoprotein-triglycerides kinetics. Am J Physiol Endocrinol Metab 2009;296:E165-73. [PMID: 18984851 DOI: 10.1152/ajpendo.90675.2008] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 1.8] [Reference Citation Analysis]
65 D’souza AM, Beaudry JL, Szigiato AA, Trumble SJ, Snook LA, Bonen A, Giacca A, Riddell MC. Consumption of a high-fat diet rapidly exacerbates the development of fatty liver disease that occurs with chronically elevated glucocorticoids. Am J Physiol Gastrointest Liver Physiol. 2012;302:G850-G863. [PMID: 22268100 DOI: 10.1152/ajpgi.00378.2011] [Cited by in Crossref: 48] [Cited by in F6Publishing: 47] [Article Influence: 5.3] [Reference Citation Analysis]
66 Grønbaek H, Thomsen KL, Rungby J, Schmitz O, Vilstrup H. Role of nonalcoholic fatty liver disease in the development of insulin resistance and diabetes. Expert Rev Gastroenterol Hepatol. 2008;2:705-711. [PMID: 19072347 DOI: 10.1586/17474124.2.5.705] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 2.4] [Reference Citation Analysis]
67 Monago CC, Onwuka F, Osaro E. Effect of combined therapy of diabinese and nicotinic acid on liver enzymes in rabbits with dithizone-induced diabetes. J Exp Pharmacol 2010;2:145-53. [PMID: 27186100 DOI: 10.2147/JEP.S11490] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
68 Tschritter O, Preissl H, Hennige AM, Sartorius T, Grichisch Y, Stefan N, Guthoff M, Düsing S, Machann J, Schleicher E, Cegan A, Birbaumer N, Fritsche A, Häring HU. The insulin effect on cerebrocortical theta activity is associated with serum concentrations of saturated nonesterified Fatty acids. J Clin Endocrinol Metab 2009;94:4600-7. [PMID: 19820026 DOI: 10.1210/jc.2009-0469] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 2.8] [Reference Citation Analysis]
69 Modica S, Moschetta A. Nuclear bile acid receptor FXR as pharmacological target: are we there yet. FEBS Lett. 2006;580:5492-5499. [PMID: 16904670 DOI: 10.1016/j.febslet.2006.07.082] [Cited by in Crossref: 65] [Cited by in F6Publishing: 58] [Article Influence: 4.3] [Reference Citation Analysis]
70 Klein S, Burke LE, Bray GA, Blair S, Allison DB, Pi-sunyer X, Hong Y, Eckel RH. Clinical Implications of Obesity With Specific Focus on Cardiovascular Disease: A Statement for Professionals From the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: Endorsed by the American College of Cardiology Foundation. Circulation 2004;110:2952-67. [DOI: 10.1161/01.cir.0000145546.97738.1e] [Cited by in Crossref: 616] [Cited by in F6Publishing: 223] [Article Influence: 36.2] [Reference Citation Analysis]
71 Basaranoglu M, Basaranoglu G, Sabuncu T, Sentürk H. Fructose as a key player in the development of fatty liver disease. World J Gastroenterol. 2013;19:1166-1172. [PMID: 23482247 DOI: 10.3748/wjg.v19.i8.1166] [Cited by in CrossRef: 131] [Cited by in F6Publishing: 109] [Article Influence: 16.4] [Reference Citation Analysis]
72 Manco M, Nobili V. Utility of magnetic resonance imaging in the evaluation of hepatic fat content. Hepatology 2009;50:328-9. [DOI: 10.1002/hep.23039] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
73 Han H, Hu C, Wang L, Zhang G, Liu S, Li F, Sun D, Hu S. Duodenal-jejunal bypass surgery suppresses hepatic de novo lipogenesis and alleviates liver fat accumulation in a diabetic rat model. Obes Surg. 2014;24:2152-2160. [PMID: 24898720 DOI: 10.1007/s11695-014-1308-9] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
74 López-Bermejo A, Botas P, Funahashi T, Delgado E, Kihara S, Ricart W, Fernández-Real JM. Adiponectin, hepatocellular dysfunction and insulin sensitivity. Clin Endocrinol (Oxf) 2004;60:256-63. [PMID: 14725689 DOI: 10.1046/j.1365-2265.2004.01977.x] [Cited by in Crossref: 80] [Cited by in F6Publishing: 76] [Article Influence: 4.7] [Reference Citation Analysis]
75 Yamada T, Fukatsu M, Suzuki S, Wada T, Yoshida T, Joh T. Fatty liver predicts impaired fasting glucose and type 2 diabetes mellitus in Japanese undergoing a health checkup. J Gastroenterol Hepatol. 2010;25:352-356. [PMID: 19817963 DOI: 10.1111/j.1440-1746.2009.05998.x] [Cited by in Crossref: 85] [Cited by in F6Publishing: 85] [Article Influence: 7.1] [Reference Citation Analysis]
76 Petersen KF, Dufour S, Hariri A, Nelson-Williams C, Foo JN, Zhang XM, Dziura J, Lifton RP, Shulman GI. Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease. N Engl J Med 2010;362:1082-9. [PMID: 20335584 DOI: 10.1056/NEJMoa0907295] [Cited by in Crossref: 287] [Cited by in F6Publishing: 139] [Article Influence: 26.1] [Reference Citation Analysis]
77 Marcus Y, Shefer G, Sasson K, Kohen F, Limor R, Pappo O, Nevo N, Biton I, Bach M, Berkutzki T, Fridkin M, Benayahu D, Shechter Y, Stern N. Angiotensin 1-7 as means to prevent the metabolic syndrome: lessons from the fructose-fed rat model. Diabetes 2013;62:1121-30. [PMID: 23250359 DOI: 10.2337/db12-0792] [Cited by in Crossref: 50] [Cited by in F6Publishing: 42] [Article Influence: 5.6] [Reference Citation Analysis]
78 Zhu Q, Shen F, Ye T, Zhou Q, Deng H, Gu X. Waist-to-height ratio is an appropriate index for identifying cardiometabolic risk in Chinese individuals with normal body mass index and waist circumference 腰臀比是鉴别体重指数和腰围正常的中国人群的心血管代谢风险的适宜指标: Waist-to-height ratio and cardiometabolic risk. Journal of Diabetes 2014;6:527-34. [DOI: 10.1111/1753-0407.12157] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 2.9] [Reference Citation Analysis]
79 Kalra S, Bhattacharya S, Rawal P. Hepatocrinology. Med Sci (Basel) 2021;9:39. [PMID: 34205986 DOI: 10.3390/medsci9020039] [Reference Citation Analysis]
80 Ter Horst KW, Gilijamse PW, Versteeg RI, Ackermans MT, Nederveen AJ, la Fleur SE, Romijn JA, Nieuwdorp M, Zhang D, Samuel VT, Vatner DF, Petersen KF, Shulman GI, Serlie MJ. Hepatic Diacylglycerol-Associated Protein Kinase Cε Translocation Links Hepatic Steatosis to Hepatic Insulin Resistance in Humans. Cell Rep 2017;19:1997-2004. [PMID: 28591572 DOI: 10.1016/j.celrep.2017.05.035] [Cited by in Crossref: 77] [Cited by in F6Publishing: 66] [Article Influence: 25.7] [Reference Citation Analysis]
81 Dobbins RL, Malloy CR. Measuring in-vivo metabolism using nuclear magnetic resonance. Curr Opin Clin Nutr Metab Care. 2003;6:501-509. [PMID: 12913667 DOI: 10.1097/00075197-200309000-00003] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
82 Li MR, Zhang SH, Chao K, Liao XH, Yao JY, Chen MH, Zhong BH. Apolipoprotein C3 (-455T& gt; C) polymorphism confers susceptibility to nonalcoholic fatty liver disease in the Southern Han Chinese population. World J Gastroenterol. 2014;20:14010-14017. [PMID: 25320541 DOI: 10.3748/wjg.v20.i38.14010] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 18] [Article Influence: 3.5] [Reference Citation Analysis]
83 Watt MJ, Miotto PM, De Nardo W, Montgomery MK. The Liver as an Endocrine Organ-Linking NAFLD and Insulin Resistance. Endocr Rev. 2019;40:1367-1393. [PMID: 31098621 DOI: 10.1210/er.2019-00034] [Cited by in Crossref: 66] [Cited by in F6Publishing: 58] [Article Influence: 66.0] [Reference Citation Analysis]
84 Snel M, Jonker JT, Schoones J, Lamb H, de Roos A, Pijl H, Smit JW, Meinders AE, Jazet IM. Ectopic fat and insulin resistance: pathophysiology and effect of diet and lifestyle interventions. Int J Endocrinol. 2012;2012:983814. [PMID: 22675355 DOI: 10.1155/2012/983814] [Cited by in Crossref: 134] [Cited by in F6Publishing: 108] [Article Influence: 14.9] [Reference Citation Analysis]
85 Snijder MB, Visser M, Dekker JM, Goodpaster BH, Harris TB, Kritchevsky SB, De Rekeneire N, Kanaya AM, Newman AB, Tylavsky FA, Seidell JC; Health ABC Study. Low subcutaneous thigh fat is a risk factor for unfavourable glucose and lipid levels, independently of high abdominal fat. The Health ABC Study. Diabetologia 2005;48:301-8. [PMID: 15660262 DOI: 10.1007/s00125-004-1637-7] [Cited by in Crossref: 254] [Cited by in F6Publishing: 230] [Article Influence: 15.9] [Reference Citation Analysis]
86 Greco D, Kotronen A, Westerbacka J, Puig O, Arkkila P, Kiviluoto T, Laitinen S, Kolak M, Fisher RM, Hamsten A, Auvinen P, Yki-järvinen H. Gene expression in human NAFLD. American Journal of Physiology-Gastrointestinal and Liver Physiology 2008;294:G1281-7. [DOI: 10.1152/ajpgi.00074.2008] [Cited by in Crossref: 242] [Cited by in F6Publishing: 231] [Article Influence: 18.6] [Reference Citation Analysis]
87 Fukuyama K, Ohara T, Hirota Y, Maeda K, Kuno S, Zenibayashi M, Teranishi T, Kouyama K, Maeda E, Sakamoto N, Kasuga M. Association of the -112A>C polymorphism of the uncoupling protein 1 gene with insulin resistance in Japanese individuals with type 2 diabetes. Biochem Biophys Res Commun 2006;339:1212-6. [PMID: 16338218 DOI: 10.1016/j.bbrc.2005.11.140] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
88 De Chiara F, Ureta Checcllo C, Ramón Azcón J. High Protein Diet and Metabolic Plasticity in Non-Alcoholic Fatty Liver Disease: Myths and Truths. Nutrients 2019;11:E2985. [PMID: 31817648 DOI: 10.3390/nu11122985] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
89 Lee HY, Birkenfeld AL, Jornayvaz FR, Jurczak MJ, Kanda S, Popov V, Frederick DW, Zhang D, Guigni B, Bharadwaj KG, Choi CS, Goldberg IJ, Park JH, Petersen KF, Samuel VT, Shulman GI. Apolipoprotein CIII overexpressing mice are predisposed to diet-induced hepatic steatosis and hepatic insulin resistance. Hepatology. 2011;54:1650-1660. [PMID: 21793029 DOI: 10.1002/hep.24571] [Cited by in Crossref: 91] [Cited by in F6Publishing: 82] [Article Influence: 9.1] [Reference Citation Analysis]
90 Ravikumar B, Carey PE, Snaar JE, Deelchand DK, Cook DB, Neely RD, English PT, Firbank MJ, Morris PG, Taylor R. Real-time assessment of postprandial fat storage in liver and skeletal muscle in health and type 2 diabetes. Am J Physiol Endocrinol Metab 2005;288:E789-97. [PMID: 15572652 DOI: 10.1152/ajpendo.00557.2004] [Cited by in Crossref: 88] [Cited by in F6Publishing: 85] [Article Influence: 5.2] [Reference Citation Analysis]
91 Ruderman N, Prentki M. AMP kinase and malonyl-CoA: targets for therapy of the metabolic syndrome. Nat Rev Drug Discov 2004;3:340-51. [PMID: 15060529 DOI: 10.1038/nrd1344] [Cited by in Crossref: 307] [Cited by in F6Publishing: 269] [Article Influence: 18.1] [Reference Citation Analysis]
92 Gauthier MS, Couturier K, Charbonneau A, Lavoie JM. Effects of introducing physical training in the course of a 16-week high-fat diet regimen on hepatic steatosis, adipose tissue fat accumulation, and plasma lipid profile. Int J Obes Relat Metab Disord. 2004;28:1064-1071. [PMID: 15254487 DOI: 10.1038/sj.ijo.0802628] [Cited by in Crossref: 55] [Cited by in F6Publishing: 55] [Article Influence: 3.2] [Reference Citation Analysis]
93 Yatsuya H, Nihashi T, Li Y, Hotta Y, Matsushita K, Muramatsu T, Otsuka R, Matsunaga M, Yamashita K, Wang C, Uemura M, Harada A, Fukatsu H, Toyoshima H, Aoyama A, Tamakoshi K. Independent association of liver fat accumulation with insulin resistance. Obes Res Clin Pract 2014;8:e350-5. [PMID: 25091356 DOI: 10.1016/j.orcp.2013.08.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
94 Lim JS, Mietus-Snyder M, Valente A, Schwarz JM, Lustig RH. The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome. Nat Rev Gastroenterol Hepatol. 2010;7:251-264. [PMID: 20368739 DOI: 10.1038/nrgastro.2010.41] [Cited by in Crossref: 426] [Cited by in F6Publishing: 374] [Article Influence: 38.7] [Reference Citation Analysis]
95 Chang Y, Noh YH, Suh BS, Kim Y, Sung E, Jung HS, Kim CW, Kwon MJ, Yun KE, Noh JW, Shin H, Cho YK, Ryu S. Bidirectional Association between Nonalcoholic Fatty Liver Disease and Gallstone Disease: A Cohort Study. J Clin Med. 2018;7:458. [PMID: 30469392 DOI: 10.3390/jcm7110458] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
96 Katsanos CS. Lipid-Induced Insulin Resistance in the Liver: Role of Exercise. Sports Medicine 2004;34:955-65. [DOI: 10.2165/00007256-200434140-00002] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
97 Wendel AA, Li LO, Li Y, Cline GW, Shulman GI, Coleman RA. Glycerol-3-phosphate acyltransferase 1 deficiency in ob/ob mice diminishes hepatic steatosis but does not protect against insulin resistance or obesity. Diabetes 2010;59:1321-9. [PMID: 20200319 DOI: 10.2337/db09-1380] [Cited by in Crossref: 43] [Cited by in F6Publishing: 40] [Article Influence: 3.9] [Reference Citation Analysis]
98 Ou HY, Wang CY, Yang YC, Chen MF, Chang CJ. The association between nonalcoholic fatty pancreas disease and diabetes. PLoS One. 2013;8:e62561. [PMID: 23671610 DOI: 10.1371/journal.pone.0062561] [Cited by in Crossref: 72] [Cited by in F6Publishing: 66] [Article Influence: 9.0] [Reference Citation Analysis]
99 Shin Y, Lee D, Ahn J, Lee M, Shin SS, Yoon M. The herbal extract ALS-L1023 from Melissa officinalis reduces weight gain, elevated glucose levels and β-cell loss in Otsuka Long-Evans Tokushima fatty rats. J Ethnopharmacol 2021;264:113360. [PMID: 32918993 DOI: 10.1016/j.jep.2020.113360] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
100 Fruci B, Giuliano S, Mazza A, Malaguarnera R, Belfiore A. Nonalcoholic Fatty liver: a possible new target for type 2 diabetes prevention and treatment. Int J Mol Sci. 2013;14:22933-22966. [PMID: 24264040 DOI: 10.3390/ijms141122933] [Cited by in Crossref: 62] [Cited by in F6Publishing: 55] [Article Influence: 7.8] [Reference Citation Analysis]
101 Ballestri S, Nascimbeni F, Romagnoli D, Baldelli E, Targher G, Lonardo A. Type 2 Diabetes in Non-Alcoholic Fatty Liver Disease and Hepatitis C Virus Infection--Liver: The "Musketeer" in the Spotlight. Int J Mol Sci. 2016;17:355. [PMID: 27005620 DOI: 10.3390/ijms17030355] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 5.8] [Reference Citation Analysis]
102 Gallagher D, Kelley DE, Yim JE, Spence N, Albu J, Boxt L, Pi-Sunyer FX, Heshka S. Adipose tissue distribution is different in type 2 diabetes. Am J Clin Nutr. 2009;89:807-814. [PMID: 19158213 DOI: 10.3945/ajcn.2008.26955] [Cited by in Crossref: 125] [Cited by in F6Publishing: 109] [Article Influence: 10.4] [Reference Citation Analysis]
103 Basaranoglu M, Kayacetin S, Yilmaz N, Kayacetin E, Tarcin O, Sonsuz A. Understanding mechanisms of the pathogenesis of nonalcoholic fatty liver disease. World J Gastroenterol. 2010;16:2223-2226. [PMID: 20458758 DOI: 10.3748/wjg.v16.i18.2223] [Cited by in CrossRef: 40] [Cited by in F6Publishing: 39] [Article Influence: 3.6] [Reference Citation Analysis]
104 Michaliszyn SF, Lee S, Tfayli H, Arslanian S. Polycystic ovary syndrome and nonalcoholic fatty liver in obese adolescents: association with metabolic risk profile. Fertil Steril. 2013;100:1745-1751. [PMID: 24034940 DOI: 10.1016/j.fertnstert.2013.08.015] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
105 Otten J, Mellberg C, Ryberg M, Sandberg S, Kullberg J, Lindahl B, Larsson C, Hauksson J, Olsson T. Strong and persistent effect on liver fat with a Paleolithic diet during a two-year intervention. Int J Obes (Lond). 2016;40:747-753. [PMID: 26786351 DOI: 10.1038/ijo.2016.4] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 5.8] [Reference Citation Analysis]
106 Rebelos E, Iozzo P, Guzzardi MA, Brunetto MR, Bonino F. Brain-gut-liver interactions across the spectrum of insulin resistance in metabolic fatty liver disease. WJG 2021;27:4999-5018. [DOI: 10.3748/wjg.v27.i30.4999] [Reference Citation Analysis]
107 Rector RS, Thyfault JP, Wei Y, Ibdah JA. Non-alcoholic fatty liver disease and the metabolic syndrome: an update. World J Gastroenterol. 2008;14:185-192. [PMID: 18186553 DOI: 10.3748/wjg.14.185] [Cited by in CrossRef: 197] [Cited by in F6Publishing: 185] [Article Influence: 15.2] [Reference Citation Analysis]
108 Yki-Järvinen H, Luukkonen PK, Hodson L, Moore JB. Dietary carbohydrates and fats in nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol 2021. [PMID: 34257427 DOI: 10.1038/s41575-021-00472-y] [Reference Citation Analysis]
109 Engberg S, Glümer C, Witte DR, Jørgensen T, Borch-johnsen K. Differential relationship between physical activity and progression to diabetes by glucose tolerance status: the Inter99 Study. Diabetologia 2010;53:70-8. [DOI: 10.1007/s00125-009-1587-1] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
110 Steven S, Woodcock S, Small PK, Taylor R. Type 2 diabetes, bariatric surgery and the risk of subsequent gestational diabetes. Obstet Med 2011;4:171-3. [PMID: 27579120 DOI: 10.1258/om.2011.110020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
111 Lim J, Iyer A, Suen JY, Seow V, Reid RC, Brown L, Fairlie DP. C5aR and C3aR antagonists each inhibit diet-induced obesity, metabolic dysfunction, and adipocyte and macrophage signaling. FASEB J 2013;27:822-31. [PMID: 23118029 DOI: 10.1096/fj.12-220582] [Cited by in Crossref: 75] [Cited by in F6Publishing: 63] [Article Influence: 8.3] [Reference Citation Analysis]
112 Shojaee-Moradie F, Baynes KC, Pentecost C, Bell JD, Thomas EL, Jackson NC, Stolinski M, Whyte M, Lovell D, Bowes SB. Exercise training reduces fatty acid availability and improves the insulin sensitivity of glucose metabolism. Diabetologia. 2007;50:404-413. [PMID: 17149589 DOI: 10.1007/s00125-006-0498-7] [Cited by in Crossref: 121] [Cited by in F6Publishing: 106] [Article Influence: 8.1] [Reference Citation Analysis]
113 Cho JH, Namgung JS, Lee J, Moon DH, Lee HK. Analysis of biochemical markers related to Fatty liver patients. J Phys Ther Sci 2014;26:1865-8. [PMID: 25540483 DOI: 10.1589/jpts.26.1865] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
114 Alzahrani AH, Skytte MJ, Samkani A, Thomsen MN, Astrup A, Ritz C, Chabanova E, Frystyk J, Holst JJ, Thomsen HS, Madsbad S, Haugaard SB, Krarup T, Larsen TM, Magkos F. Body weight and metabolic risk factors in patients with type 2 diabetes on a self-selected high-protein low-carbohydrate diet. Eur J Nutr 2021. [PMID: 34101004 DOI: 10.1007/s00394-021-02605-0] [Reference Citation Analysis]
115 Manco M, Mingrone G. Effects of weight loss and calorie restriction on carbohydrate metabolism: . Current Opinion in Clinical Nutrition and Metabolic Care 2005;8:431-9. [DOI: 10.1097/01.mco.0000172585.09762.8e] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
116 Yki-Järvinen H. Fat in the liver and insulin resistance. Ann Med 2005;37:347-56. [PMID: 16179270 DOI: 10.1080/07853890510037383] [Cited by in Crossref: 180] [Cited by in F6Publishing: 166] [Article Influence: 11.3] [Reference Citation Analysis]
117 Liu W, Baker RD, Bhatia T, Zhu L, Baker SS. Pathogenesis of nonalcoholic steatohepatitis. Cell Mol Life Sci. 2016;73:1969-1987. [PMID: 26894897 DOI: 10.1007/s00018-016-2161-x] [Cited by in Crossref: 91] [Cited by in F6Publishing: 84] [Article Influence: 18.2] [Reference Citation Analysis]
118 Hirata A, Sugiyama D, Kuwabara K, Hirata T, Tsutatani H, Funamoto M, Watanabe K, Miyamatsu N, Okamura T. Fatty liver index predicts incident diabetes in a Japanese general population with and without impaired fasting glucose. Hepatol Res 2018;48:708-16. [PMID: 29341419 DOI: 10.1111/hepr.13065] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
119 Ruderman NB, Shulman GI. Metabolic Syndrome. Endocrinology: Adult and Pediatric. Elsevier; 2016. pp. 752-769.e7. [DOI: 10.1016/b978-0-323-18907-1.00043-3] [Cited by in Crossref: 4] [Article Influence: 0.8] [Reference Citation Analysis]
120 Vassilatou E. Nonalcoholic fatty liver disease and polycystic ovary syndrome. World J Gastroenterol. 2014;20:8351-8363. [PMID: 25024594 DOI: 10.3748/wjg.v20.i26.8351] [Cited by in CrossRef: 63] [Cited by in F6Publishing: 50] [Article Influence: 10.5] [Reference Citation Analysis]
121 Savage DB, Choi CS, Samuel VT, Liu ZX, Zhang D, Wang A, Zhang XM, Cline GW, Yu XX, Geisler JG. Reversal of diet-induced hepatic steatosis and hepatic insulin resistance by antisense oligonucleotide inhibitors of acetyl-CoA carboxylases 1 and 2. J Clin Invest. 2006;116:817-824. [PMID: 16485039 DOI: 10.1172/jci27300] [Cited by in Crossref: 302] [Cited by in F6Publishing: 151] [Article Influence: 20.1] [Reference Citation Analysis]
122 Holt HB, Wild SH, Wood PJ, Zhang J, Darekar AA, Dewbury K, Poole RB, Holt RIG, Phillips DI, Byrne CD. Non-esterified fatty acid concentrations are independently associated with hepatic steatosis in obese subjects. Diabetologia 2006;49:141-8. [DOI: 10.1007/s00125-005-0070-x] [Cited by in Crossref: 64] [Cited by in F6Publishing: 58] [Article Influence: 4.0] [Reference Citation Analysis]
123 Cortez-pinto H, Machado M. Impact of body weight, diet and lifestyle on nonalcoholic fatty liver disease. Expert Review of Gastroenterology & Hepatology 2014;2:217-31. [DOI: 10.1586/17474124.2.2.217] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
124 Machado M, Cortez-Pinto H. Non-alcoholic steatohepatitis and metabolic syndrome. Curr Opin Clin Nutr Metab Care. 2006;9:637-642. [PMID: 16912563 DOI: 10.1097/01.mco.0000241677.40170.17] [Cited by in Crossref: 76] [Cited by in F6Publishing: 71] [Article Influence: 5.1] [Reference Citation Analysis]
125 Fischbach F, Bruhn H. Assessment of in vivo 1H magnetic resonance spectroscopy in the liver: a review. Liver Int. 2008;28:297-307. [PMID: 18290772 DOI: 10.1111/j.1478-3231.2007.01647.x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 45] [Article Influence: 3.8] [Reference Citation Analysis]
126 Kawamoto R, Kohara K, Kusunoki T, Tabara Y, Abe M, Miki T. Alanine aminotransferase/aspartate aminotransferase ratio is the best surrogate marker for insulin resistance in non-obese Japanese adults. Cardiovasc Diabetol 2012;11:117. [PMID: 23020992 DOI: 10.1186/1475-2840-11-117] [Cited by in Crossref: 31] [Cited by in F6Publishing: 23] [Article Influence: 3.4] [Reference Citation Analysis]
127 Moon J, Kong E, Lee J, Jung J, Kim E, Park SB, Kim P. Intravital longitudinal imaging of hepatic lipid droplet accumulation in a murine model for nonalcoholic fatty liver disease. Biomed Opt Express 2020;11:5132-46. [PMID: 33014604 DOI: 10.1364/BOE.395890] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
128 Liu S, Sheng L, Miao H, Saunders TL, MacDougald OA, Koenig RJ, Xu B. SRA gene knockout protects against diet-induced obesity and improves glucose tolerance. J Biol Chem 2014;289:13000-9. [PMID: 24675075 DOI: 10.1074/jbc.M114.564658] [Cited by in Crossref: 66] [Cited by in F6Publishing: 35] [Article Influence: 9.4] [Reference Citation Analysis]
129 Bell LN, Wang J, Muralidharan S, Chalasani S, Fullenkamp AM, Wilson LA, Sanyal AJ, Kowdley KV, Neuschwander-Tetri BA, Brunt EM. Relationship between adipose tissue insulin resistance and liver histology in nonalcoholic steatohepatitis: a pioglitazone versus vitamin E versus placebo for the treatment of nondiabetic patients with nonalcoholic steatohepatitis trial follow-up study. Hepatology. 2012;56:1311-1318. [PMID: 22532269 DOI: 10.1002/hep.25805] [Cited by in Crossref: 64] [Cited by in F6Publishing: 54] [Article Influence: 7.1] [Reference Citation Analysis]
130 Karelis AD, St-Pierre DH, Conus F, Rabasa-Lhoret R, Poehlman ET. Metabolic and body composition factors in subgroups of obesity: what do we know? J Clin Endocrinol Metab. 2004;89:2569-2575. [PMID: 15181025 DOI: 10.1210/jc.2004-0165] [Cited by in Crossref: 463] [Cited by in F6Publishing: 384] [Article Influence: 27.2] [Reference Citation Analysis]
131 Madauss KP, Burkhart WA, Consler TG, Cowan DJ, Gottschalk WK, Miller AB, Short SA, Tran TB, Williams SP. The human ACC2 CT-domain C-terminus is required for full functionality and has a novel twist. Acta Crystallogr D Biol Crystallogr 2009;65:449-61. [PMID: 19390150 DOI: 10.1107/S0907444909008014] [Cited by in Crossref: 18] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
132 Catalano KJ, Bergman RN, Ader M. Increased Susceptibility to Insulin Resistance Associated with Abdominal Obesity in Aging Rats **. Obesity Research 2005;13:11-20. [DOI: 10.1038/oby.2005.4] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 4.2] [Reference Citation Analysis]
133 Régnier M, Polizzi A, Guillou H, Loiseau N. Sphingolipid metabolism in non-alcoholic fatty liver diseases. Biochimie 2019;159:9-22. [PMID: 30071259 DOI: 10.1016/j.biochi.2018.07.021] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
134 Mazi TA, Borkowski K, Newman JW, Fiehn O, Bowlus CL, Sarkar S, Matsukuma K, Ali MR, Kieffer DA, Wan YY, Stanhope KL, Havel PJ, Medici V. Ethnicity-specific alterations of plasma and hepatic lipidomic profiles are related to high NAFLD rate and severity in Hispanic Americans, a pilot study. Free Radic Biol Med 2021;172:490-502. [PMID: 34182070 DOI: 10.1016/j.freeradbiomed.2021.06.024] [Reference Citation Analysis]
135 Iozzo P, Turpeinen AK, Takala T, Oikonen V, Solin O, Ferrannini E, Nuutila P, Knuuti J. Liver uptake of free fatty acids in vivo in humans as determined with 14( R, S)-[18F]fluoro-6-thia-heptadecanoic acid and PET. Eur J Nucl Med Mol Imaging 2003;30:1160-4. [PMID: 12811532 DOI: 10.1007/s00259-003-1215-0] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
136 Bajaj M, Suraamornkul S, Hardies LJ, Glass L, Musi N, Defronzo RA. Effects of peroxisome proliferator-activated receptor (PPAR)-α and PPAR-γ agonists on glucose and lipid metabolism in patients with type 2 diabetes mellitus. Diabetologia 2007;50:1723-31. [DOI: 10.1007/s00125-007-0698-9] [Cited by in Crossref: 97] [Cited by in F6Publishing: 87] [Article Influence: 6.9] [Reference Citation Analysis]
137 van Eyk HJ, Paiman EHM, Bizino MB, de Heer P, Geelhoed-Duijvestijn PH, Kharagjitsingh AV, Smit JWA, Lamb HJ, Rensen PCN, Jazet IM. A double-blind, placebo-controlled, randomised trial to assess the effect of liraglutide on ectopic fat accumulation in South Asian type 2 diabetes patients. Cardiovasc Diabetol 2019;18:87. [PMID: 31288820 DOI: 10.1186/s12933-019-0890-5] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 9.5] [Reference Citation Analysis]
138 Furukawa Y, Tamura Y, Takeno K, Funayama T, Kaga H, Suzuki R, Watanabe T, Kakehi S, Kanazawa A, Kawamori R, Watada H. Impaired peripheral insulin sensitivity in non-obese Japanese patients with type 2 diabetes mellitus and fatty liver. J Diabetes Investig 2017. [PMID: 28836350 DOI: 10.1111/jdi.12731] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
139 Fabbrini E, deHaseth D, Deivanayagam S, Mohammed BS, Vitola BE, Klein S. Alterations in fatty acid kinetics in obese adolescents with increased intrahepatic triglyceride content. Obesity (Silver Spring) 2009;17:25-9. [PMID: 18948971 DOI: 10.1038/oby.2008.494] [Cited by in Crossref: 65] [Cited by in F6Publishing: 63] [Article Influence: 5.0] [Reference Citation Analysis]
140 Bettaieb A, Vazquez Prieto MA, Rodriguez Lanzi C, Miatello RM, Haj FG, Fraga CG, Oteiza PI. (-)-Epicatechin mitigates high-fructose-associated insulin resistance by modulating redox signaling and endoplasmic reticulum stress. Free Radic Biol Med 2014;72:247-56. [PMID: 24746618 DOI: 10.1016/j.freeradbiomed.2014.04.011] [Cited by in Crossref: 82] [Cited by in F6Publishing: 69] [Article Influence: 11.7] [Reference Citation Analysis]
141 Sasaki H, Hirai K, Martins CM, Furusho H, Battaglino R, Hashimoto K. Interrelationship Between Periapical Lesion and Systemic Metabolic Disorders. Curr Pharm Des 2016;22:2204-15. [PMID: 26881444 DOI: 10.2174/1381612822666160216145107] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 7.3] [Reference Citation Analysis]
142 Heyman L, Axling U, Blanco N, Sterner O, Holm C, Berger K. Evaluation of Beneficial Metabolic Effects of Berries in High-Fat Fed C57BL/6J Mice. J Nutr Metab 2014;2014:403041. [PMID: 24669315 DOI: 10.1155/2014/403041] [Cited by in Crossref: 48] [Cited by in F6Publishing: 43] [Article Influence: 6.9] [Reference Citation Analysis]
143 Demir K, Akyuz F, Ozdil S, Aksoy N, Kaymakoglu S, Poturoglu S, Akyüz Ü, Besisik F, Boztas G, Mungan Z, Cevikbas U, Cakaloglu Y, Okten A. What is the reason of elevated alanine aminotransferase level in HBeAg negative patients with low viremia: NAFLD or chronic hepatitis? Annals of Hepatology 2007;6:92-6. [DOI: 10.1016/s1665-2681(19)31938-6] [Cited by in Crossref: 14] [Article Influence: 1.0] [Reference Citation Analysis]
144 Ren Q, Guo M, Yang F, Han T, Du W, Zhao F, Li J, Li W, Feng Y, Wang S, Zhang Y, Wu W. Association of CPT1A gene polymorphism with the risk of gestational diabetes mellitus: a case-control study. J Assist Reprod Genet 2021;38:1861-9. [PMID: 33687587 DOI: 10.1007/s10815-021-02143-y] [Reference Citation Analysis]
145 Kowalski GM, Kloehn J, Burch ML, Selathurai A, Hamley S, Bayol SA, Lamon S, Watt MJ, Lee-Young RS, McConville MJ, Bruce CR. Overexpression of sphingosine kinase 1 in liver reduces triglyceride content in mice fed a low but not high-fat diet. Biochim Biophys Acta 2015;1851:210-9. [PMID: 25490466 DOI: 10.1016/j.bbalip.2014.12.002] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 3.9] [Reference Citation Analysis]
146 Perseghin G. Viewpoints on the way to a consensus session: where does insulin resistance start? The liver. Diabetes Care 2009;32 Suppl 2:S164-7. [PMID: 19875545 DOI: 10.2337/dc09-S303] [Cited by in Crossref: 32] [Cited by in F6Publishing: 15] [Article Influence: 2.9] [Reference Citation Analysis]
147 Fabbrini E, Magkos F. Hepatic Steatosis as a Marker of Metabolic Dysfunction. Nutrients 2015;7:4995-5019. [PMID: 26102213 DOI: 10.3390/nu7064995] [Cited by in Crossref: 90] [Cited by in F6Publishing: 74] [Article Influence: 15.0] [Reference Citation Analysis]
148 Cordeiro A, Costa R, Andrade N, Silva C, Canabrava N, Pena MJ, Rodrigues I, Andrade S, Ramalho A. Does adipose tissue inflammation drive the development of non-alcoholic fatty liver disease in obesity? Clin Res Hepatol Gastroenterol 2020;44:394-402. [PMID: 32044284 DOI: 10.1016/j.clinre.2019.10.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
149 Sugiyama E, Tanaka N, Nakajima T, Kamijo Y, Yokoyama S, Li Y, Gonzalez FJ, Aoyama T. Haploinsufficiency in the PPARalpha and LDL receptor genes leads to gender- and age-specific obesity and hyperinsulinemia. Biochem Biophys Res Commun 2006;350:370-6. [PMID: 17011521 DOI: 10.1016/j.bbrc.2006.09.048] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
150 Petersen KF, Dufour S, Feng J, Befroy D, Dziura J, Dalla Man C, Cobelli C, Shulman GI. Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men. Proc Natl Acad Sci USA. 2006;103:18273-18277. [PMID: 17114290 DOI: 10.1073/pnas.0608537103] [Cited by in Crossref: 256] [Cited by in F6Publishing: 229] [Article Influence: 17.1] [Reference Citation Analysis]
151 Cao CY, Li YY, Zhou YJ, Nie YQ, Wan YJ. The C-681G polymorphism of the PPAR-γ gene is associated with susceptibility to non-alcoholic fatty liver disease. Tohoku J Exp Med 2012;227:253-62. [PMID: 22820754 DOI: 10.1620/tjem.227.253] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
152 Haufe S, Engeli S, Budziarek P, Utz W, Schulz-Menger J, Hermsdorf M, Wiesner S, Otto C, Haas V, de Greiff A, Luft FC, Boschmann M, Jordan J. Cardiorespiratory fitness and insulin sensitivity in overweight or obese subjects may be linked through intrahepatic lipid content. Diabetes 2010;59:1640-7. [PMID: 20357364 DOI: 10.2337/db09-1200] [Cited by in Crossref: 38] [Cited by in F6Publishing: 30] [Article Influence: 3.5] [Reference Citation Analysis]
153 Scott NJA, Cameron VA, Raudsepp S, Lewis LK, Simpson ER, Richards AM, Ellmers LJ. Generation and characterization of a mouse model of the metabolic syndrome: apolipoprotein E and aromatase double knockout mice. American Journal of Physiology-Endocrinology and Metabolism 2012;302:E576-84. [DOI: 10.1152/ajpendo.00222.2011] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
154 Parry SA, Hodson L. Influence of dietary macronutrients on liver fat accumulation and metabolism. J Investig Med 2017;65:1102-15. [PMID: 28947639 DOI: 10.1136/jim-2017-000524] [Cited by in Crossref: 55] [Cited by in F6Publishing: 45] [Article Influence: 13.8] [Reference Citation Analysis]
155 Gauthier MS, Couturier K, Latour JG, Lavoie JM. Concurrent exercise prevents high-fat-diet-induced macrovesicular hepatic steatosis. J Appl Physiol (1985). 2003;94:2127-2134. [PMID: 12547845 DOI: 10.1152/japplphysiol.01164.2002] [Cited by in Crossref: 115] [Cited by in F6Publishing: 103] [Article Influence: 6.4] [Reference Citation Analysis]
156 Tarcin O, Bajaj M, Akalin S. Insulin Resistance, Adipocyte Biology, and Thiazolidinediones: A Review. Metabolic Syndrome and Related Disorders 2007;5:103-15. [DOI: 10.1089/met.2007.0001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
157 Juurinen L, Kotronen A, Granér M, Yki-Järvinen H. Rosiglitazone reduces liver fat and insulin requirements and improves hepatic insulin sensitivity and glycemic control in patients with type 2 diabetes requiring high insulin doses. J Clin Endocrinol Metab 2008;93:118-24. [PMID: 17956948 DOI: 10.1210/jc.2007-1825] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 2.9] [Reference Citation Analysis]
158 Buettner R, Ottinger I, Schölmerich J, Bollheimer LC. Preserved direct hepatic insulin action in rats with diet-induced hepatic steatosis. Am J Physiol Endocrinol Metab 2004;286:E828-33. [PMID: 14722026 DOI: 10.1152/ajpendo.00453.2003] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 1.9] [Reference Citation Analysis]
159 Almeda-valdés P, Cuevas-ramos D, Alberto Aguilar-salinas C. Metabolic syndrome and non-alcoholic fatty liver disease. Annals of Hepatology 2009;8:S18-24. [DOI: 10.1016/s1665-2681(19)31822-8] [Cited by in Crossref: 99] [Article Influence: 8.3] [Reference Citation Analysis]
160 Wang XC, Zhan XR, Li XY, Yu JJ, Liu XM. Identification and validation co-differentially expressed genes with NAFLD and insulin resistance. Endocrine 2015;48:143-51. [PMID: 24699882 DOI: 10.1007/s12020-014-0247-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
161 Stanhope KL, Schwarz JM, Keim NL, Griffen SC, Bremer AA, Graham JL, Hatcher B, Cox CL, Dyachenko A, Zhang W. Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J Clin Invest. 2009;119:1322-1334. [PMID: 19381015 DOI: 10.1172/jci37385] [Cited by in Crossref: 1060] [Cited by in F6Publishing: 492] [Article Influence: 88.3] [Reference Citation Analysis]
162 Nwadozi E, Rudnicki M, De Ciantis M, Milkovich S, Pulbere A, Roudier E, Birot O, Gustafsson T, Ellis CG, Haas TL. High-fat diet pre-conditioning improves microvascular remodelling during regeneration of ischaemic mouse skeletal muscle. Acta Physiol (Oxf) 2020;229:e13449. [PMID: 32012450 DOI: 10.1111/apha.13449] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
163 Hossain IA, Akter S, Rahman MK, Ali L. Gender Specific Association of Serum Leptin and Insulinemic Indices with Nonalcoholic Fatty Liver Disease in Prediabetic Subjects. PLoS One. 2015;10:e0142165. [PMID: 26569494 DOI: 10.1371/journal.pone.0142165] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
164 Barchetta I, Angelico F, Del Ben M, Di Martino M, Cimini FA, Bertoccini L, Polimeni L, Catalano C, Fraioli A, Del Vescovo R, Morini S, Baroni MG, Cavallo MG. Phenotypical heterogeneity linked to adipose tissue dysfunction in patients with Type 2 diabetes. Clin Sci (Lond) 2016;130:1753-62. [PMID: 27458255 DOI: 10.1042/CS20160348] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
165 Coats V, Després JP, Alméras N, Martin M, Sin DD, Rabasa-Lhoret R, Larose É, Tan WC, Bourbeau J, Maltais F; CanCOLD Collaborative Research Group and the Canadian Respiratory Research Network. Ectopic adiposity and cardiometabolic health in COPD. Int J Chron Obstruct Pulmon Dis 2018;13:3331-40. [PMID: 30410322 DOI: 10.2147/COPD.S168963] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 2.7] [Reference Citation Analysis]
166 Rodríguez A, Ezquerro S, Méndez-Giménez L, Becerril S, Frühbeck G. Revisiting the adipocyte: a model for integration of cytokine signaling in the regulation of energy metabolism. Am J Physiol Endocrinol Metab 2015;309:E691-714. [PMID: 26330344 DOI: 10.1152/ajpendo.00297.2015] [Cited by in Crossref: 137] [Cited by in F6Publishing: 115] [Article Influence: 22.8] [Reference Citation Analysis]
167 Lee H, Park M, Lee KI, An Y, Kim JM, Park JY, Han Y, Hong S, Choi S, Yoo YH, Suh JD, Kim DK. Prevention of Diabetes by Fenofibrate in OLETF Rats: Hepatic Mechanism for Reducing Visceral Adiposity. J Korean Diabetes Assoc 2007;31:63. [DOI: 10.4093/jkda.2007.31.1.63] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
168 Stenholm S, Koster A, Alley DE, Visser M, Maggio M, Harris TB, Egan JM, Bandinelli S, Guralnik JM, Ferrucci L. Adipocytokines and the metabolic syndrome among older persons with and without obesity: the InCHIANTI study. Clin Endocrinol (Oxf) 2010;73:55-65. [PMID: 19878507 DOI: 10.1111/j.1365-2265.2009.03742.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 25] [Article Influence: 1.1] [Reference Citation Analysis]
169 Yki-Järvinen H. Nutritional Modulation of Non-Alcoholic Fatty Liver Disease and Insulin Resistance. Nutrients 2015;7:9127-38. [PMID: 26556368 DOI: 10.3390/nu7115454] [Cited by in Crossref: 85] [Cited by in F6Publishing: 70] [Article Influence: 14.2] [Reference Citation Analysis]
170 Tarantino G, Savastano S, Colao A. Hepatic steatosis, low-grade chronic inflammation and hormone/growth factor/adipokine imbalance. World J Gastroenterol. 2010;16:4773-4783. [PMID: 20939105 DOI: 10.3748/wjg.v16.i38.4773] [Cited by in CrossRef: 111] [Cited by in F6Publishing: 108] [Article Influence: 11.1] [Reference Citation Analysis]
171 Chen SC, Tsai SP, Jhao JY, Jiang WK, Tsao CK, Chang LY. Liver Fat, Hepatic Enzymes, Alkaline Phosphatase and the Risk of Incident Type 2 Diabetes: A Prospective Study of 132,377 Adults. Sci Rep 2017;7:4649. [PMID: 28680048 DOI: 10.1038/s41598-017-04631-7] [Cited by in Crossref: 46] [Cited by in F6Publishing: 31] [Article Influence: 11.5] [Reference Citation Analysis]
172 Hogan MF, Ravnskjaer K, Matsumura S, Huising MO, Hull RL, Kahn SE, Montminy M. Hepatic Insulin Resistance Following Chronic Activation of the CREB Coactivator CRTC2. J Biol Chem 2015;290:25997-6006. [PMID: 26342077 DOI: 10.1074/jbc.M115.679266] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
173 Taskinen MR. Diabetic dyslipidaemia: from basic research to clinical practice. Diabetologia. 2003;46:733-749. [PMID: 12774165 DOI: 10.1007/s00125-003-1111-y] [Cited by in Crossref: 530] [Cited by in F6Publishing: 436] [Article Influence: 29.4] [Reference Citation Analysis]
174 Perseghin G, Caumo A, Lattuada G, De Cobelli F, Ntali G, Esposito A, Belloni E, Canu T, Ragogna F, Scifo P, Del Maschio A, Luzi L. Elevated fasting plasma C-peptide occurs in non-diabetic individuals with fatty liver, irrespective of insulin resistance. Diabetic Medicine 2009;26:847-54. [DOI: 10.1111/j.1464-5491.2009.02785.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
175 Varda NM, Gregoric A. Metabolic syndrome in the pediatric population: a short overview. Pediatr Rep 2009;1:e1. [PMID: 21589817 DOI: 10.4081/pr.2009.e1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
176 Motiani KK, Savolainen AM, Toivanen J, Eskelinen JJ, Yli-Karjanmaa M, Virtanen KA, Saunavaara V, Heiskanen MA, Parkkola R, Haaparanta-Solin M, Solin O, Savisto N, Löyttyniemi E, Knuuti J, Nuutila P, Kalliokoski KK, Hannukainen JC. Effects of short-term sprint interval and moderate-intensity continuous training on liver fat content, lipoprotein profile, and substrate uptake: a randomized trial. J Appl Physiol (1985) 2019;126:1756-68. [PMID: 30998125 DOI: 10.1152/japplphysiol.00900.2018] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
177 Fabbrini E, Mohammed BS, Magkos F, Korenblat KM, Patterson BW, Klein S. Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease. Gastroenterology. 2008;134:424-431. [PMID: 18242210 DOI: 0.1053/j.gastro.2007.11.038] [Reference Citation Analysis]
178 Ruiz R, Jideonwo V, Ahn M, Surendran S, Tagliabracci VS, Hou Y, Gamble A, Kerner J, Irimia-Dominguez JM, Puchowicz MA, DePaoli-Roach A, Hoppel C, Roach P, Morral N. Sterol regulatory element-binding protein-1 (SREBP-1) is required to regulate glycogen synthesis and gluconeogenic gene expression in mouse liver. J Biol Chem 2014;289:5510-7. [PMID: 24398675 DOI: 10.1074/jbc.M113.541110] [Cited by in Crossref: 61] [Cited by in F6Publishing: 35] [Article Influence: 8.7] [Reference Citation Analysis]
179 Fakhoury-sayegh N, Trak-smayra V, Sayegh R, Haidar F, Obeid O, Asmar S, Khazzaka A. Fructose threshold for inducing organ damage in a rat model of nonalcoholic fatty liver disease. Nutrition Research 2019;62:101-12. [DOI: 10.1016/j.nutres.2018.11.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
180 Bae JC, Kim SK, Han JM, Kwon S, Lee DY, Kim J, Park SE, Park C, Lee W, Oh K, Park S, Rhee EJ. Additive effect of non-alcoholic fatty liver disease on the development of diabetes in individuals with metabolic syndrome. Diabetes Research and Clinical Practice 2017;129:136-43. [DOI: 10.1016/j.diabres.2017.03.037] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
181 Soares AF, Duarte JMN, Gruetter R. Increased hepatic fatty acid polyunsaturation precedes ectopic lipid deposition in the liver in adaptation to high-fat diets in mice. MAGMA 2018;31:341-54. [PMID: 29027041 DOI: 10.1007/s10334-017-0654-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
182 Devries MC, Samjoo IA, Hamadeh MJ, Tarnopolsky MA. Effect of Endurance Exercise on Hepatic Lipid Content, Enzymes, and Adiposity in Men and Women. Obesity 2008;16:2281-8. [DOI: 10.1038/oby.2008.358] [Cited by in Crossref: 65] [Cited by in F6Publishing: 48] [Article Influence: 7.2] [Reference Citation Analysis]
183 Lallukka S, Sädevirta S, Kallio MT, Luukkonen PK, Zhou Y, Hakkarainen A, Lundbom N, Orho-Melander M, Yki-Järvinen H. Predictors of Liver Fat and Stiffness in Non-Alcoholic Fatty Liver Disease (NAFLD) - an 11-Year Prospective Study. Sci Rep 2017;7:14561. [PMID: 29109528 DOI: 10.1038/s41598-017-14706-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
184 Matsubara F, Nagai Y, Tsukiyama H, Shimizu H, Yamanouchi E, Iwamoto T, Sada Y, Kato H, Ohta A, Tanaka Y. Proposed cut-off value of the intrahepatic lipid content for metabolically normal persons assessed by proton magnetic resonance spectroscopy in a Japanese population. Diabetes Research and Clinical Practice 2016;119:75-82. [DOI: 10.1016/j.diabres.2016.07.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
185 Morettini M, Di Nardo F, Ingrillini L, Fioretti S, Göbl C, Kautzky-Willer A, Tura A, Pacini G, Burattini L. Glucose effectiveness and its components in relation to body mass index. Eur J Clin Invest 2019;:e13099. [PMID: 30838644 DOI: 10.1111/eci.13099] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
186 Yoo T, Choi W, Hong JH, Lee JY, Kim JM, Shin IS, Yang SJ, Amminger P, Berk M, Yoon JS, Kim SW. Association Between Vitamin D Insufficiency and Metabolic Syndrome in Patients With Psychotic Disorders. Psychiatry Investig 2018;15:396-401. [PMID: 29486549 DOI: 10.30773/pi.2017.08.30] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
187 Koh HJ, Toyoda T, Didesch MM, Lee MY, Sleeman MW, Kulkarni RN, Musi N, Hirshman MF, Goodyear LJ. Tribbles 3 mediates endoplasmic reticulum stress-induced insulin resistance in skeletal muscle. Nat Commun 2013;4:1871. [PMID: 23695665 DOI: 10.1038/ncomms2851] [Cited by in Crossref: 66] [Cited by in F6Publishing: 57] [Article Influence: 8.3] [Reference Citation Analysis]
188 Chon CW, Kim BS, Cho YK, Sung KC, Bae JC, Kim TW, Won HS, Joo KJ. Effect of nonalcoholic Fatty liver disease on the development of type 2 diabetes in nonobese, nondiabetic korean men. Gut Liver. 2012;6:368-373. [PMID: 22844567 DOI: 10.5009/gnl.2012.6.3.368] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
189 Lettner A, Roden M. Ectopic fat and insulin resistance. Curr Diab Rep 2008;8:185-91. [PMID: 18625114 DOI: 10.1007/s11892-008-0032-z] [Cited by in Crossref: 63] [Cited by in F6Publishing: 50] [Article Influence: 4.8] [Reference Citation Analysis]
190 Sliz E, Sebert S, Würtz P, Kangas AJ, Soininen P, Lehtimäki T, Kähönen M, Viikari J, Männikkö M, Ala-Korpela M, Raitakari OT, Kettunen J. NAFLD risk alleles in PNPLA3, TM6SF2, GCKR and LYPLAL1 show divergent metabolic effects. Hum Mol Genet 2018;27:2214-23. [PMID: 29648650 DOI: 10.1093/hmg/ddy124] [Cited by in Crossref: 52] [Cited by in F6Publishing: 48] [Article Influence: 26.0] [Reference Citation Analysis]
191 Foroughi M, Maghsoudi Z, Askari G. The effect of vitamin D supplementation on blood sugar and different indices of insulin resistance in patients with non-alcoholic fatty liver disease (NAFLD). Iran J Nurs Midwifery Res 2016;21:100-4. [PMID: 26985230 DOI: 10.4103/1735-9066.174759] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
192 Ma X, Lee P, Chisholm DJ, James DE. Control of adipocyte differentiation in different fat depots; implications for pathophysiology or therapy. Front Endocrinol (Lausanne) 2015;6:1. [PMID: 25688231 DOI: 10.3389/fendo.2015.00001] [Cited by in Crossref: 46] [Cited by in F6Publishing: 49] [Article Influence: 7.7] [Reference Citation Analysis]
193 Juurinen L, Tiikkainen M, Häkkinen AM, Hakkarainen A, Yki-Järvinen H. Effects of insulin therapy on liver fat content and hepatic insulin sensitivity in patients with type 2 diabetes. Am J Physiol Endocrinol Metab. 2007;292:E829-E835. [PMID: 17090752 DOI: 10.1152/ajpendo.00133.2006] [Cited by in Crossref: 84] [Cited by in F6Publishing: 75] [Article Influence: 5.6] [Reference Citation Analysis]
194 Yki-Järvinen H, Kauppinen-Mäkelin R, Tiikkainen M, Vähätalo M, Virtamo H, Nikkilä K, Tulokas T, Hulme S, Hardy K, McNulty S. Insulin glargine or NPH combined with metformin in type 2 diabetes: the LANMET study. Diabetologia. 2006;49:442-451. [PMID: 16456680 DOI: 10.1007/s00125-005-0132-0] [Cited by in Crossref: 321] [Cited by in F6Publishing: 215] [Article Influence: 21.4] [Reference Citation Analysis]
195 Yki-järvinen H, Sutinen J, Silveira A, Korsheninnikova E, Fisher RM, Kannisto K, Ehrenborg E, Eriksson P, Hamsten A. Regulation of Plasma PAI-1 Concentrations in HAART-Associated Lipodystrophy During Rosiglitazone Therapy. ATVB 2003;23:688-94. [DOI: 10.1161/01.atv.0000062885.61917.a5] [Cited by in Crossref: 49] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
196 Fabbrini E, Sullivan S, Klein S. Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology. 2010;51:679-689. [PMID: 20041406 DOI: 10.1002/hep.23280] [Cited by in Crossref: 1076] [Cited by in F6Publishing: 947] [Article Influence: 97.8] [Reference Citation Analysis]
197 Rasul S, Wagner L, Kautzky-Willer A. Fetuin-A and angiopoietins in obesity and type 2 diabetes mellitus. Endocrine 2012;42:496-505. [PMID: 22820893 DOI: 10.1007/s12020-012-9754-4] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
198 Conti R, Mannucci E, Pessotto P, Tassoni E, Carminati P, Giannessi F, Arduini A. Selective reversible inhibition of liver carnitine palmitoyl-transferase 1 by teglicar reduces gluconeogenesis and improves glucose homeostasis. Diabetes 2011;60:644-51. [PMID: 21270274 DOI: 10.2337/db10-0346] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 3.8] [Reference Citation Analysis]
199 Fraser A, Ebrahim S, Smith GD, Lawlor DA. A comparison of associations of alanine aminotransferase and gamma-glutamyltransferase with fasting glucose, fasting insulin, and glycated hemoglobin in women with and without diabetes. Hepatology 2007;46:158-65. [PMID: 17596883 DOI: 10.1002/hep.21667] [Cited by in Crossref: 55] [Cited by in F6Publishing: 45] [Article Influence: 3.9] [Reference Citation Analysis]
200 Logie L, Ruiz-Alcaraz AJ, Schofield CJ, Hundal HS, Feuerstein GZ, Brady JD, Crowther D, Tommasi AM, Grierson CE, Shepherd B, Morris AD, Hansen MK, Pearson E, Sutherland C. Generation, validation and humanisation of a novel insulin resistant cell model. Biochem Pharmacol 2010;80:1042-9. [PMID: 20599791 DOI: 10.1016/j.bcp.2010.06.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
201 Goran MI, Lane C, Toledo-Corral C, Weigensberg MJ. Persistence of pre-diabetes in overweight and obese Hispanic children: association with progressive insulin resistance, poor beta-cell function, and increasing visceral fat. Diabetes 2008;57:3007-12. [PMID: 18678615 DOI: 10.2337/db08-0445] [Cited by in Crossref: 55] [Cited by in F6Publishing: 51] [Article Influence: 4.2] [Reference Citation Analysis]
202 Mehta SR, Godsland IF, Thomas EL, Pavitt DV, Morin SX, Bell JD, Taylor-robinson SD, Johnston DG. Intrahepatic Insulin Exposure, Intrahepatocellular Lipid and Regional Body Fat in Nonalcoholic Fatty Liver Disease. The Journal of Clinical Endocrinology & Metabolism 2012;97:2151-9. [DOI: 10.1210/jc.2011-2430] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
203 Højland Ipsen D, Tveden-Nyborg P, Lykkesfeldt J. Normal weight dyslipidemia: Is it all about the liver? Obesity (Silver Spring) 2016;24:556-67. [PMID: 26868960 DOI: 10.1002/oby.21443] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 4.8] [Reference Citation Analysis]
204 Sevastianova K, Sutinen J, Kannisto K, Hamsten A, Ristola M, Yki-Järvinen H. Adipose tissue inflammation and liver fat in patients with highly active antiretroviral therapy-associated lipodystrophy. Am J Physiol Endocrinol Metab 2008;295:E85-91. [PMID: 18430964 DOI: 10.1152/ajpendo.90224.2008] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 2.9] [Reference Citation Analysis]
205 Lindeboom L, de Graaf RA. Measurement of lipid composition in human skeletal muscle and adipose tissue with 1 H-MRS homonuclear spectral editing: Noninvasive Characterization of Ectopic Fat Stores With 1 H-MRS. Magn Reson Med 2018;79:619-27. [DOI: 10.1002/mrm.26740] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
206 Wolf D, Jehle F, Ortiz Rodriguez A, Dufner B, Hoppe N, Colberg C, Lozhkin A, Bassler N, Rupprecht B, Wiedemann A, Hilgendorf I, Stachon P, Willecke F, Febbraio M, von zur Muhlen C, Binder CJ, Bode C, Zirlik A, Peter K. CD40L deficiency attenuates diet-induced adipose tissue inflammation by impairing immune cell accumulation and production of pathogenic IgG-antibodies. PLoS One 2012;7:e33026. [PMID: 22412980 DOI: 10.1371/journal.pone.0033026] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 3.1] [Reference Citation Analysis]
207 Ma L, Mondal AK, Murea M, Sharma NK, Tönjes A, Langberg KA, Das SK, Franks PW, Kovacs P, Antinozzi PA, Stumvoll M, Parks JS, Elbein SC, Freedman BI. The effect of ACACB cis-variants on gene expression and metabolic traits. PLoS One 2011;6:e23860. [PMID: 21887335 DOI: 10.1371/journal.pone.0023860] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
208 Mattiasson G, Sullivan PG. The emerging functions of UCP2 in health, disease, and therapeutics. Antioxid Redox Signal. 2006;8:1-38. [PMID: 16487034 DOI: 10.1089/ars.2006.8.1] [Cited by in Crossref: 115] [Cited by in F6Publishing: 115] [Article Influence: 7.7] [Reference Citation Analysis]
209 Ravikumar B, Gerrard J, Dalla Man C, Firbank MJ, Lane A, English PT, Cobelli C, Taylor R. Pioglitazone decreases fasting and postprandial endogenous glucose production in proportion to decrease in hepatic triglyceride content. Diabetes 2008;57:2288-95. [PMID: 18535187 DOI: 10.2337/db07-1828] [Cited by in Crossref: 49] [Cited by in F6Publishing: 40] [Article Influence: 3.8] [Reference Citation Analysis]
210 Bulum T, Kolarić B, Duvnjak L, Duvnjak M. Nonalcoholic fatty liver disease markers are associated with insulin resistance in type 1 diabetes. Dig Dis Sci 2011;56:3655-63. [PMID: 21735081 DOI: 10.1007/s10620-011-1807-7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
211 Kulozik P, Jones A, Mattijssen F, Rose AJ, Reimann A, Strzoda D, Kleinsorg S, Raupp C, Kleinschmidt J, Müller-Decker K, Wahli W, Sticht C, Gretz N, von Loeffelholz C, Stockmann M, Pfeiffer A, Stöhr S, Dallinga-Thie GM, Nawroth PP, Diaz MB, Herzig S. Hepatic deficiency in transcriptional cofactor TBL1 promotes liver steatosis and hypertriglyceridemia. Cell Metab 2011;13:389-400. [PMID: 21459324 DOI: 10.1016/j.cmet.2011.02.011] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 3.1] [Reference Citation Analysis]
212 Tanoli T, Yue P, Yablonskiy D, Schonfeld G. Fatty liver in familial hypobetalipoproteinemia: roles of the APOB defects, intra-abdominal adipose tissue, and insulin sensitivity. J Lipid Res. 2004;45:941-947. [PMID: 14967820 DOI: 10.1194/jlr.m300508-jlr200] [Cited by in Crossref: 97] [Cited by in F6Publishing: 36] [Article Influence: 5.7] [Reference Citation Analysis]
213 Lee SY, Lee HY, Song JH, Kim GT, Jeon S, Song YJ, Lee JS, Hur JH, Oh HH, Park SY, Shim SM, Yoo HJ, Lee BC, Jiang XC, Choi CS, Park TS. Adipocyte-Specific Deficiency of De Novo Sphingolipid Biosynthesis Leads to Lipodystrophy and Insulin Resistance. Diabetes 2017;66:2596-609. [PMID: 28698261 DOI: 10.2337/db16-1232] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 8.0] [Reference Citation Analysis]
214 Stanhope KL, Havel PJ. Fructose consumption: potential mechanisms for its effects to increase visceral adiposity and induce dyslipidemia and insulin resistance. Curr Opin Lipidol 2008;19:16-24. [PMID: 18196982 DOI: 10.1097/MOL.0b013e3282f2b24a] [Cited by in Crossref: 169] [Cited by in F6Publishing: 77] [Article Influence: 13.0] [Reference Citation Analysis]
215 Mori T, Kondo H, Hase T, Murase T. Dietary phospholipids ameliorate fructose-induced hepatic lipid and metabolic abnormalities in rats. J Nutr. 2011;141:2003-2009. [PMID: 21940513 DOI: 10.3945/jn.111.143602] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
216 Pezeshki A, Safi S, Feizi A, Askari G, Karami F. The Effect of Green Tea Extract Supplementation on Liver Enzymes in Patients with Nonalcoholic Fatty Liver Disease. Int J Prev Med 2016;7:28. [PMID: 26955458 DOI: 10.4103/2008-7802.173051] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 7.6] [Reference Citation Analysis]
217 Partridge CG, Fawcett GL, Wang B, Semenkovich CF, Cheverud JM. The effect of dietary fat intake on hepatic gene expression in LG/J AND SM/J mice. BMC Genomics 2014;15:99. [PMID: 24499025 DOI: 10.1186/1471-2164-15-99] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 3.1] [Reference Citation Analysis]
218 Ma S, Li T, Guo K, Li X, An S, Hou S, Chen R, Yang B, Liu S, Fu J. Effective treatment with combination of peripheral 5-hydroxytryptamine synthetic inhibitor and 5-hydroxytryptamine 2 receptor antagonist on glucocorticoid-induced whole-body insulin resistance with hyperglycemia. J Diabetes Investig 2016;7:833-44. [PMID: 27177506 DOI: 10.1111/jdi.12526] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
219 Sierra-Johnson J, Johnson BD, Bailey KR, Turner ST. Relationships between insulin sensitivity and measures of body fat in asymptomatic men and women. Obes Res 2004;12:2070-7. [PMID: 15687409 DOI: 10.1038/oby.2004.258] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 1.8] [Reference Citation Analysis]
220 Immonen H, Hannukainen JC, Iozzo P, Soinio M, Salminen P, Saunavaara V, Borra R, Parkkola R, Mari A, Lehtimäki T, Pham T, Laine J, Kärjä V, Pihlajamäki J, Nelimarkka L, Nuutila P. Effect of bariatric surgery on liver glucose metabolism in morbidly obese diabetic and non-diabetic patients. J Hepatol 2014;60:377-83. [PMID: 24060855 DOI: 10.1016/j.jhep.2013.09.012] [Cited by in Crossref: 63] [Cited by in F6Publishing: 50] [Article Influence: 7.9] [Reference Citation Analysis]
221 Ha E, Kim MJ, Choi BK, Rho JJ, Oh DJ, Rho TH, Kim KH, Lee HJ, Shin DH, Yim SV, Baik HH, Chung JH, Kim JW. Positive association of obesity with single nucleotide polymorphisms of syndecan 3 in the Korean population. J Clin Endocrinol Metab 2006;91:5095-9. [PMID: 17018662 DOI: 10.1210/jc.2005-2086] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
222 Carter S, Li Z, Lemieux I, Alméras N, Tremblay A, Bergeron J, Poirier P, Deshaies Y, Després JP, Picard F. Circulating IGFBP-2 levels are incrementally linked to correlates of the metabolic syndrome and independently associated with VLDL triglycerides. Atherosclerosis 2014;237:645-51. [PMID: 25463100 DOI: 10.1016/j.atherosclerosis.2014.09.022] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 3.4] [Reference Citation Analysis]
223 Sutinen J, Kannisto K, Korsheninnikova E, Fisher RM, Ehrenborg E, Nyman T, Virkamäki A, Funahashi T, Matsuzawa Y, Vidal H, Hamsten A, Yki-järvinen H. Effects of rosiglitazone on gene expression in subcutaneous adipose tissue in highly active antiretroviral therapy-associated lipodystrophy. American Journal of Physiology-Endocrinology and Metabolism 2004;286:E941-9. [DOI: 10.1152/ajpendo.00490.2003] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 2.3] [Reference Citation Analysis]
224 Adiels M, Taskinen M, Packard C, Caslake MJ, Soro-paavonen A, Westerbacka J, Vehkavaara S, Häkkinen A, Olofsson S, Yki-järvinen H, Borén J. Overproduction of large VLDL particles is driven by increased liver fat content in man. Diabetologia 2006;49:755-65. [DOI: 10.1007/s00125-005-0125-z] [Cited by in Crossref: 421] [Cited by in F6Publishing: 370] [Article Influence: 28.1] [Reference Citation Analysis]
225 de Larrañaga G, Wingeyer SP, Graffigna M, Belli S, Bendezú K, Alvarez S, Levalle O, Fainboim H. Plasma Plasminogen Activator Inhibitor-1 Levels and Nonalcoholic Fatty Liver in Individuals With Features of Metabolic Syndrome. Clin Appl Thromb Hemost 2008;14:319-24. [DOI: 10.1177/1076029607304094] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
226 Perseghin G, Lattuada G, De Cobelli F, Esposito A, Costantino F, Canu T, Scifo P, De Taddeo F, Maffi P, Secchi A, Del Maschio A, Luzi L. Reduced intrahepatic fat content is associated with increased whole-body lipid oxidation in patients with type 1 diabetes. Diabetologia 2005;48:2615-21. [PMID: 16261312 DOI: 10.1007/s00125-005-0014-5] [Cited by in Crossref: 51] [Cited by in F6Publishing: 43] [Article Influence: 3.2] [Reference Citation Analysis]
227 Kahleova H, Belinova L, Malinska H, Oliyarnyk O, Trnovska J, Skop V, Kazdova L, Dezortova M, Hajek M, Tura A. Eating two larger meals a day (breakfast and lunch) is more effective than six smaller meals in a reduced-energy regimen for patients with type 2 diabetes: a randomised crossover study. Diabetologia. 2014;57:1552-1560. [PMID: 24838678 DOI: 10.1007/s00125-014-3253-5] [Cited by in Crossref: 76] [Cited by in F6Publishing: 53] [Article Influence: 10.9] [Reference Citation Analysis]
228 Kirchhoff K, Kantartzis K, Machann J, Schick F, Thamer C, Machicao F, Fritsche A, Häring HU, Stefan N. Impact of different fat depots on insulin sensitivity: predominant role of liver fat. J Diabetes Sci Technol 2007;1:753-9. [PMID: 19885144 DOI: 10.1177/193229680700100521] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
229 Harwood HJ Jr. Treating the metabolic syndrome: acetyl-CoA carboxylase inhibition. Expert Opin Ther Targets 2005;9:267-81. [PMID: 15934915 DOI: 10.1517/14728222.9.2.267] [Cited by in Crossref: 85] [Cited by in F6Publishing: 77] [Article Influence: 5.7] [Reference Citation Analysis]
230 Shi SY, Martin RG, Duncan RE, Choi D, Lu SY, Schroer SA, Cai EP, Luk CT, Hopperton KE, Domenichiello AF, Tang C, Naples M, Dekker MJ, Giacca A, Adeli K, Wagner KU, Bazinet RP, Woo M. Hepatocyte-specific deletion of Janus kinase 2 (JAK2) protects against diet-induced steatohepatitis and glucose intolerance. J Biol Chem 2012;287:10277-88. [PMID: 22275361 DOI: 10.1074/jbc.M111.317453] [Cited by in Crossref: 47] [Cited by in F6Publishing: 27] [Article Influence: 5.2] [Reference Citation Analysis]
231 Dallak MA. Acylated ghrelin induces but deacylated ghrelin prevents hepatic steatosis and insulin resistance in lean rats: Effects on DAG/ PKC/JNK pathway. Biomed Pharmacother 2018;105:299-311. [PMID: 29860222 DOI: 10.1016/j.biopha.2018.05.098] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 3.7] [Reference Citation Analysis]
232 Lytle KA, Bush NC, Triay JM, Kellogg TA, Kendrick ML, Swain JM, Gathaiya NW, Hames KC, Jensen MD. Hepatic Fatty Acid Balance and Hepatic Fat Content in Humans With Severe Obesity. J Clin Endocrinol Metab 2019;104:6171-81. [PMID: 31408176 DOI: 10.1210/jc.2019-00875] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
233 Laaksonen DE, Niskanen L, Nyyssönen K, Punnonen K, Tuomainen TP, Valkonen VP, Salonen R, Salonen JT. C-reactive protein and the development of the metabolic syndrome and diabetes in middle-aged men. Diabetologia. 2004;47:1403-1410. [PMID: 15309290 DOI: 10.1007/s00125-004-1472-x] [Cited by in Crossref: 173] [Cited by in F6Publishing: 155] [Article Influence: 10.2] [Reference Citation Analysis]
234 Srinivasan SR, Wang R, Chen W, Wei CY, Xu J, Berenson GS. Utility of waist-to-height ratio in detecting central obesity and related adverse cardiovascular risk profile among normal weight younger adults (from the Bogalusa Heart Study). Am J Cardiol 2009;104:721-4. [PMID: 19699351 DOI: 10.1016/j.amjcard.2009.04.037] [Cited by in Crossref: 61] [Cited by in F6Publishing: 47] [Article Influence: 5.1] [Reference Citation Analysis]
235 Befroy DE, Falk Petersen K, Rothman DL, Shulman GI. Assessment of in vivo mitochondrial metabolism by magnetic resonance spectroscopy. Methods Enzymol 2009;457:373-93. [PMID: 19426879 DOI: 10.1016/S0076-6879(09)05021-6] [Cited by in Crossref: 30] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
236 Sun W, Bi Y, Liang H, Cai M, Chen X, Zhu Y, Li M, Xu F, Yu Q, He X, Ye J, Weng J. Inhibition of obesity-induced hepatic ER stress by early insulin therapy in obese diabetic rats. Endocrine 2011;39:235-41. [PMID: 21088934 DOI: 10.1007/s12020-010-9429-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
237 Pais R, Giral P, Khan JF, Rosenbaum D, Housset C, Poynard T, Ratziu V; LIDO Study Group. Fatty liver is an independent predictor of early carotid atherosclerosis. J Hepatol. 2016;65:95-102. [PMID: 27129836 DOI: 10.1016/j.jhep.2016.02.023] [Cited by in Crossref: 56] [Cited by in F6Publishing: 42] [Article Influence: 11.2] [Reference Citation Analysis]
238 Hill MJ, Metcalfe D, McTernan PG. Obesity and diabetes: lipids, ‘nowhere to run to’. Clin Sci (Lond). 2009;116:113-123. [PMID: 19076064 DOI: 10.1042/cs20080050] [Cited by in Crossref: 47] [Cited by in F6Publishing: 16] [Article Influence: 3.9] [Reference Citation Analysis]
239 Misra A, Khurana L. The Metabolic Syndrome in South Asians: Epidemiology, Determinants, and Prevention. Metabolic Syndrome and Related Disorders 2009;7:497-514. [DOI: 10.1089/met.2009.0024] [Cited by in Crossref: 184] [Cited by in F6Publishing: 157] [Article Influence: 15.3] [Reference Citation Analysis]
240 Ameer F, Scandiuzzi L, Hasnain S, Kalbacher H, Zaidi N. De novo lipogenesis in health and disease. Metabolism 2014;63:895-902. [PMID: 24814684 DOI: 10.1016/j.metabol.2014.04.003] [Cited by in Crossref: 201] [Cited by in F6Publishing: 173] [Article Influence: 28.7] [Reference Citation Analysis]
241 Bradley D, Magkos F, Klein S. Effects of bariatric surgery on glucose homeostasis and type 2 diabetes. Gastroenterology. 2012;143:897-912. [PMID: 22885332 DOI: 10.1053/j.gastro.2012.07.114] [Cited by in Crossref: 98] [Cited by in F6Publishing: 77] [Article Influence: 10.9] [Reference Citation Analysis]
242 Stumvoll M. Thiazolidinediones -- some recent developments. Expert Opin Investig Drugs 2003;12:1179-87. [PMID: 12831352 DOI: 10.1517/13543784.12.7.1179] [Cited by in Crossref: 53] [Cited by in F6Publishing: 41] [Article Influence: 2.9] [Reference Citation Analysis]
243 London A, Lundsgaard AM, Kiens B, Bojsen-Møller KN. The Role of Hepatic Fat Accumulation in Glucose and Insulin Homeostasis-Dysregulation by the Liver. J Clin Med 2021;10:390. [PMID: 33498493 DOI: 10.3390/jcm10030390] [Reference Citation Analysis]
244 DiNicolantonio JJ, Mehta V, Onkaramurthy N, O'Keefe JH. Fructose-induced inflammation and increased cortisol: A new mechanism for how sugar induces visceral adiposity. Prog Cardiovasc Dis 2018;61:3-9. [PMID: 29225114 DOI: 10.1016/j.pcad.2017.12.001] [Cited by in Crossref: 28] [Cited by in F6Publishing: 19] [Article Influence: 7.0] [Reference Citation Analysis]
245 Ferolla SM, Armiliato GN, Couto CA, Ferrari TC. Probiotics as a complementary therapeutic approach in nonalcoholic fatty liver disease. World J Hepatol. 2015;7:559-565. [PMID: 25848479 DOI: 10.4254/wjh.v7.i3.559] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 4.5] [Reference Citation Analysis]
246 Zhang H, Yang H, Lai C, Xu X, Huang K, Fu J. Quantitative relationship between liver fat content and metabolic syndrome in obese children and adolescents. Clin Endocrinol (Oxf) 2015;83:43-9. [PMID: 25711346 DOI: 10.1111/cen.12758] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
247 Ryoo JH, Oh CM, Kim HS, Park SK, Choi JM. Clinical association between serum γ-glutamyltransferase levels and the development of insulin resistance in Korean men: a 5-year follow-up study. Diabet Med 2014;31:455-61. [PMID: 24102943 DOI: 10.1111/dme.12315] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
248 Bugianesi E, Gastaldelli A, Vanni E, Gambino R, Cassader M, Baldi S, Ponti V, Pagano G, Ferrannini E, Rizzetto M. Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms. Diabetologia 2005;48:634-42. [PMID: 15747110 DOI: 10.1007/s00125-005-1682-x] [Cited by in Crossref: 428] [Cited by in F6Publishing: 378] [Article Influence: 26.8] [Reference Citation Analysis]
249 Kotler DP, He Q, Engelson ES, Albu JB, Glesby MJ. The effect of recombinant human growth hormone with or without rosiglitazone on hepatic fat content in HIV-1-infected individuals: a randomized clinical trial. Antivir Ther 2016;21:107-16. [PMID: 25536669 DOI: 10.3851/IMP2927] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
250 Wang DQ, Portincasa P, Neuschwander-Tetri BA. Steatosis in the liver. Compr Physiol 2013;3:1493-532. [PMID: 24265237 DOI: 10.1002/cphy.c130001] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
251 Orešič M, Hyötyläinen T, Kotronen A, Gopalacharyulu P, Nygren H, Arola J, Castillo S, Mattila I, Hakkarainen A, Borra RJ, Honka MJ, Verrijken A, Francque S, Iozzo P, Leivonen M, Jaser N, Juuti A, Sørensen TI, Nuutila P, Van Gaal L, Yki-Järvinen H. Prediction of non-alcoholic fatty-liver disease and liver fat content by serum molecular lipids. Diabetologia 2013;56:2266-74. [PMID: 23824212 DOI: 10.1007/s00125-013-2981-2] [Cited by in Crossref: 86] [Cited by in F6Publishing: 74] [Article Influence: 10.8] [Reference Citation Analysis]
252 Li YX, Sang YQ, Sun Y, Liu XK, Geng HF, Zha M, Wang B, Teng F, Sun HJ, Wang Y, Qiu QQ, Zang X, Wang Y, Wu TT, Jones PM, Liang J, Xu W. Pancreatic Fat is not significantly correlated with β-cell Dysfunction in Patients with new-onset Type 2 Diabetes Mellitus using quantitative Computed Tomography. Int J Med Sci 2020;17:1673-82. [PMID: 32714070 DOI: 10.7150/ijms.46395] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
253 Elizondo-Montemayor L, Ugalde-Casas PA, Lam-Franco L, Bustamante-Careaga H, Serrano-González M, Gutiérrez NG, Martínez U. Association of ALT and the metabolic syndrome among Mexican children. Obes Res Clin Pract 2014;8:e79-87. [PMID: 24548580 DOI: 10.1016/j.orcp.2012.08.191] [Cited by in Crossref: 28] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
254 Yoon A, Tammen SA, Park S, Han SN, Choi SW. Genome-wide hepatic DNA methylation changes in high-fat diet-induced obese mice. Nutr Res Pract 2017;11:105-13. [PMID: 28386383 DOI: 10.4162/nrp.2017.11.2.105] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
255 Lowndes J, Sinnett SS, Rippe JM. No Effect of Added Sugar Consumed at Median American Intake Level on Glucose Tolerance or Insulin Resistance. Nutrients 2015;7:8830-45. [PMID: 26512691 DOI: 10.3390/nu7105430] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
256 Milić S, Lulić D, Štimac D. Non-alcoholic fatty liver disease and obesity: biochemical, metabolic and clinical presentations. World J Gastroenterol 2014;20:9330-7. [PMID: 25071327 DOI: 10.3748/wjg.v20.i28.9330] [Cited by in F6Publishing: 106] [Reference Citation Analysis]
257 Berglund ED, Vianna CR, Donato J Jr, Kim MH, Chuang JC, Lee CE, Lauzon DA, Lin P, Brule LJ, Scott MM, Coppari R, Elmquist JK. Direct leptin action on POMC neurons regulates glucose homeostasis and hepatic insulin sensitivity in mice. J Clin Invest 2012;122:1000-9. [PMID: 22326958 DOI: 10.1172/JCI59816] [Cited by in Crossref: 214] [Cited by in F6Publishing: 148] [Article Influence: 23.8] [Reference Citation Analysis]
258 Machann J, Thamer C, Schnoedt B, Stefan N, Haring HU, Claussen CD, Fritsche A, Schick F. Hepatic lipid accumulation in healthy subjects: a comparative study using spectral fat-selective MRI and volume-localized 1H-MR spectroscopy. Magn Reson Med. 2006;55:913-917. [PMID: 16506186 DOI: 10.1002/mrm.20825] [Cited by in Crossref: 119] [Cited by in F6Publishing: 104] [Article Influence: 7.9] [Reference Citation Analysis]
259 Stefanovic-Racic M, Perdomo G, Mantell BS, Sipula IJ, Brown NF, O'Doherty RM. A moderate increase in carnitine palmitoyltransferase 1a activity is sufficient to substantially reduce hepatic triglyceride levels. Am J Physiol Endocrinol Metab 2008;294:E969-77. [PMID: 18349115 DOI: 10.1152/ajpendo.00497.2007] [Cited by in Crossref: 117] [Cited by in F6Publishing: 105] [Article Influence: 9.0] [Reference Citation Analysis]
260 Kim SP, Catalano KJ, Hsu IR, Chiu JD, Richey JM, Bergman RN. Nocturnal free fatty acids are uniquely elevated in the longitudinal development of diet-induced insulin resistance and hyperinsulinemia. Am J Physiol Endocrinol Metab 2007;292:E1590-8. [PMID: 17264230 DOI: 10.1152/ajpendo.00669.2006] [Cited by in Crossref: 65] [Cited by in F6Publishing: 61] [Article Influence: 4.6] [Reference Citation Analysis]
261 Wang M. The role of glucocorticoid action in the pathophysiology of the Metabolic Syndrome. Nutr Metab (Lond). 2005;2:3. [PMID: 15689240 DOI: 10.1186/1743-7075-2-3] [Cited by in Crossref: 175] [Cited by in F6Publishing: 141] [Article Influence: 10.9] [Reference Citation Analysis]
262 Lorenzo C, Hanley AJ, Rewers MJ, Haffner SM. The association of alanine aminotransferase within the normal and mildly elevated range with lipoproteins and apolipoproteins: the Insulin Resistance Atherosclerosis Study. Diabetologia 2013;56:746-57. [PMID: 23344727 DOI: 10.1007/s00125-012-2826-4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
263 Gijbels A, Trouwborst I, Jardon KM, Hul GB, Siebelink E, Bowser SM, Yildiz D, Wanders L, Erdos B, Thijssen DHJ, Feskens EJM, Goossens GH, Afman LA, Blaak EE. The PERSonalized Glucose Optimization Through Nutritional Intervention (PERSON) Study: Rationale, Design and Preliminary Screening Results. Front Nutr 2021;8:694568. [PMID: 34277687 DOI: 10.3389/fnut.2021.694568] [Reference Citation Analysis]
264 Cusi K. The Epidemic of Type 2 Diabetes Mellitus: Its Links to Obesity, Insulin Resistance, and Lipotoxicity. In: Regensteiner JG, Reusch JE, Stewart KJ, Veves A, editors. Diabetes and Exercise. Totowa: Humana Press; 2009. pp. 3-54. [DOI: 10.1007/978-1-59745-260-1_1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
265 Bidar AW, Ploj K, Lelliott C, Nelander K, Winzell MS, Böttcher G, Oscarsson J, Storlien L, Hockings PD. In vivo imaging of lipid storage and regression in diet-induced obesity during nutrition manipulation. Am J Physiol Endocrinol Metab 2012;303:E1287-95. [PMID: 23032688 DOI: 10.1152/ajpendo.00274.2012] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
266 Bennet L, Groop L, Franks PW. Ethnic differences in the contribution of insulin action and secretion to type 2 diabetes in immigrants from the Middle East compared to native Swedes. Diabetes Res Clin Pract 2014;105:79-87. [PMID: 24842242 DOI: 10.1016/j.diabres.2014.04.025] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 2.1] [Reference Citation Analysis]
267 de Carvalho FP, Moretto TL, Benfato ID, Barthichoto M, Ferreira SM, Costa-Júnior JM, de Oliveira CAM. Central and peripheral effects of physical exercise without weight reduction in obese and lean mice. Biosci Rep 2018;38:BSR20171033. [PMID: 29371411 DOI: 10.1042/BSR20171033] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 2.7] [Reference Citation Analysis]
268 Lin X, Chen Z, Yue P, Averna MR, Ostlund RE Jr, Watson MA, Schonfeld G. A targeted apoB38.9 mutation in mice is associated with reduced hepatic cholesterol synthesis and enhanced lipid peroxidation. Am J Physiol Gastrointest Liver Physiol 2006;290:G1170-6. [PMID: 16455790 DOI: 10.1152/ajpgi.00402.2005] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
269 Perseghin G, Bonfanti R, Magni S, Lattuada G, De Cobelli F, Canu T, Esposito A, Scifo P, Ntali G, Costantino F, Bosio L, Ragogna F, Del Maschio A, Chiumello G, Luzi L. Insulin resistance and whole body energy homeostasis in obese adolescents with fatty liver disease. Am J Physiol Endocrinol Metab 2006;291:E697-703. [PMID: 16684857 DOI: 10.1152/ajpendo.00017.2006] [Cited by in Crossref: 75] [Cited by in F6Publishing: 70] [Article Influence: 5.0] [Reference Citation Analysis]
270 Lindeboom L, de Graaf RA, Nabuurs CI, van Ewijk PA, Hesselink MK, Wildberger JE, Schrauwen P, Schrauwen-Hinderling VB. Quantum coherence spectroscopy to measure dietary fat retention in the liver. JCI Insight 2016;1:e84671. [PMID: 27699229 DOI: 10.1172/jci.insight.84671] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
271 Eckard C, Cole R, Lockwood J, Torres DM, Williams CD, Shaw JC, Harrison SA. Prospective histopathologic evaluation of lifestyle modification in nonalcoholic fatty liver disease: a randomized trial. Therap Adv Gastroenterol. 2013;6:249-259. [PMID: 23814606 DOI: 10.1177/1756283x13484078] [Cited by in Crossref: 69] [Cited by in F6Publishing: 34] [Article Influence: 8.6] [Reference Citation Analysis]
272 Rankin KC, O'Brien LC, Segal L, Khan MR, Gorgey AS. Liver Adiposity and Metabolic Profile in Individuals with Chronic Spinal Cord Injury. Biomed Res Int 2017;2017:1364818. [PMID: 28948164 DOI: 10.1155/2017/1364818] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 4.5] [Reference Citation Analysis]
273 Yao HT, Huang SY, Chiang MT. A comparative study on hypoglycemic and hypocholesterolemic effects of high and low molecular weight chitosan in streptozotocin-induced diabetic rats. Food Chem Toxicol 2008;46:1525-34. [PMID: 18255211 DOI: 10.1016/j.fct.2007.12.012] [Cited by in Crossref: 56] [Cited by in F6Publishing: 41] [Article Influence: 4.3] [Reference Citation Analysis]
274 Fabbrini E, Mohammed BS, Magkos F, Korenblat KM, Patterson BW, Klein S. Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease. Gastroenterology. 2008;134:424-431. [PMID: 18242210 DOI: 10.1053/j.gastro.2007.11.038] [Cited by in Crossref: 320] [Cited by in F6Publishing: 291] [Article Influence: 22.9] [Reference Citation Analysis]
275 Korenblat KM, Fabbrini E, Mohammed BS, Klein S. Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects. Gastroenterology. 2008;134:1369-1375. [PMID: 18355813 DOI: 10.1053/j.gastro.2008.01.075] [Cited by in Crossref: 357] [Cited by in F6Publishing: 330] [Article Influence: 27.5] [Reference Citation Analysis]
276 Petäjä EM, Sevastianova K, Hakkarainen A, Orho-melander M, Lundbom N, Yki-järvinen H. Adipocyte size is associated with NAFLD independent of obesity, fat distribution, and PNPLA3 genotype: Adipocyte Size, Liver Fat. Obesity 2013;21:1174-9. [DOI: 10.1002/oby.20114] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
277 Huang J, Iqbal J, Saha PK, Liu J, Chan L, Hussain MM, Moore DD, Wang L. Molecular characterization of the role of orphan receptor small heterodimer partner in development of fatty liver. Hepatology. 2007;46:147-157. [PMID: 17526026 DOI: 10.1002/hep.21632] [Cited by in Crossref: 116] [Cited by in F6Publishing: 106] [Article Influence: 8.3] [Reference Citation Analysis]
278 Rotman Y, Neuschwander-Tetri BA. Liver fat accumulation as a barometer of insulin responsiveness again points to adipose tissue as the culprit. Hepatology 2017;65:1088-90. [PMID: 28152575 DOI: 10.1002/hep.29094] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
279 Utzschneider KM, Kahn SE. The Role of Insulin Resistance in Nonalcoholic Fatty Liver Disease. The Journal of Clinical Endocrinology & Metabolism 2006;91:4753-61. [DOI: 10.1210/jc.2006-0587] [Cited by in Crossref: 476] [Cited by in F6Publishing: 428] [Article Influence: 31.7] [Reference Citation Analysis]
280 Khandelwal R, Dassanayake AS, Conjeevaram HS, Singh SP. Non-alcoholic fatty liver disease in diabetes: When to refer to the hepatologist? WJD 2021;12:1479-93. [DOI: 10.4239/wjd.v12.i9.1479] [Reference Citation Analysis]
281 Andersson CX, Gustafson B, Hammarstedt A, Hedjazifar S, Smith U. Inflamed adipose tissue, insulin resistance and vascular injury. Diabetes Metab Res Rev 2008;24:595-603. [DOI: 10.1002/dmrr.889] [Cited by in Crossref: 80] [Cited by in F6Publishing: 71] [Article Influence: 6.2] [Reference Citation Analysis]
282 Kotronen A, Vehkavaara S, Seppälä-Lindroos A, Bergholm R, Yki-Järvinen H. Effect of liver fat on insulin clearance. Am J Physiol Endocrinol Metab. 2007;293:E1709-E1715. [PMID: 17895288 DOI: 10.1152/ajpendo.00444.2007] [Cited by in Crossref: 140] [Cited by in F6Publishing: 139] [Article Influence: 10.0] [Reference Citation Analysis]
283 Edens MA, Kuipers F, Stolk RP. Non-alcoholic fatty liver disease is associated with cardiovascular disease risk markers. Obesity Reviews 2009;10:412-9. [DOI: 10.1111/j.1467-789x.2009.00594.x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 30] [Article Influence: 4.0] [Reference Citation Analysis]
284 North KE, Graff M, Franceschini N, Reiner AP, Feitosa MF, Carr JJ, Gordon-Larsen P, Wojczynski MK, Borecki IB. Sex and race differences in the prevalence of fatty liver disease as measured by computed tomography liver attenuation in European American and African American participants of the NHLBI family heart study. Eur J Gastroenterol Hepatol. 2012;24:9-16. [PMID: 21900826 DOI: 10.1097/meg.0b013e32834a94fb] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
285 Lanthier N, Molendi-Coste O, Horsmans Y, van Rooijen N, Cani PD, Leclercq IA. Kupffer cell activation is a causal factor for hepatic insulin resistance. Am J Physiol Gastrointest Liver Physiol. 2010;298:G107-G116. [PMID: 19875703 DOI: 10.1152/ajpgi.00391.2009] [Cited by in Crossref: 149] [Cited by in F6Publishing: 138] [Article Influence: 12.4] [Reference Citation Analysis]
286 Roden M. Mechanisms of Disease: hepatic steatosis in type 2 diabetes--pathogenesis and clinical relevance. Nat Clin Pract Endocrinol Metab. 2006;2:335-348. [PMID: 16932311 DOI: 10.1038/ncpendmet0190] [Cited by in Crossref: 259] [Cited by in F6Publishing: 239] [Article Influence: 17.3] [Reference Citation Analysis]
287 Jakobsdottir G, Xu J, Molin G, Ahrné S, Nyman M. High-fat diet reduces the formation of butyrate, but increases succinate, inflammation, liver fat and cholesterol in rats, while dietary fibre counteracts these effects. PLoS One. 2013;8:e80476. [PMID: 24236183 DOI: 10.1371/journal.pone.0080476] [Cited by in Crossref: 178] [Cited by in F6Publishing: 160] [Article Influence: 22.3] [Reference Citation Analysis]
288 Kotronen A, Yki-Järvinen H, Sevastianova K, Bergholm R, Hakkarainen A, Pietiläinen KH, Juurinen L, Lundbom N, Sørensen TI. Comparison of the relative contributions of intra-abdominal and liver fat to components of the metabolic syndrome. Obesity (Silver Spring). 2011;19:23-28. [PMID: 20539297 DOI: 10.1038/oby.2010.137] [Cited by in Crossref: 47] [Cited by in F6Publishing: 41] [Article Influence: 4.3] [Reference Citation Analysis]
289 Westerbacka J, Kotronen A, Fielding BA, Wahren J, Hodson L, Perttilä J, Seppänen-Laakso T, Suortti T, Arola J, Hultcrantz R. Splanchnic balance of free fatty acids, endocannabinoids, and lipids in subjects with nonalcoholic fatty liver disease. Gastroenterology. 2010;139:1961-1971.e1. [PMID: 20600015 DOI: 10.1053/j.gastro.2010.06.064] [Cited by in Crossref: 47] [Cited by in F6Publishing: 40] [Article Influence: 4.3] [Reference Citation Analysis]
290 Catalano KJ, Stefanovski D, Bergman RN. Critical role of the mesenteric depot versus other intra-abdominal adipose depots in the development of insulin resistance in young rats. Diabetes 2010;59:1416-23. [PMID: 20299478 DOI: 10.2337/db08-0675] [Cited by in Crossref: 53] [Cited by in F6Publishing: 50] [Article Influence: 4.8] [Reference Citation Analysis]
291 Hang TC, Lauffenburger DA, Griffith LG, Stolz DB. Lipids promote survival, proliferation, and maintenance of differentiation of rat liver sinusoidal endothelial cells in vitro. Am J Physiol Gastrointest Liver Physiol. 2012;302:G375-G388. [PMID: 22075778 DOI: 10.1152/ajpgi.00288.2011] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
292 Masuda S, Fujishima Y, Maeda N, Tsugawa-Shimizu Y, Nakamura Y, Tanaka Y, Obata Y, Fukuda S, Nagao H, Kita S, Nishizawa H, Shimomura I. Impact of glycosylphosphatidylinositol-specific phospholipase D on hepatic diacylglycerol accumulation, steatosis, and insulin resistance in diet-induced obesity. Am J Physiol Endocrinol Metab 2019;316:E239-50. [PMID: 30457913 DOI: 10.1152/ajpendo.00319.2018] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
293 Taylor R, Al-Mrabeh A, Sattar N. Understanding the mechanisms of reversal of type 2 diabetes. Lancet Diabetes Endocrinol. 2019;7:726-736. [PMID: 31097391 DOI: 10.1016/s2213-8587(19)30076-2] [Cited by in Crossref: 52] [Cited by in F6Publishing: 22] [Article Influence: 26.0] [Reference Citation Analysis]
294 Xourafas D, Ardestani A, Ashley SW, Tavakkoli A. Impact of weight-loss surgery and diabetes status on serum ALT levels. Obes Surg 2012;22:1540-7. [PMID: 22610995 DOI: 10.1007/s11695-012-0677-1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
295 Lee J, Chung DS, Kang JH, Yu BY. Comparison of visceral fat and liver fat as risk factors of metabolic syndrome. J Korean Med Sci. 2012;27:184-189. [PMID: 22323866 DOI: 10.3346/jkms.2012.27.2.184] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
296 Wang O, Cheng Q, Liu J, Wang Y, Zhao L, Zhou F, Ji B. Hepatoprotective effect of Schisandra chinensis (Turcz.) Baill. lignans and its formula with Rubus idaeus on chronic alcohol-induced liver injury in mice. Food Funct 2014;5:3018-25. [DOI: 10.1039/c4fo00550c] [Cited by in Crossref: 28] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
297 Harrison SA, Di Bisceglie AM. Advances in the Understanding and Treatment of Nonalcoholic Fatty Liver Disease: . Drugs 2003;63:2379-94. [DOI: 10.2165/00003495-200363220-00001] [Cited by in Crossref: 41] [Cited by in F6Publishing: 33] [Article Influence: 2.3] [Reference Citation Analysis]
298 Petersen KF, Befroy D, Dufour S, Dziura J, Ariyan C, Rothman DL, DiPietro L, Cline GW, Shulman GI. Mitochondrial dysfunction in the elderly: possible role in insulin re-sistance. Science. 2003;300:1140-1142. [PMID: 12750520 DOI: 10.1126/science.1082889] [Cited by in Crossref: 1449] [Cited by in F6Publishing: 1253] [Article Influence: 80.5] [Reference Citation Analysis]
299 Tripathy D, Eriksson KF, Orho-Melander M, Fredriksson J, Ahlqvist G, Groop L. Parallel manifestation of insulin resistance and beta cell decompensation is compatible with a common defect in Type 2 diabetes. Diabetologia 2004;47:782-93. [PMID: 15114470 DOI: 10.1007/s00125-004-1393-8] [Cited by in Crossref: 53] [Cited by in F6Publishing: 44] [Article Influence: 3.1] [Reference Citation Analysis]
300 Mehta SR, Thomas EL, Bell JD, Johnston DG, Taylor-Robinson SD. Non-invasive means of measuring hepatic fat content. World J Gastroenterol. 2008;14:3476-3483. [PMID: 18567074 DOI: 10.3748/wjg.14.3476] [Cited by in CrossRef: 169] [Cited by in F6Publishing: 144] [Article Influence: 13.0] [Reference Citation Analysis]
301 Luukkonen PK, Zhou Y, Sädevirta S, Leivonen M, Arola J, Orešič M, Hyötyläinen T, Yki-Järvinen H. Hepatic ceramides dissociate steatosis and insulin resistance in patients with non-alcoholic fatty liver disease. J Hepatol 2016;64:1167-75. [PMID: 26780287 DOI: 10.1016/j.jhep.2016.01.002] [Cited by in Crossref: 208] [Cited by in F6Publishing: 184] [Article Influence: 41.6] [Reference Citation Analysis]
302 Hao J, Chen C, Huang K, Huang J, Li J, Liu P, Huang H. Polydatin improves glucose and lipid metabolism in experimental diabetes through activating the Akt signaling pathway. European Journal of Pharmacology 2014;745:152-65. [DOI: 10.1016/j.ejphar.2014.09.047] [Cited by in Crossref: 46] [Cited by in F6Publishing: 43] [Article Influence: 6.6] [Reference Citation Analysis]
303 Lawlor DA, Sattar N, Smith GD, Ebrahim S. The associations of physical activity and adiposity with alanine aminotransferase and gamma-glutamyltransferase. Am J Epidemiol 2005;161:1081-8. [PMID: 15901629 DOI: 10.1093/aje/kwi125] [Cited by in Crossref: 125] [Cited by in F6Publishing: 55] [Article Influence: 7.8] [Reference Citation Analysis]
304 Ratziu V, Giral P, Jacqueminet S, Charlotte F, Hartemann-Heurtier A, Serfaty L, Podevin P, Lacorte JM, Bernhardt C, Bruckert E, Grimaldi A, Poynard T;  LIDO Study Group. Rosiglitazone for nonalcoholic steatohepatitis: one-year results of the randomized placebo-controlled Fatty Liver Improvement with Rosiglitazone Therapy (FLIRT) Trial. Gastroenterology. 2008;135:100-110. [PMID: 18503774 DOI: 10.1053/j.gastro.2008.03.078] [Cited by in Crossref: 421] [Cited by in F6Publishing: 373] [Article Influence: 32.4] [Reference Citation Analysis]
305 Perez M, Gonzáles L, Olarte R, Rodríguez NI, Tabares M, Salazar JP, Jaimes S, García RG, López-Jaramillo P. Nonalcoholic fatty liver disease is associated with insulin resistance in a young Hispanic population. Prev Med. 2011;52:174-177. [PMID: 21147154 DOI: 10.1016/j.ypmed.2010.11.021] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
306 Bowen J, Luscombe-marsh ND, Stonehouse W, Tran C, Rogers GB, Johnson N, Thompson CH, Brinkworth GD. Effects of almond consumption on metabolic function and liver fat in overweight and obese adults with elevated fasting blood glucose: A randomised controlled trial. Clinical Nutrition ESPEN 2019;30:10-8. [DOI: 10.1016/j.clnesp.2018.12.088] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 10.5] [Reference Citation Analysis]
307 Yang H, Li Q, Lee JH, Shu Y. Reduction in Tcf7l2 expression decreases diabetic susceptibility in mice. Int J Biol Sci 2012;8:791-801. [PMID: 22719219 DOI: 10.7150/ijbs.4568] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.2] [Reference Citation Analysis]
308 Wang PW, Kuo HM, Huang HT, Chang AY, Weng SW, Tai MH, Chuang JH, Chen IY, Huang SC, Lin TK, Liou CW. Biphasic response of mitochondrial biogenesis to oxidative stress in visceral fat of diet-induced obesity mice. Antioxid Redox Signal 2014;20:2572-88. [PMID: 24111683 DOI: 10.1089/ars.2013.5334] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 3.1] [Reference Citation Analysis]
309 Hossain IA, Akter S, Bhuiyan FR, Shah MR, Rahman MK, Ali L. Subclinical inflammation in relation to insulin resistance in prediabetic subjects with nonalcoholic fatty liver disease. BMC Res Notes. 2016;9:266. [PMID: 27169860 DOI: 10.1186/s13104-016-2071-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
310 Ladwa M, Bello O, Hakim O, Shojaee-Moradie F, Boselli L, Charles-Edwards G, Stadler M, Peacock JL, Umpleby AM, Amiel SA, Bonadonna RC, Goff LM. Insulin clearance as the major player in the hyperinsulinaemia of black African men without diabetes. Diabetes Obes Metab 2020;22:1808-17. [PMID: 32488928 DOI: 10.1111/dom.14101] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
311 Machann J, Thamer C, Schnoedt B, Stefan N, Stumvoll M, Haring H, Claussen C, Schick F, Fritsche A. Age and gender related effects on adipose tissue compartments of subjects with increased risk for type 2 diabetes: a whole body MRI / MRS study. MAGMA 2005;18:128-37. [DOI: 10.1007/s10334-005-0104-x] [Cited by in Crossref: 85] [Cited by in F6Publishing: 74] [Article Influence: 5.3] [Reference Citation Analysis]
312 Klein S, Allison DB, Heymsfield SB, Kelley DE, Leibel RL, Nonas C, Kahn R. Waist Circumference and Cardiometabolic Risk: a Consensus Statement from Shaping America's Health: Association for Weight Management and Obesity Prevention; NAASO, the Obesity Society; the American Society for Nutrition; and the American Diabetes Association. Obesity (Silver Spring) 2007;15:1061-7. [PMID: 17495180 DOI: 10.1038/oby.2007.632] [Cited by in Crossref: 230] [Cited by in F6Publishing: 183] [Article Influence: 16.4] [Reference Citation Analysis]
313 Cali AM, De Oliveira AM, Kim H, Chen S, Reyes-Mugica M, Escalera S, Dziura J, Taksali SE, Kursawe R, Shaw M, Savoye M, Pierpont B, Constable RT, Caprio S. Glucose dysregulation and hepatic steatosis in obese adolescents: is there a link? Hepatology 2009;49:1896-903. [PMID: 19434725 DOI: 10.1002/hep.22858] [Cited by in Crossref: 112] [Cited by in F6Publishing: 105] [Article Influence: 9.3] [Reference Citation Analysis]
314 Yang W, Xu H, Yu X, Wang Y. Association between retinal artery lesions and nonalcoholic fatty liver disease. Hepatol Int 2015;9:278-82. [PMID: 25788195 DOI: 10.1007/s12072-015-9607-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
315 Parola M, Marra F. Adipokines and Redox Signaling: Impact on Fatty Liver Disease. Antioxidants & Redox Signaling 2011;15:461-83. [DOI: 10.1089/ars.2010.3848] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 3.8] [Reference Citation Analysis]
316 Kim YJ, Jung UJ. Honokiol Improves Insulin Resistance, Hepatic Steatosis, and Inflammation in Type 2 Diabetic db/db Mice. Int J Mol Sci 2019;20:E2303. [PMID: 31075962 DOI: 10.3390/ijms20092303] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
317 Bonekamp S, Ghosh P, Crawford S, Solga SF, Horska A, Brancati FL, Diehl AM, Smith S, Clark JM. Quantitative comparison and evaluation of software packages for assessment of abdominal adipose tissue distribution by magnetic resonance imaging. Int J Obes (Lond) 2008;32:100-11. [PMID: 17700582 DOI: 10.1038/sj.ijo.0803696] [Cited by in Crossref: 67] [Cited by in F6Publishing: 60] [Article Influence: 4.8] [Reference Citation Analysis]
318 Honka H, Koffert J, Kauhanen S, Kudomi N, Hurme S, Mari A, Lindqvist A, Wierup N, Parkkola R, Groop L, Nuutila P. Liver blood dynamics after bariatric surgery: the effects of mixed-meal test and incretin infusions. Endocr Connect 2018;7:888-96. [PMID: 29941634 DOI: 10.1530/EC-18-0234] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 2.7] [Reference Citation Analysis]
319 Yudkin JS, Eringa E, Stehouwer CD. “Vasocrine” signalling from perivascular fat: a mechanism linking insulin resistance to vascular disease. The Lancet 2005;365:1817-20. [DOI: 10.1016/s0140-6736(05)66585-3] [Cited by in Crossref: 368] [Cited by in F6Publishing: 137] [Article Influence: 23.0] [Reference Citation Analysis]
320 Kumazawa M, Kobayashi M, Io F, Kawai T, Nishimura M, Ohno T, Horio F. Searching for genetic factors of fatty liver in SMXA-5 mice by quantitative trait loci analysis under a high-fat diet. J Lipid Res 2007;48:2039-46. [PMID: 17595448 DOI: 10.1194/jlr.M700222-JLR200] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
321 López-Bermejo A, Bosch M, Recasens M, Biarnés J, Esteve E, Casamitjana R, Vendrell J, Ricart W, Fernández-Real JM. Potential role of interleukin-18 in liver disease associated with insulin resistance. Obes Res. 2005;13:1925-1931. [PMID: 16339124 DOI: 10.1038/oby.2005.237] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
322 Matikainen N, Mänttäri S, Westerbacka J, Vehkavaara S, Lundbom N, Yki-järvinen H, Taskinen M. Postprandial Lipemia Associates with Liver Fat Content. The Journal of Clinical Endocrinology & Metabolism 2007;92:3052-9. [DOI: 10.1210/jc.2007-0187] [Cited by in Crossref: 58] [Cited by in F6Publishing: 51] [Article Influence: 4.1] [Reference Citation Analysis]
323 Valenti L, Bugianesi E, Pajvani U, Targher G. Nonalcoholic fatty liver disease: cause or consequence of type 2 diabetes? Liver Int 2016;36:1563-79. [DOI: 10.1111/liv.13185] [Cited by in Crossref: 85] [Cited by in F6Publishing: 75] [Article Influence: 17.0] [Reference Citation Analysis]
324 Yoshimura E, Kumahara H, Tobina T, Matono S, Kiyonaga A, Kimura M, Tsukikawa H, Kono S, Etou T, Irie S. Relationships between fat deposition in the liver and skeletal muscle and insulin sensitivity in Japanese individuals: a pilot study. Diabetes Metab Syndr Obes. 2011;4:35-43. [PMID: 21448320 DOI: 10.2147/dmso.s16175] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
325 Kim JH, Lee HS, Park HM, Lee YJ. Serum alkaline phosphatase level is positively associated with metabolic syndrome: A nationwide population-based study. Clin Chim Acta 2020;500:189-94. [PMID: 31678575 DOI: 10.1016/j.cca.2019.10.015] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
326 Zhou J, Mo Y, Li H, Ran X, Yang W, Li Q, Peng Y, Li Y, Gao X, Luan X, Wang W, Jia W. Alanine aminotransferase is associated with an adverse nocturnal blood glucose profile in individuals with normal glucose regulation. PLoS One 2013;8:e56072. [PMID: 23424646 DOI: 10.1371/journal.pone.0056072] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
327 Kotronen A, Velagapudi VR, Yetukuri L, Westerbacka J, Bergholm R, Ekroos K, Makkonen J, Taskinen M, Orešič M, Yki-järvinen H. Serum saturated fatty acids containing triacylglycerols are better markers of insulin resistance than total serum triacylglycerol concentrations. Diabetologia 2009;52:684-90. [DOI: 10.1007/s00125-009-1282-2] [Cited by in Crossref: 129] [Cited by in F6Publishing: 108] [Article Influence: 10.8] [Reference Citation Analysis]
328 Milanski M, Arruda AP, Coope A, Ignacio-Souza LM, Nunez CE, Roman EA, Romanatto T, Pascoal LB, Caricilli AM, Torsoni MA, Prada PO, Saad MJ, Velloso LA. Inhibition of hypothalamic inflammation reverses diet-induced insulin resistance in the liver. Diabetes 2012;61:1455-62. [PMID: 22522614 DOI: 10.2337/db11-0390] [Cited by in Crossref: 148] [Cited by in F6Publishing: 134] [Article Influence: 16.4] [Reference Citation Analysis]
329 Iyer A, Brown L, Whitehead JP, Prins JB, Fairlie DP. Nutrient and immune sensing are obligate pathways in metabolism, immunity, and disease. FASEB J. 2015;29:3612-3625. [PMID: 26065858 DOI: 10.1096/fj.15-271155] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
330 Petäjä E, Yki-järvinen H. Definitions of Normal Liver Fat and the Association of Insulin Sensitivity with Acquired and Genetic NAFLD—A Systematic Review. IJMS 2016;17:633. [DOI: 10.3390/ijms17050633] [Cited by in Crossref: 75] [Cited by in F6Publishing: 59] [Article Influence: 15.0] [Reference Citation Analysis]
331 Thomas EL, Hamilton G, Patel N, O'Dwyer R, Doré CJ, Goldin RD, Bell JD, Taylor-Robinson SD. Hepatic triglyceride content and its relation to body adiposity: a magnetic resonance imaging and proton magnetic resonance spectroscopy study. Gut 2005;54:122-7. [PMID: 15591516 DOI: 10.1136/gut.2003.036566] [Cited by in Crossref: 234] [Cited by in F6Publishing: 209] [Article Influence: 14.6] [Reference Citation Analysis]
332 Petersen KF, Dufour S, Befroy D, Lehrke M, Hendler RE, Shulman GI. Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes. Diabetes. 2005;54:603-608. [PMID: 15734833 DOI: 10.2337/diabetes.54.3.603] [Cited by in Crossref: 595] [Cited by in F6Publishing: 533] [Article Influence: 37.2] [Reference Citation Analysis]
333 Rijzewijk LJ, van der Meer RW, Lubberink M, Lamb HJ, Romijn JA, de Roos A, Twisk JW, Heine RJ, Lammertsma AA, Smit JW. Liver fat content in type 2 diabetes: relationship with hepatic perfusion and substrate metabolism. Diabetes. 2010;59:2747-2754. [PMID: 20693345 DOI: 10.2337/db09-1201] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 2.7] [Reference Citation Analysis]
334 Muurling M, van den Hoek AM, Mensink RP, Pijl H, Romijn JA, Havekes LM, Voshol PJ. Overexpression of APOC1 in obob mice leads to hepatic steatosis and severe hepatic insulin resistance. J Lipid Res 2004;45:9-16. [PMID: 14523051 DOI: 10.1194/jlr.M300240-JLR200] [Cited by in Crossref: 34] [Cited by in F6Publishing: 8] [Article Influence: 1.9] [Reference Citation Analysis]
335 Pickens CA, Vazquez AI, Jones AD, Fenton JI. Obesity, adipokines, and C-peptide are associated with distinct plasma phospholipid profiles in adult males, an untargeted lipidomic approach. Sci Rep 2017;7:6335. [PMID: 28740130 DOI: 10.1038/s41598-017-05785-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
336 Bouchouirab FZ, Fortin M, Noll C, Dubé J, Carpentier AC. Plasma Palmitoyl-Carnitine (AC16:0) Is a Marker of Increased Postprandial Nonesterified Incomplete Fatty Acid Oxidation Rate in Adults With Type 2 Diabetes. Can J Diabetes 2018;42:382-388.e1. [PMID: 29129455 DOI: 10.1016/j.jcjd.2017.09.002] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
337 Hockings PD, Changani KK, Saeed N, Reid DG, Birmingham J, O'brien P, Osborne J, Toseland CN, Buckingham RE. Rapid reversal of hepatic steatosis, and reduction of muscle triglyceride, by rosiglitazone: MRI/S studies in Zucker fatty rats: Rosiglitazone: effects on liver and muscle fat. Diabetes, Obesity and Metabolism 2003;5:234-43. [DOI: 10.1046/j.1463-1326.2003.00268.x] [Cited by in Crossref: 54] [Cited by in F6Publishing: 42] [Article Influence: 3.0] [Reference Citation Analysis]
338 Meli R, Mattace Raso G, Calignano A. Role of innate immune response in non-alcoholic Fatty liver disease: metabolic complications and therapeutic tools. Front Immunol. 2014;5:177. [PMID: 24795720 DOI: 10.3389/fimmu.2014. 00177] [Reference Citation Analysis]
339 Rietman A, Sluik D, Feskens EJM, Kok FJ, Mensink M. Associations between dietary factors and markers of NAFLD in a general Dutch adult population. Eur J Clin Nutr 2018;72:117-23. [DOI: 10.1038/ejcn.2017.148] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 7.8] [Reference Citation Analysis]
340 Koska J, Stefan N, Permana PA, Weyer C, Sonoda M, Bogardus C, Smith SR, Joanisse DR, Funahashi T, Krakoff J, Bunt JC. Increased fat accumulation in liver may link insulin resistance with subcutaneous abdominal adipocyte enlargement, visceral adiposity, and hypoadiponectinemia in obese individuals. Am J Clin Nutr 2008;87:295-302. [PMID: 18258617 DOI: 10.1093/ajcn/87.2.295] [Cited by in Crossref: 77] [Cited by in F6Publishing: 72] [Article Influence: 5.9] [Reference Citation Analysis]
341 Taylor R. Type 2 diabetes and remission: practical management guided by pathophysiology. J Intern Med 2021;289:754-70. [PMID: 33289165 DOI: 10.1111/joim.13214] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
342 Karsenty J, Landrier JF, Rousseau-Ralliard D, Robbez-Masson V, Margotat A, Deprez P, Lechêne P, Grynberg A, Lairon D, Planells R, Gastaldi M. Beneficial effects of omega-3 fatty acids on the consequences of a fructose diet are not mediated by PPAR delta or PGC1 alpha. Eur J Nutr 2013;52:1865-74. [PMID: 23269653 DOI: 10.1007/s00394-012-0488-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
343 Tuyama AC, Chang CY. Non-alcoholic fatty liver disease: Non-alcoholic fatty liver disease. Journal of Diabetes 2012;4:266-80. [DOI: 10.1111/j.1753-0407.2012.00204.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 4.1] [Reference Citation Analysis]
344 Tamura Y, Tanaka Y, Sato F, Choi JB, Watada H, Niwa M, Kinoshita J, Ooka A, Kumashiro N, Igarashi Y, Kyogoku S, Maehara T, Kawasumi M, Hirose T, Kawamori R. Effects of diet and exercise on muscle and liver intracellular lipid contents and insulin sensitivity in type 2 diabetic patients. J Clin Endocrinol Metab 2005;90:3191-6. [PMID: 15769987 DOI: 10.1210/jc.2004-1959] [Cited by in Crossref: 216] [Cited by in F6Publishing: 175] [Article Influence: 13.5] [Reference Citation Analysis]
345 Priego T, Sánchez J, Palou A, Picó C. Leptin intake during the suckling period improves the metabolic response of adipose tissue to a high-fat diet. Int J Obes (Lond) 2010;34:809-19. [PMID: 20157325 DOI: 10.1038/ijo.2010.18] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 3.0] [Reference Citation Analysis]
346 Roldan-valadez E, Favila R, Martínez-lópez M, Uribe M, Méndez-sánchez N. Imaging techniques for assessing hepatic fat content in nonalcoholic fatty liver disease. Annals of Hepatology 2008;7:212-20. [DOI: 10.1016/s1665-2681(19)31850-2] [Cited by in Crossref: 70] [Article Influence: 5.4] [Reference Citation Analysis]
347 Staehr P, Hother-Nielsen O, Beck-Nielsen H. The role of the liver in type 2 diabetes. Rev Endocr Metab Disord. 2004;5:105-110. [PMID: 15041785 DOI: 10.1023/B:REMD.0000021431.90494.0c] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
348 Frayn KN. Obesity and metabolic disease: is adipose tissue the culprit? Proc Nutr Soc 2005;64:7-13. [PMID: 15877917 DOI: 10.1079/pns2004403] [Cited by in Crossref: 71] [Cited by in F6Publishing: 18] [Article Influence: 4.4] [Reference Citation Analysis]
349 den Boer M, Voshol PJ, Kuipers F, Havekes LM, Romijn JA. Hepatic steatosis: a mediator of the metabolic syndrome. Lessons from animal models. Arterioscler Thromb Vasc Biol. 2004;24:644-649. [PMID: 14715643 DOI: 10.1161/01.atv.0000116217.57583.6e] [Cited by in Crossref: 192] [Cited by in F6Publishing: 68] [Article Influence: 11.3] [Reference Citation Analysis]
350 Dufour S, Petersen KF. Disassociation of liver and muscle insulin resistance from ectopic lipid accumulation in low-birth-weight individuals. J Clin Endocrinol Metab 2011;96:3873-80. [PMID: 21994962 DOI: 10.1210/jc.2011-1747] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
351 Magkos F, Fabbrini E, Mohammed BS, Patterson BW, Klein S. Increased whole-body adiposity without a concomitant increase in liver fat is not associated with augmented metabolic dysfunction. Obesity (Silver Spring) 2010;18:1510-5. [PMID: 20395947 DOI: 10.1038/oby.2010.90] [Cited by in Crossref: 64] [Cited by in F6Publishing: 61] [Article Influence: 5.8] [Reference Citation Analysis]
352 Perseghin G, Lattuada G, De Cobelli F, Esposito A, Belloni E, Ntali G, Ragogna F, Canu T, Scifo P, Del Maschio A. Increased mediastinal fat and impaired left ventricular energy metabolism in young men with newly found fatty liver. Hepatology. 2008;47:51-58. [PMID: 17955548 DOI: 10.1002/hep.21983] [Cited by in Crossref: 143] [Cited by in F6Publishing: 128] [Article Influence: 11.0] [Reference Citation Analysis]
353 Zidek LM, Ackermann T, Hartleben G, Eichwald S, Kortman G, Kiehntopf M, Leutz A, Sonenberg N, Wang ZQ, von Maltzahn J, Müller C, Calkhoven CF. Deficiency in mTORC1-controlled C/EBPβ-mRNA translation improves metabolic health in mice. EMBO Rep 2015;16:1022-36. [PMID: 26113365 DOI: 10.15252/embr.201439837] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 3.7] [Reference Citation Analysis]
354 Kotronen A, Westerbacka J, Bergholm R, Pietiläinen KH, Yki-Järvinen H. Liver fat in the metabolic syndrome. J Clin Endocrinol Metab. 2007;92:3490-3497. [PMID: 17595248 DOI: 10.1210/jc.2007-0482] [Cited by in Crossref: 280] [Cited by in F6Publishing: 262] [Article Influence: 20.0] [Reference Citation Analysis]
355 Stefan N, Kantartzis K, Häring H. Causes and Metabolic Consequences of Fatty Liver. Endocrine Reviews 2008;29:939-60. [DOI: 10.1210/er.2008-0009] [Cited by in Crossref: 338] [Cited by in F6Publishing: 303] [Article Influence: 26.0] [Reference Citation Analysis]
356 McArdle MA, Finucane OM, Connaughton RM, McMorrow AM, Roche HM. Mechanisms of obesity-induced inflammation and insulin resistance: insights into the emerging role of nutritional strategies. Front Endocrinol (Lausanne). 2013;4:52. [PMID: 23675368 DOI: 10.3389/fendo.2013.00052] [Cited by in Crossref: 266] [Cited by in F6Publishing: 226] [Article Influence: 33.3] [Reference Citation Analysis]
357 Moore DD. Nuclear receptors reverse McGarry's vicious cycle to insulin resistance. Cell Metab 2012;15:615-22. [PMID: 22560214 DOI: 10.1016/j.cmet.2012.03.016] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 2.7] [Reference Citation Analysis]
358 DeFronzo RA. Dysfunctional fat cells, lipotoxicity and type 2 diabetes. Int J Clin Pract Suppl. 2004;9-21. [PMID: 16035392 DOI: 10.1111/j.1368-504x.2004.00389.x] [Cited by in Crossref: 133] [Cited by in F6Publishing: 56] [Article Influence: 8.3] [Reference Citation Analysis]
359 Perseghin G. Lipids in the wrong place: visceral fat and nonalcoholic steatohepatitis. Diabetes Care. 2011;34 Suppl 2:S367-S370. [PMID: 21525484 DOI: 10.2337/dc11-s249] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 2.5] [Reference Citation Analysis]
360 Gauthier MS, Favier R, Lavoie JM. Time course of the development of non-alcoholic hepatic steatosis in response to high-fat diet-induced obesity in rats. Br J Nutr. 2006;95:273-281. [PMID: 16469142 DOI: 10.1079/BJN20051635] [Cited by in Crossref: 76] [Cited by in F6Publishing: 27] [Article Influence: 5.1] [Reference Citation Analysis]
361 Stanhope KL, Goran MI, Bosy-Westphal A, King JC, Schmidt LA, Schwarz JM, Stice E, Sylvetsky AC, Turnbaugh PJ, Bray GA, Gardner CD, Havel PJ, Malik V, Mason AE, Ravussin E, Rosenbaum M, Welsh JA, Allister-Price C, Sigala DM, Greenwood MRC, Astrup A, Krauss RM. Pathways and mechanisms linking dietary components to cardiometabolic disease: thinking beyond calories. Obes Rev 2018;19:1205-35. [PMID: 29761610 DOI: 10.1111/obr.12699] [Cited by in Crossref: 34] [Cited by in F6Publishing: 26] [Article Influence: 11.3] [Reference Citation Analysis]
362 Slyper AH, Rosenberg H, Kabra A, Huang WM, Blech B, Matsumura MM. Fatty liver disease, glucose tolerance and insulin resistance in obese adolescents. Pediatr Obes 2015;10:423-7. [PMID: 25522002 DOI: 10.1111/ijpo.279] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
363 Yu TY, Wang CY. Impact of non-alcoholic fatty pancreas disease on glucose metabolism. J Diabetes Investig. 2017;8:735-747. [PMID: 28371475 DOI: 10.1111/jdi.12665] [Cited by in Crossref: 31] [Cited by in F6Publishing: 23] [Article Influence: 7.8] [Reference Citation Analysis]
364 Pi-sunyer FX. Pathophysiology and Long-Term Management of the Metabolic Syndrome. Obesity Research 2004;12:174S-80S. [DOI: 10.1038/oby.2004.285] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
365 Perseghin G, Lattuada G, De Cobelli F, Ntali G, Esposito A, Burska A, Belloni E, Canu T, Ragogna F, Scifo P. Serum resistin and hepatic fat content in nondiabetic individuals. J Clin Endocrinol Metab. 2006;91:5122-5125. [PMID: 16968796 DOI: 10.1210/jc.2006-1368] [Cited by in Crossref: 37] [Cited by in F6Publishing: 31] [Article Influence: 2.5] [Reference Citation Analysis]
366 Watanabe T, Tamura Y, Kakehi S, Funayama T, Gastaldelli A, Takeno K, Kawaguchi M, Yamamoto R, Sato F, Ikeda S, Taka H, Fujimura T, Fujitani Y, Kawamori R, Watada H. Effects of sitagliptin on ectopic fat contents and glucose metabolism in type 2 diabetic patients with fatty liver: A pilot study. J Diabetes Investig 2015;6:164-72. [PMID: 25802724 DOI: 10.1111/jdi.12262] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
367 Bian H, Yan H, Zeng M, Rao S, Yao X, Zhou J, Jia W, Gao X. Increased liver fat content and unfavorable glucose profiles in subjects without diabetes. Diabetes Technol Ther 2011;13:149-55. [PMID: 21284482 DOI: 10.1089/dia.2010.0101] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
368 Thieringer R, Hermanowski-Vosatka A. Inhibition of 11beta-HSD1 as a novel treatment for the metabolic syndrome: do glucocorticoids play a role? Expert Rev Cardiovasc Ther 2005;3:911-24. [PMID: 16181035 DOI: 10.1586/14779072.3.5.911] [Cited by in Crossref: 42] [Cited by in F6Publishing: 31] [Article Influence: 2.8] [Reference Citation Analysis]
369 Bartlett DB, Slentz CA, Connelly MA, Piner LW, Willis LH, Bateman LA, Granville EO, Bales CW, Huffman KM, Kraus WE. Association of the Composite Inflammatory Biomarker GlycA, with Exercise-Induced Changes in Body Habitus in Men and Women with Prediabetes. Oxid Med Cell Longev 2017;2017:5608287. [PMID: 28642810 DOI: 10.1155/2017/5608287] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
370 Patti ME, Corvera S. The role of mitochondria in the pathogenesis of type 2 diabetes. Endocr Rev. 2010;31:364-395. [PMID: 20156986 DOI: 10.1210/er.2009-0027] [Cited by in Crossref: 334] [Cited by in F6Publishing: 300] [Article Influence: 30.4] [Reference Citation Analysis]
371 Vroegrijk IO, van Klinken JB, van Diepen JA, van den Berg SA, Febbraio M, Steinbusch LK, Glatz JF, Havekes LM, Voshol PJ, Rensen PC, van Dijk KW, van Harmelen V. CD36 is important for adipocyte recruitment and affects lipolysis. Obesity (Silver Spring) 2013;21:2037-45. [PMID: 23512311 DOI: 10.1002/oby.20354] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 4.9] [Reference Citation Analysis]
372 Meli R, Mattace Raso G, Calignano A. Role of innate immune response in non-alcoholic Fatty liver disease: metabolic complications and therapeutic tools. Front Immunol 2014;5:177. [PMID: 24795720 DOI: 10.3389/fimmu.2014.00177] [Cited by in Crossref: 78] [Cited by in F6Publishing: 74] [Article Influence: 11.1] [Reference Citation Analysis]
373 Grefhorst A, Hoekstra J, Derks TG, Ouwens DM, Baller JF, Havinga R, Havekes LM, Romijn JA, Kuipers F. Acute hepatic steatosis in mice by blocking beta-oxidation does not reduce insulin sensitivity of very-low-density lipoprotein production. Am J Physiol Gastrointest Liver Physiol. 2005;289:G592-G598. [PMID: 15817811 DOI: 10.1152/ajpgi.00063.2005] [Cited by in Crossref: 46] [Cited by in F6Publishing: 45] [Article Influence: 2.9] [Reference Citation Analysis]
374 Pietiläinen KH, Rissanen A, Kaprio J, Mäkimattila S, Häkkinen AM, Westerbacka J, Sutinen J, Vehkavaara S, Yki-Järvinen H. Acquired obesity is associated with increased liver fat, intra-abdominal fat, and insulin resistance in young adult monozygotic twins. Am J Physiol Endocrinol Metab 2005;288:E768-74. [PMID: 15585588 DOI: 10.1152/ajpendo.00381.2004] [Cited by in Crossref: 61] [Cited by in F6Publishing: 62] [Article Influence: 3.6] [Reference Citation Analysis]
375 Dhurandhar EJ, Krishnapuram R, Hegde V, Dubuisson O, Tao R, Dong XC, Ye J, Dhurandhar NV. E4orf1 improves lipid and glucose metabolism in hepatocytes: a template to improve steatosis & hyperglycemia. PLoS One. 2012;7:e47813. [PMID: 23110104 DOI: 10.1371/journal.pone.0047813] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
376 Koutsari C, Jensen MD. Thematic review series: Patient-Oriented Research. Free fatty acid metabolism in human obesity. Journal of Lipid Research 2006;47:1643-50. [DOI: 10.1194/jlr.r600011-jlr200] [Cited by in Crossref: 133] [Cited by in F6Publishing: 55] [Article Influence: 8.9] [Reference Citation Analysis]
377 Kotronen A, Seppälä-Lindroos A, Bergholm R, Yki-Järvinen H. Tissue specificity of insulin resistance in humans: fat in the liver rather than muscle is associated with features of the metabolic syndrome. Diabetologia. 2008;51:130-138. [PMID: 18008059 DOI: 10.1007/s00125-007-0867-x] [Cited by in Crossref: 83] [Cited by in F6Publishing: 77] [Article Influence: 5.9] [Reference Citation Analysis]
378 Grander C, Grabherr F, Moschen AR, Tilg H. Non-Alcoholic Fatty Liver Disease: Cause or Effect of Metabolic Syndrome. Visc Med 2016;32:329-34. [PMID: 27921044 DOI: 10.1159/000448940] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 3.6] [Reference Citation Analysis]
379 Park M, Jang H, Lee J, Lee Y, Kim J, Park J, Park D. Effect of Hog Millet Supplementation on Hepatic Steatosis and Insulin Resistance in Mice Fed a High-fat Diet. Journal of the Korean Society of Food Science and Nutrition 2012;41:501-9. [DOI: 10.3746/jkfn.2012.41.4.501] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
380 Schindhelm RK, Dekker JM, Nijpels G, Stehouwer CD, Bouter LM, Heine RJ, Diamant M. Alanine aminotransferase and the 6-year risk of the metabolic syndrome in Caucasian men and women: the Hoorn Study. Diabet Med. 2007;24:430-435. [PMID: 17388959 DOI: 10.1111/j.1464-5491.2007.02100.x] [Cited by in Crossref: 52] [Cited by in F6Publishing: 45] [Article Influence: 3.7] [Reference Citation Analysis]
381 Stanhope KL, Havel PJ. Fructose consumption: considerations for future research on its effects on adipose distribution, lipid metabolism, and insulin sensitivity in humans. J Nutr 2009;139:1236S-41S. [PMID: 19403712 DOI: 10.3945/jn.109.106641] [Cited by in Crossref: 70] [Cited by in F6Publishing: 58] [Article Influence: 5.8] [Reference Citation Analysis]
382 Khan MY, Mihali AB, Rawala MS, Aslam A, Siddiqui WJ. The promising role of probiotic and synbiotic therapy in aminotransferase levels and inflammatory markers in patients with nonalcoholic fatty liver disease - a systematic review and meta-analysis. Eur J Gastroenterol Hepatol 2019;31:703-15. [PMID: 31009401 DOI: 10.1097/MEG.0000000000001371] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
383 D'Adamo E, Cali AM, Weiss R, Santoro N, Pierpont B, Northrup V, Caprio S. Central role of fatty liver in the pathogenesis of insulin resistance in obese adolescents. Diabetes Care 2010;33:1817-22. [PMID: 20668154 DOI: 10.2337/dc10-0284] [Cited by in Crossref: 139] [Cited by in F6Publishing: 129] [Article Influence: 15.4] [Reference Citation Analysis]
384 Spahis S, Alvarez F, Ahmed N, Dubois J, Jalbout R, Paganelli M, Grzywacz K, Delvin E, Peretti N, Levy E. Non-alcoholic fatty liver disease severity and metabolic complications in obese children: impact of omega-3 fatty acids. The Journal of Nutritional Biochemistry 2018;58:28-36. [DOI: 10.1016/j.jnutbio.2018.03.025] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 6.7] [Reference Citation Analysis]
385 Tsunoda M, Kobayashi N, Ide T, Utsumi M, Nagasawa M, Murakami K. A novel PPARα agonist ameliorates insulin resistance in dogs fed a high-fat diet. American Journal of Physiology-Endocrinology and Metabolism 2008;294:E833-40. [DOI: 10.1152/ajpendo.00627.2007] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
386 Italian Association for the Study of the Liver (AISF). AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions. Dig Liver Dis. 2017;49:471-483. [PMID: 28215516 DOI: 10.1016/j.dld.2017.01.147] [Cited by in Crossref: 161] [Cited by in F6Publishing: 144] [Article Influence: 40.3] [Reference Citation Analysis]
387 Heni M, Machann J, Staiger H, Schwenzer NF, Peter A, Schick F, Claussen CD, Stefan N, Häring HU, Fritsche A. Pancreatic fat is negatively associated with insulin secretion in individuals with impaired fasting glucose and/or impaired glucose tolerance: a nuclear magnetic resonance study. Diabetes Metab Res Rev. 2010;26:200-205. [PMID: 20225188 DOI: 10.1002/dmrr.1073] [Cited by in Crossref: 157] [Cited by in F6Publishing: 131] [Article Influence: 14.3] [Reference Citation Analysis]
388 Scheja L, Toedter K, Mohr R, Niederfellner G, Michael MD, Meissner A, Schoettler A, Pospisil H, Beisiegel U, Heeren J. Liver TAG transiently decreases while PL n-3 and n-6 fatty acids are persistently elevated in insulin resistant mice. Lipids 2008;43:1039-51. [PMID: 18763007 DOI: 10.1007/s11745-008-3220-3] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
389 Larson-Meyer DE, Heilbronn LK, Redman LM, Newcomer BR, Frisard MI, Anton S, Smith SR, Alfonso A, Ravussin E. Effect of calorie restriction with or without exercise on insulin sensitivity, beta-cell function, fat cell size, and ectopic lipid in overweight subjects. Diabetes Care. 2006;29:1337-1344. [PMID: 16732018 DOI: 10.2337/dc05-2565] [Cited by in Crossref: 339] [Cited by in F6Publishing: 292] [Article Influence: 22.6] [Reference Citation Analysis]
390 Houghton D, Thoma C, Hallsworth K, Cassidy S, Hardy T, Burt AD, Tiniakos D, Hollingsworth KG, Taylor R, Day CP, McPherson S, Anstee QM, Trenell MI. Exercise Reduces Liver Lipids and Visceral Adiposity in Patients With Nonalcoholic Steatohepatitis in a Randomized Controlled Trial. Clin Gastroenterol Hepatol. 2017;15:96-102.e3. [PMID: 27521509 DOI: 10.1016/j.cgh.2016.07.031] [Cited by in Crossref: 75] [Cited by in F6Publishing: 63] [Article Influence: 15.0] [Reference Citation Analysis]
391 Yoon HJ, Cha BS. Pathogenesis and therapeutic approaches for non-alcoholic fatty liver disease. World J Hepatol. 2014;6:800-811. [PMID: 25429318 DOI: 10.4254/wjh.v6.i11.800] [Cited by in Crossref: 50] [Cited by in F6Publishing: 41] [Article Influence: 7.1] [Reference Citation Analysis]
392 Banini BA, Sanyal AJ. Nonalcoholic Fatty Liver Disease: Epidemiology, Pathogenesis, Natural History, Diagnosis, and Current Treatment Options. Clin Med Insights Ther 2016;8:75-84. [PMID: 28670148 DOI: 10.4137/cmt.s18885] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
393 Yu JH, Lee KS, Lee SY, Hong AR, Park YS. The association of cardiovascular risk factors with nonalcoholic fatty liver disease in health checkup examinees. J Prev Med Public Health. 2008;41:407-412. [PMID: 19037170 DOI: 10.3961/jpmph.2008.41.6.407] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
394 Lonardo A, Nascimbeni F, Maurantonio M, Marrazzo A, Rinaldi L, Adinolfi LE. Nonalcoholic fatty liver disease: Evolving paradigms. World J Gastroenterol. 2017;23:6571-6592. [PMID: 29085206 DOI: 10.3748/wjg.v23.i36.6571] [Cited by in CrossRef: 78] [Cited by in F6Publishing: 67] [Article Influence: 26.0] [Reference Citation Analysis]
395 Pi-Sunyer X. Changes in body composition and metabolic disease risk. Eur J Clin Nutr 2019;73:231-5. [PMID: 30275524 DOI: 10.1038/s41430-018-0320-x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
396 Hodson L, Bhatia L, Scorletti E, Smith DE, Jackson NC, Shojaee-Moradie F, Umpleby M, Calder PC, Byrne CD. Docosahexaenoic acid enrichment in NAFLD is associated with improvements in hepatic metabolism and hepatic insulin sensitivity: a pilot study. Eur J Clin Nutr 2017;71:973-9. [PMID: 28294174 DOI: 10.1038/ejcn.2017.9] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 6.8] [Reference Citation Analysis]
397 van Nielen M, Feskens EJ, Rietman A, Siebelink E, Mensink M. Partly replacing meat protein with soy protein alters insulin resistance and blood lipids in postmenopausal women with abdominal obesity. J Nutr 2014;144:1423-9. [PMID: 25008579 DOI: 10.3945/jn.114.193706] [Cited by in Crossref: 47] [Cited by in F6Publishing: 33] [Article Influence: 6.7] [Reference Citation Analysis]
398 Wei Y, Rector RS, Thyfault JP, Ibdah JA. Nonalcoholic fatty liver disease and mitochondrial dysfunction. World J Gastroenterol 2008;14:193-9. [PMID: 18186554 DOI: 10.3748/wjg.14.193] [Cited by in CrossRef: 207] [Cited by in F6Publishing: 181] [Article Influence: 15.9] [Reference Citation Analysis]
399 Yaligar J, Gopalan V, Kiat OW, Sugii S, Shui G, Lam BD, Henry CJ, Wenk MR, Tai ES, Velan SS. Evaluation of dietary effects on hepatic lipids in high fat and placebo diet fed rats by in vivo MRS and LC-MS techniques. PLoS One 2014;9:e91436. [PMID: 24638096 DOI: 10.1371/journal.pone.0091436] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
400 Potu RB, Lu H, Adeola O, Ajuwon KM. Metabolic markers in Ossabaw pigs fed high fat diets enriched in regular or low α-linolenic acid soy oil. Nutr Metab (Lond) 2013;10:27. [PMID: 23497195 DOI: 10.1186/1743-7075-10-27] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
401 Abdul-Ghani MA, Muller FL, Liu Y, Chavez AO, Balas B, Zuo P, Chang Z, Tripathy D, Jani R, Molina-Carrion M, Monroy A, Folli F, Van Remmen H, DeFronzo RA. Deleterious action of FA metabolites on ATP synthesis: possible link between lipotoxicity, mitochondrial dysfunction, and insulin resistance. Am J Physiol Endocrinol Metab 2008;295:E678-85. [PMID: 18593850 DOI: 10.1152/ajpendo.90287.2008] [Cited by in Crossref: 96] [Cited by in F6Publishing: 89] [Article Influence: 7.4] [Reference Citation Analysis]
402 Tajima K, Shirakawa J, Togashi Y, Yamazaki S, Okuyama T, Kyohara M, Konishi H, Terauchi Y. Metabolic recovery of lipodystrophy, liver steatosis, and pancreatic β cell proliferation after the withdrawal of OSI-906. Sci Rep 2017;7:4119. [PMID: 28646158 DOI: 10.1038/s41598-017-04304-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
403 Misra A, Khurana L. Obesity-related non-communicable diseases: South Asians vs White Caucasians. Int J Obes (Lond). 2011;35:167-187. [PMID: 20644557 DOI: 10.1038/ijo.2010.135] [Cited by in Crossref: 219] [Cited by in F6Publishing: 170] [Article Influence: 19.9] [Reference Citation Analysis]
404 Yoon H, Lee Y, Cha B. Causal Relationship of Non-alcoholic Fatty Liver Disease with Obesity and Insulin Resistance. J Korean Diabetes 2014;15:76. [DOI: 10.4093/jkd.2014.15.2.76] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
405 Pagliassotti MJ, Wei Y, Wang D. Insulin protects liver cells from saturated fatty acid-induced apoptosis via inhibition of c-Jun NH2 terminal kinase activity. Endocrinology. 2007;148:3338-3345. [PMID: 17431009 DOI: 10.1210/en.2006-1710] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 2.1] [Reference Citation Analysis]
406 Schwimmer JB, Pardee PE, Lavine JE, Blumkin AK, Cook S. Cardiovascular risk factors and the metabolic syndrome in pediatric nonalcoholic fatty liver disease. Circulation. 2008;118:277-283. [PMID: 18591439 DOI: 10.1161/circulationaha.107.739920] [Cited by in Crossref: 246] [Cited by in F6Publishing: 127] [Article Influence: 18.9] [Reference Citation Analysis]
407 Gastaldelli A, Cusi K, Pettiti M, Hardies J, Miyazaki Y, Berria R, Buzzigoli E, Sironi AM, Cersosimo E, Ferrannini E. Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects. Gastroenterology. 2007;133:496-506. [PMID: 17681171 DOI: 10.1053/j.gastro.2007.04.068] [Cited by in Crossref: 350] [Cited by in F6Publishing: 320] [Article Influence: 25.0] [Reference Citation Analysis]
408 Yki-Järvinen H. Diagnosis of non-alcoholic fatty liver disease (NAFLD). Diabetologia. 2016;59:1104-1111. [PMID: 27091184 DOI: 10.1007/s00125-016-3944-1] [Cited by in Crossref: 48] [Cited by in F6Publishing: 39] [Article Influence: 9.6] [Reference Citation Analysis]
409 Khalafi M, Symonds ME. The impact of high intensity interval training on liver fat content in overweight or obese adults: A meta-analysis. Physiol Behav 2021;236:113416. [PMID: 33823178 DOI: 10.1016/j.physbeh.2021.113416] [Reference Citation Analysis]
410 Ali M, Bukhari SA, Ali M, Lee HW. Upstream signalling of mTORC1 and its hyperactivation in type 2 diabetes (T2D). BMB Rep 2017;50:601-9. [PMID: 29187279 DOI: 10.5483/bmbrep.2017.50.12.206] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
411 McCurdy CE, Bishop JM, Williams SM, Grayson BE, Smith MS, Friedman JE, Grove KL. Maternal high-fat diet triggers lipotoxicity in the fetal livers of nonhuman primates. J Clin Invest 2009;119:323-35. [PMID: 19147984 DOI: 10.1172/JCI32661] [Cited by in Crossref: 61] [Cited by in F6Publishing: 254] [Article Influence: 5.1] [Reference Citation Analysis]
412 Ma K, Saha PK, Chan L, Moore DD. Farnesoid X receptor is essential for normal glucose homeostasis. J Clin Invest. 2006;116:1102-1109. [PMID: 16557297 DOI: 10.1172/jci25604] [Cited by in Crossref: 548] [Cited by in F6Publishing: 256] [Article Influence: 36.5] [Reference Citation Analysis]
413 Larson-Meyer DE, Newcomer BR, VanVrancken-Tompkins CL, Sothern M. Feasibility of assessing liver lipid by proton magnetic resonance spectroscopy in healthy normal and overweight prepubertal children. Diabetes Technol Ther. 2010;12:207-212. [PMID: 20151771 DOI: 10.1089/dia.2009.0069] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
414 Befroy DE, Shulman GI. Magnetic resonance spectroscopy studies of human metabolism. Diabetes 2011;60:1361-9. [PMID: 21525507 DOI: 10.2337/db09-0916] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
415 Cuthbertson DJ, Shojaee-Moradie F, Sprung VS, Jones H, Pugh CJ, Richardson P, Kemp GJ, Barrett M, Jackson NC, Thomas EL, Bell JD, Umpleby AM. Dissociation between exercise-induced reduction in liver fat and changes in hepatic and peripheral glucose homoeostasis in obese patients with non-alcoholic fatty liver disease. Clin Sci (Lond). 2016;130:93-104. [PMID: 26424731 DOI: 10.1042/cs20150447] [Cited by in Crossref: 52] [Cited by in F6Publishing: 29] [Article Influence: 8.7] [Reference Citation Analysis]
416 Taylor R. Pathogenesis of type 2 diabetes: tracing the reverse route from cure to cause. Diabetologia. 2008;51:1781-1789. [PMID: 18726585 DOI: 10.1007/s00125-008-1116-7] [Cited by in Crossref: 158] [Cited by in F6Publishing: 123] [Article Influence: 12.2] [Reference Citation Analysis]
417 Lv Q, Le L, Xiang J, Jiang B, Chen S, Xiao P. Liver Transcriptomic Reveals Novel Pathways of Empagliflozin Associated With Type 2 Diabetic Rats. Front Endocrinol (Lausanne) 2020;11:111. [PMID: 32256445 DOI: 10.3389/fendo.2020.00111] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
418 Lin HY, Yu IC, Wang RS, Chen YT, Liu NC, Altuwaijri S, Hsu CL, Ma WL, Jokinen J, Sparks JD, Yeh S, Chang C. Increased hepatic steatosis and insulin resistance in mice lacking hepatic androgen receptor. Hepatology. 2008;47:1924-1935. [PMID: 18449947 DOI: 10.1002/hep.22252] [Cited by in Crossref: 125] [Cited by in F6Publishing: 118] [Article Influence: 9.6] [Reference Citation Analysis]
419 Tiikkainen M, Bergholm R, Rissanen A, Aro A, Salminen I, Tamminen M, Teramo K, Yki-järvinen H. Effects of equal weight loss with orlistat and placebo on body fat and serum fatty acid composition and insulin resistance in obese women. The American Journal of Clinical Nutrition 2004;79:22-30. [DOI: 10.1093/ajcn/79.1.22] [Cited by in Crossref: 56] [Cited by in F6Publishing: 45] [Article Influence: 3.3] [Reference Citation Analysis]
420 Lindén D, William-Olsson L, Ahnmark A, Ekroos K, Hallberg C, Sjögren HP, Becker B, Svensson L, Clapham JC, Oscarsson J, Schreyer S. Liver-directed overexpression of mitochondrial glycerol-3-phosphate acyltransferase results in hepatic steatosis, increased triacylglycerol secretion and reduced fatty acid oxidation. FASEB J 2006;20:434-43. [PMID: 16507761 DOI: 10.1096/fj.05-4568com] [Cited by in Crossref: 84] [Cited by in F6Publishing: 84] [Article Influence: 5.6] [Reference Citation Analysis]
421 Gatineau E, Polakof S, Dardevet D, Mosoni L. Similarities and interactions between the ageing process and high chronic intake of added sugars. Nutr Res Rev 2017;30:191-207. [DOI: 10.1017/s0954422417000051] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
422 Shah PK, Mudaliar S, Chang AR, Aroda V, Andre M, Burke P, Henry RR. Effects of intensive insulin therapy alone and in combination with pioglitazone on body weight, composition, distribution and liver fat content in patients with type 2 diabetes. Diabetes Obes Metab 2011;13:505-10. [PMID: 21272186 DOI: 10.1111/j.1463-1326.2011.01370.x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 32] [Article Influence: 4.1] [Reference Citation Analysis]
423 Mehta R, Birerdinc A, Wang L, Younoszai Z, Moazzez A, Elariny H, Goodman Z, Chandhoke V, Baranova A, Younossi ZM. Expression of energy metabolism related genes in the gastric tissue of obese individuals with non-alcoholic fatty liver disease. BMC Gastroenterol. 2014;14:72. [PMID: 24716593 DOI: 10.1186/1471-230x-14-72] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
424 Misra A. Prevention of Diabetes: Countless Opportunities and Clear Challenges. Am J Lifestyle Med 2018;12:25-9. [PMID: 30283242 DOI: 10.1177/1559827617735775] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
425 Snijder MB, van Dam RM, Visser M, Seidell JC. What aspects of body fat are particularly hazardous and how do we measure them? Int J Epidemiol. 2006;35:83-92. [PMID: 16339600 DOI: 10.1093/ije/dyi253] [Cited by in Crossref: 306] [Cited by in F6Publishing: 260] [Article Influence: 19.1] [Reference Citation Analysis]
426 Magkos F, Su X, Bradley D, Fabbrini E, Conte C, Eagon JC, Varela JE, Brunt EM, Patterson BW, Klein S. Intrahepatic diacylglycerol content is associated with hepatic insulin resistance in obese subjects. Gastroenterology. 2012;142:1444-1446.e2. [PMID: 22425588 DOI: 10.1053/j.gastro.2012.03.003] [Cited by in Crossref: 122] [Cited by in F6Publishing: 112] [Article Influence: 13.6] [Reference Citation Analysis]
427 Machado MV, Cortez-Pinto H. No need for a large belly to have NASH. J Hepatol. 2011;54:1090-1093. [PMID: 21281684 DOI: 10.1016/j.jhep.2011.01.010] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
428 Monetti M, Levin MC, Watt MJ, Sajan MP, Marmor S, Hubbard BK, Stevens RD, Bain JR, Newgard CB, Farese RV Sr, Hevener AL, Farese RV Jr. Dissociation of hepatic steatosis and insulin resistance in mice overexpressing DGAT in the liver. Cell Metab. 2007;6:69-78. [PMID: 17618857 DOI: 10.1016/j.cmet.2007.05.005] [Cited by in Crossref: 374] [Cited by in F6Publishing: 349] [Article Influence: 26.7] [Reference Citation Analysis]
429 Kirk EP, Klein S. Pathogenesis and pathophysiology of the cardiometabolic syndrome. J Clin Hypertens (Greenwich) 2009;11:761-5. [PMID: 20021538 DOI: 10.1111/j.1559-4572.2009.00054.x] [Cited by in Crossref: 57] [Cited by in F6Publishing: 48] [Article Influence: 5.2] [Reference Citation Analysis]
430 Kotronen A, Yki-järvinen H. Fatty Liver: A Novel Component of the Metabolic Syndrome. ATVB 2008;28:27-38. [DOI: 10.1161/atvbaha.107.147538] [Cited by in Crossref: 541] [Cited by in F6Publishing: 245] [Article Influence: 41.6] [Reference Citation Analysis]
431 Ratziu V, Bellentani S, Cortez-Pinto H, Day C, Marchesini G. A position statement on NAFLD/NASH based on the EASL 2009 special conference. J Hepatol. 2010;53:372-384. [PMID: 20494470 DOI: 10.1016/j.jhep.2010.04.008] [Cited by in Crossref: 637] [Cited by in F6Publishing: 578] [Article Influence: 57.9] [Reference Citation Analysis]
432 Hwang B, Jeoung NH, Harris RA. Pyruvate dehydrogenase kinase isoenzyme 4 (PDHK4) deficiency attenuates the long-term negative effects of a high-saturated fat diet. Biochem J 2009;423:243-52. [PMID: 19627255 DOI: 10.1042/BJ20090390] [Cited by in Crossref: 49] [Cited by in F6Publishing: 34] [Article Influence: 4.1] [Reference Citation Analysis]
433 Fishman S, Muzumdar RH, Atzmon G, Ma X, Yang X, Einstein FH, Barzilai N. Resistance to leptin action is the major determinant of hepatic triglyceride accumulation in vivo. FASEB J. 2007;21:53-60. [PMID: 17099068 DOI: 10.1096/fj.06-6557com] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 2.6] [Reference Citation Analysis]
434 Olde D, Alpert P, Dalusung-Angosta A. Metabolic syndrome: clinical perspective for best practice. J Am Assoc Nurse Pract 2013;25:644-52. [PMID: 24170690 DOI: 10.1002/2327-6924.12048] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
435 Klein S, Allison DB, Heymsfield SB, Kelley DE, Leibel RL, Nonas C, Kahn R. Waist circumference and cardiometabolic risk: a consensus statement from Shaping America's Health: Association for Weight Management and Obesity Prevention; NAASO, The Obesity Society; the American Society for Nutrition; and the American Diabetes Association. The American Journal of Clinical Nutrition 2007;85:1197-202. [DOI: 10.1093/ajcn/85.5.1197] [Cited by in Crossref: 224] [Cited by in F6Publishing: 178] [Article Influence: 16.0] [Reference Citation Analysis]
436 Aijälä M, Malo E, Ukkola O, Bloigu R, Lehenkari P, Autio-Harmainen H, Santaniemi M, Kesäniemi YA. Long-term fructose feeding changes the expression of leptin receptors and autophagy genes in the adipose tissue and liver of male rats: a possible link to elevated triglycerides. Genes Nutr 2013;8:623-35. [PMID: 24085619 DOI: 10.1007/s12263-013-0357-3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
437 Taylor R, Al-mrabeh A, Zhyzhneuskaya S, Peters C, Barnes AC, Aribisala BS, Hollingsworth KG, Mathers JC, Sattar N, Lean ME. Remission of Human Type 2 Diabetes Requires Decrease in Liver and Pancreas Fat Content but Is Dependent upon Capacity for β Cell Recovery. Cell Metabolism 2018;28:547-556.e3. [DOI: 10.1016/j.cmet.2018.07.003] [Cited by in Crossref: 111] [Cited by in F6Publishing: 83] [Article Influence: 37.0] [Reference Citation Analysis]
438 Hays NP, Galassetti PR, Coker RH. Prevention and treatment of type 2 diabetes: current role of lifestyle, natural product, and pharmacological interventions. Pharmacol Ther 2008;118:181-91. [PMID: 18423879 DOI: 10.1016/j.pharmthera.2008.02.003] [Cited by in Crossref: 78] [Cited by in F6Publishing: 52] [Article Influence: 6.0] [Reference Citation Analysis]
439 Phillips ML, Boase S, Wahlroos S, Dugar M, Kow L, Stahl J, Slavotinek JP, Valentine R, Toouli J, Thompson CH. Associates of change in liver fat content in the morbidly obese after laparoscopic gastric banding surgery. Diabetes Obes Metab. 2008;10:661-667. [PMID: 17941875 DOI: 10.1111/j.1463-1326.2007.00793.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
440 Lehtonen H, Suomela J, Tahvonen R, Vaarno J, Venojärvi M, Viikari J, Kallio H. Berry meals and risk factors associated with metabolic syndrome. Eur J Clin Nutr 2010;64:614-21. [DOI: 10.1038/ejcn.2010.27] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 3.2] [Reference Citation Analysis]
441 Luukkonen PK, Dufour S, Lyu K, Zhang XM, Hakkarainen A, Lehtimäki TE, Cline GW, Petersen KF, Shulman GI, Yki-Järvinen H. Effect of a ketogenic diet on hepatic steatosis and hepatic mitochondrial metabolism in nonalcoholic fatty liver disease. Proc Natl Acad Sci U S A 2020;117:7347-54. [PMID: 32179679 DOI: 10.1073/pnas.1922344117] [Cited by in Crossref: 37] [Cited by in F6Publishing: 31] [Article Influence: 37.0] [Reference Citation Analysis]
442 Misra A. Ethnic-Specific Criteria for Classification of Body Mass Index: A Perspective for Asian Indians and American Diabetes Association Position Statement. Diabetes Technol Ther 2015;17:667-71. [PMID: 25902357 DOI: 10.1089/dia.2015.0007] [Cited by in Crossref: 72] [Cited by in F6Publishing: 43] [Article Influence: 12.0] [Reference Citation Analysis]
443 Choi MR, Kwak SM, Bang SH, Jeong JE, Kim DJ. Chronic saponin treatment attenuates damage to the pancreas in chronic alcohol-treated diabetic rats. J Ginseng Res 2017;41:503-12. [PMID: 29021697 DOI: 10.1016/j.jgr.2016.09.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
444 Rijkelijkhuizen JM, Doesburg T, Girman CJ, Mari A, Rhodes T, Gastaldelli A, Nijpels G, Dekker JM. Hepatic fat is not associated with beta-cell function or postprandial free fatty acid response. Metabolism 2009;58:196-203. [PMID: 19154952 DOI: 10.1016/j.metabol.2008.09.013] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
445 Kars M, Yang L, Gregor MF, Mohammed BS, Pietka TA, Finck BN, Patterson BW, Horton JD, Mittendorfer B, Hotamisligil GS, Klein S. Tauroursodeoxycholic Acid may improve liver and muscle but not adipose tissue insulin sensitivity in obese men and women. Diabetes 2010;59:1899-905. [PMID: 20522594 DOI: 10.2337/db10-0308] [Cited by in Crossref: 263] [Cited by in F6Publishing: 246] [Article Influence: 23.9] [Reference Citation Analysis]
446 Tarantino G, Savastano S, Colao A. Hepatic steatosis, low-grade chronic inflammation and hormone/growth factor/adipokine imbalance. World J Gastroenterol. 2010;16:4773-4783. [PMID: 20939105 DOI: 10.3748/wjg.v16.i38.4773.] [Reference Citation Analysis]
447 Demerath EW, Ritter KJ, Couch WA, Rogers NL, Moreno GM, Choh A, Lee M, Remsberg K, Czerwinski SA, Chumlea WC. Validity of a new automated software program for visceral adipose tissue estimation. Int J Obes (Lond). 2007;31:285-291. [PMID: 16770332 DOI: 10.1038/sj.ijo.0803409] [Cited by in Crossref: 47] [Cited by in F6Publishing: 46] [Article Influence: 3.1] [Reference Citation Analysis]
448 Janiszewski PM, Oeffinger KC, Church TS, Dunn AL, Eshelman DA, Victor RG, Brooks S, Turoff AJ, Sinclair E, Murray JC, Bashore L, Ross R. Abdominal obesity, liver fat, and muscle composition in survivors of childhood acute lymphoblastic leukemia. J Clin Endocrinol Metab 2007;92:3816-21. [PMID: 17652222 DOI: 10.1210/jc.2006-2178] [Cited by in Crossref: 98] [Cited by in F6Publishing: 86] [Article Influence: 7.0] [Reference Citation Analysis]
449 Pi-Sunyer FX. How effective are lifestyle changes in the prevention of type 2 diabetes mellitus? Nutr Rev 2007;65:101-10. [PMID: 17425061 DOI: 10.1111/j.1753-4887.2007.tb00287.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
450 Dongiovanni P, Stender S, Pietrelli A, Mancina RM, Cespiati A, Petta S, Pelusi S, Pingitore P, Badiali S, Maggioni M, Mannisto V, Grimaudo S, Pipitone RM, Pihlajamaki J, Craxi A, Taube M, Carlsson LMS, Fargion S, Romeo S, Kozlitina J, Valenti L. Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver. J Intern Med 2018;283:356-70. [PMID: 29280273 DOI: 10.1111/joim.12719] [Cited by in Crossref: 121] [Cited by in F6Publishing: 103] [Article Influence: 30.3] [Reference Citation Analysis]
451 Phillips CM, Goumidi L, Bertrais S, Field MR, Cupples LA, Ordovas JM, McMonagle J, Defoort C, Lovegrove JA, Drevon CA, Blaak EE, Kiec-Wilk B, Riserus U, Lopez-Miranda J, McManus R, Hercberg S, Lairon D, Planells R, Roche HM. ACC2 gene polymorphisms, metabolic syndrome, and gene-nutrient interactions with dietary fat. J Lipid Res 2010;51:3500-7. [PMID: 20855566 DOI: 10.1194/jlr.M008474] [Cited by in Crossref: 24] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
452 Motoyama CS, Pinto MJ, Lira FS, Ribeiro EB, do Nascimento CM, Oyama LM. Gum Guar fiber associated with fructose reduces serum triacylglycerol but did not improve the glucose tolerance in rats. Diabetol Metab Syndr 2010;2:61. [PMID: 20979642 DOI: 10.1186/1758-5996-2-61] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
453 Wang Y, Li YY, Nie YQ, Zhou YJ, Cao CY, Xu L. Association between metabolic syndrome and the development of non-alcoholic fatty liver disease. Exp Ther Med 2013;6:77-84. [PMID: 23935723 DOI: 10.3892/etm.2013.1090] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 3.6] [Reference Citation Analysis]
454 Okada AK, Teranishi K, Isas JM, Bedrood S, Chow RH, Langen R. Diabetic Risk Factors Promote Islet Amyloid Polypeptide Misfolding by a Common, Membrane-mediated Mechanism. Sci Rep 2016;6:31094. [PMID: 27531121 DOI: 10.1038/srep31094] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
455 Lin CI, Shen CF, Hsu TH, Lin SH. A High-Fructose-High-Coconut Oil Diet Induces Dysregulating Expressions of Hippocampal Leptin and Stearoyl-CoA Desaturase, and Spatial Memory Deficits in Rats. Nutrients 2017;9:E619. [PMID: 28621759 DOI: 10.3390/nu9060619] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
456 Yki-järvinen H. Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome. The Lancet Diabetes & Endocrinology 2014;2:901-10. [DOI: 10.1016/s2213-8587(14)70032-4] [Cited by in Crossref: 528] [Cited by in F6Publishing: 256] [Article Influence: 75.4] [Reference Citation Analysis]
457 Chang PF, Lin YC, Liu K, Yeh SJ, Ni YH. Heme oxygenase-1 gene promoter polymorphism and the risk of pediatric nonalcoholic fatty liver disease. Int J Obes (Lond). 2015;39:1236-1240. [PMID: 25835554 DOI: 10.1038/ijo.2015.46] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
458 Colombo C, Haluzik M, Cutson JJ, Dietz KR, Marcus-Samuels B, Vinson C, Gavrilova O, Reitman ML. Opposite effects of background genotype on muscle and liver insulin sensitivity of lipoatrophic mice. Role of triglyceride clearance. J Biol Chem 2003;278:3992-9. [PMID: 12456680 DOI: 10.1074/jbc.M207665200] [Cited by in Crossref: 39] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
459 Mehra R, Raman R, Bayless ML, Sivitz WI. Antecedent caloric intake and glucose excursion following a subsequent meal in Type 1 diabetes. J Diabetes 2009;1:273-7. [PMID: 20700478 DOI: 10.1111/j.1753-0407.2009.00044.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
460 VanWagner LB, Rinella ME. Extrahepatic Manifestations of Nonalcoholic Fatty Liver Disease. Curr Hepatol Rep. 2016;15:75-85. [PMID: 27218012 DOI: 10.1007/s11901-016-0295-9] [Cited by in Crossref: 57] [Cited by in F6Publishing: 46] [Article Influence: 11.4] [Reference Citation Analysis]
461 Rogers NH, Perfield JW 2nd, Strissel KJ, Obin MS, Greenberg AS. Reduced energy expenditure and increased inflammation are early events in the development of ovariectomy-induced obesity. Endocrinology. 2009;150:2161-2168. [PMID: 19179442 DOI: 10.1210/en.2008-1405] [Cited by in Crossref: 260] [Cited by in F6Publishing: 242] [Article Influence: 21.7] [Reference Citation Analysis]
462 Prasannarong M, Vichaiwong K, Saengsirisuwan V. Calorie restriction prevents the development of insulin resistance and impaired insulin signaling in skeletal muscle of ovariectomized rats. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2012;1822:1051-61. [DOI: 10.1016/j.bbadis.2012.02.018] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 3.2] [Reference Citation Analysis]
463 Simons N, Debray F, Schaper NC, Kooi ME, Feskens EJM, Hollak CEM, Lindeboom L, Koek GH, Bons JAP, Lefeber DJ, Hodson L, Schalkwijk CG, Stehouwer CDA, Cassiman D, Brouwers MCGJ. Patients With Aldolase B Deficiency Are Characterized by Increased Intrahepatic Triglyceride Content. The Journal of Clinical Endocrinology & Metabolism 2019;104:5056-64. [DOI: 10.1210/jc.2018-02795] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 6.5] [Reference Citation Analysis]
464 Bang KB, Cho YK. Comorbidities and Metabolic Derangement of NAFLD. J Lifestyle Med. 2015;5:7-13. [PMID: 26528424 DOI: 10.15280/jlm.2015.5.1.7] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 4.7] [Reference Citation Analysis]
465 Cernkovich ER, Deng J, Bond MC, Combs TP, Harp JB. Adipose-specific disruption of signal transducer and activator of transcription 3 increases body weight and adiposity. Endocrinology 2008;149:1581-90. [PMID: 18096662 DOI: 10.1210/en.2007-1148] [Cited by in Crossref: 65] [Cited by in F6Publishing: 64] [Article Influence: 4.6] [Reference Citation Analysis]
466 Ter Horst KW, Serlie MJ. Fructose Consumption, Lipogenesis, and Non-Alcoholic Fatty Liver Disease. Nutrients. 2017;9. [PMID: 28878197 DOI: 10.3390/nu9090981] [Cited by in Crossref: 79] [Cited by in F6Publishing: 71] [Article Influence: 19.8] [Reference Citation Analysis]
467 Xia SF, Le GW, Wang P, Qiu YY, Jiang YY, Tang X. Regressive Effect of Myricetin on Hepatic Steatosis in Mice Fed a High-Fat Diet. Nutrients 2016;8:E799. [PMID: 27973423 DOI: 10.3390/nu8120799] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 6.0] [Reference Citation Analysis]
468 Stumvoll M, Goldstein BJ, van Haeften TW. Type 2 diabetes: principles of pathogenesis and therapy. Lancet. 2005;365:1333-1346. [PMID: 15823385 DOI: 10.1016/s0140-6736(05)61032-x] [Cited by in Crossref: 1362] [Cited by in F6Publishing: 492] [Article Influence: 85.1] [Reference Citation Analysis]
469 Burgert TS, Taksali SE, Dziura J, Goodman TR, Yeckel CW, Papademetris X, Constable RT, Weiss R, Tamborlane WV, Savoye M. Alanine aminotransferase levels and fatty liver in childhood obesity: associations with insulin resistance, adiponectin, and visceral fat. J Clin Endocrinol Metab. 2006;91:4287-4294. [PMID: 16912127 DOI: 10.1210/jc.2006-1010] [Cited by in Crossref: 252] [Cited by in F6Publishing: 227] [Article Influence: 16.8] [Reference Citation Analysis]
470 Adiels M, Westerbacka J, Soro-Paavonen A, Häkkinen AM, Vehkavaara S, Caslake MJ, Packard C, Olofsson SO, Yki-Järvinen H, Taskinen MR, Borén J. Acute suppression of VLDL1 secretion rate by insulin is associated with hepatic fat content and insulin resistance. Diabetologia 2007;50:2356-65. [PMID: 17849096 DOI: 10.1007/s00125-007-0790-1] [Cited by in Crossref: 120] [Cited by in F6Publishing: 108] [Article Influence: 8.6] [Reference Citation Analysis]
471 Lou T, Zhang Z, Xi Z, Liu K, Li L, Liu B, Huang F. Berberine inhibits inflammatory response and ameliorates insulin resistance in hepatocytes. Inflammation 2011;34:659-67. [PMID: 21110076 DOI: 10.1007/s10753-010-9276-2] [Cited by in Crossref: 60] [Cited by in F6Publishing: 58] [Article Influence: 6.7] [Reference Citation Analysis]
472 Simonen P, Kotronen A, Hallikainen M, Sevastianova K, Makkonen J, Hakkarainen A, Lundbom N, Miettinen TA, Gylling H, Yki-Järvinen H. Cholesterol synthesis is increased and absorption decreased in non-alcoholic fatty liver disease independent of obesity. J Hepatol. 2011;54:153-159. [PMID: 20947198 DOI: 10.1016/j.jhep.2010.05.037] [Cited by in Crossref: 90] [Cited by in F6Publishing: 79] [Article Influence: 8.2] [Reference Citation Analysis]
473 Hwang JH, Stein DT, Barzilai N, Cui MH, Tonelli J, Kishore P, Hawkins M. Increased intrahepatic triglyceride is associated with peripheral insulin resistance: in vivo MR imaging and spectroscopy studies. Am J Physiol Endocrinol Metab. 2007;293:E1663-E1669. [PMID: 17911339 DOI: 10.1152/ajpendo.00590.2006] [Cited by in Crossref: 127] [Cited by in F6Publishing: 113] [Article Influence: 9.1] [Reference Citation Analysis]
474 Hsieh PS, Hsieh YJ. Impact of liver diseases on the development of type 2 diabetes mellitus. World J Gastroenterol. 2011;17:5240-5245. [PMID: 22219592 DOI: 10.3748/wjg.v17.i48.5240] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 32] [Article Influence: 4.0] [Reference Citation Analysis]
475 Brouwers B, Hesselink MK, Schrauwen P, Schrauwen-Hinderling VB. Effects of exercise training on intrahepatic lipid content in humans. Diabetologia 2016;59:2068-79. [PMID: 27393135 DOI: 10.1007/s00125-016-4037-x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 35] [Article Influence: 9.0] [Reference Citation Analysis]
476 Pepin A, Stanhope KL, Imbeault P. Are Fruit Juices Healthier Than Sugar-Sweetened Beverages? A Review. Nutrients 2019;11:E1006. [PMID: 31052523 DOI: 10.3390/nu11051006] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 12.0] [Reference Citation Analysis]
477 Savage DB, Petersen KF, Shulman GI. Disordered lipid metabolism and the pathogenesis of insulin resistance. Physiol Rev. 2007;87:507-520. [PMID: 17429039 DOI: 10.1152/physrev.00024.2006] [Cited by in Crossref: 666] [Cited by in F6Publishing: 582] [Article Influence: 47.6] [Reference Citation Analysis]
478 Taylor R. Banting Memorial lecture 2012: reversing the twin cycles of type 2 diabetes. Diabet Med 2013;30:267-75. [PMID: 23075228 DOI: 10.1111/dme.12039] [Cited by in Crossref: 42] [Cited by in F6Publishing: 29] [Article Influence: 5.3] [Reference Citation Analysis]
479 d'Assignies G, Fontés G, Kauffmann C, Latour M, Gaboury L, Boulanger Y, Van Beers BE, Soulez G, Poitout V, Tang A. Early detection of liver steatosis by magnetic resonance imaging in rats infused with glucose and intralipid solutions and correlation to insulin levels. Metabolism 2013;62:1850-7. [PMID: 24035445 DOI: 10.1016/j.metabol.2013.08.003] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
480 Maiorana A, Del Bianco C, Cianfarani S. Adipose Tissue: A Metabolic Regulator. Potential Implications for the Metabolic Outcome of Subjects Born Small for Gestational Age (SGA). Rev Diabet Stud 2007;4:134-46. [PMID: 18084671 DOI: 10.1900/RDS.2007.4.134] [Cited by in Crossref: 31] [Cited by in F6Publishing: 4] [Article Influence: 2.2] [Reference Citation Analysis]
481 Wang CY, Ou HY, Chen MF, Chang TC, Chang CJ. Enigmatic ectopic fat: prevalence of nonalcoholic fatty pancreas disease and its associated factors in a Chinese population. J Am Heart Assoc. 2014;3:e000297. [PMID: 24572250 DOI: 10.1161/jaha.113.000297] [Cited by in Crossref: 68] [Cited by in F6Publishing: 40] [Article Influence: 9.7] [Reference Citation Analysis]
482 Mei M, Zhao L, Li Q, Chen Y, Huang A, Varghese Z, Moorhead JF, Zhang S, Powis SH, Li Q, Ruan XZ. Inflammatory stress exacerbates ectopic lipid deposition in C57BL/6J mice. Lipids Health Dis 2011;10:110. [PMID: 21718499 DOI: 10.1186/1476-511X-10-110] [Cited by in Crossref: 28] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
483 Gómez-Sámano MA, Cuevas-Ramos D, Mehta R, Brau-Figueroa H, Meza-Arana CE, Gulias-Herrero A. Association of Alanine Aminotransferase Levels (ALT) with the Hepatic Insulin Resistance Index (HIRI): a cross-sectional study. BMC Endocr Disord 2012;12:16. [PMID: 22947097 DOI: 10.1186/1472-6823-12-16] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
484 Lin X, Yue P, Xie Y, Davidson NO, Sakata N, Ostlund RE, Chen Z, Schonfeld G. Reduced intestinal fat absorptive capacity but enhanced susceptibility to diet-induced fatty liver in mice heterozygous for ApoB38.9 truncation. American Journal of Physiology-Gastrointestinal and Liver Physiology 2005;289:G146-52. [DOI: 10.1152/ajpgi.00309.2004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
485 Kelsey MM, Forster JE, Van Pelt RE, Reusch JE, Nadeau KJ. Adipose tissue insulin resistance in adolescents with and without type 2 diabetes. Pediatr Obes 2014;9:373-80. [PMID: 23861170 DOI: 10.1111/j.2047-6310.2013.00189.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
486 Shephard RJ, Johnson N. Effects of physical activity upon the liver. Eur J Appl Physiol 2015;115:1-46. [DOI: 10.1007/s00421-014-3031-6] [Cited by in Crossref: 48] [Cited by in F6Publishing: 30] [Article Influence: 6.9] [Reference Citation Analysis]
487 Choi CS, Savage DB, Kulkarni A, Yu XX, Liu ZX, Morino K, Kim S, Distefano A, Samuel VT, Neschen S, Zhang D, Wang A, Zhang XM, Kahn M, Cline GW, Pandey SK, Geisler JG, Bhanot S, Monia BP, Shulman GI. Suppression of diacylglycerol acyltransferase-2 (DGAT2), but not DGAT1, with antisense oligonucleotides reverses diet-induced hepatic steatosis and insulin resistance. J Biol Chem. 2007;282:22678-22688. [PMID: 17526931 DOI: 10.1074/jbc.m704213200] [Cited by in Crossref: 260] [Cited by in F6Publishing: 120] [Article Influence: 18.6] [Reference Citation Analysis]
488 Goudriaan JR, Dahlmans VE, Teusink B, Ouwens DM, Febbraio M, Maassen JA, Romijn JA, Havekes LM, Voshol PJ. CD36 deficiency increases insulin sensitivity in muscle, but induces insulin resistance in the liver in mice. J Lipid Res. 2003;44:2270-2277. [PMID: 12923231 DOI: 10.1194/jlr.M300143-JLR200] [Cited by in Crossref: 118] [Cited by in F6Publishing: 46] [Article Influence: 6.6] [Reference Citation Analysis]
489 Toledo-Corral CM, Alderete TL, Hu HH, Nayak K, Esplana S, Liu T, Goran MI, Weigensberg MJ. Ectopic fat deposition in prediabetic overweight and obese minority adolescents. J Clin Endocrinol Metab. 2013;98:1115-1121. [PMID: 23386647 DOI: 10.1210/jc.2012-3806] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 4.4] [Reference Citation Analysis]
490 Priego T, Sánchez J, Picó C, Palou A. Sex-differential expression of metabolism-related genes in response to a high-fat diet. Obesity (Silver Spring) 2008;16:819-26. [PMID: 18239587 DOI: 10.1038/oby.2007.117] [Cited by in Crossref: 75] [Cited by in F6Publishing: 67] [Article Influence: 5.8] [Reference Citation Analysis]
491 Chazenbalk G, Trivax BS, Yildiz BO, Bertolotto C, Mathur R, Heneidi S, Azziz R. Regulation of adiponectin secretion by adipocytes in the polycystic ovary syndrome: role of tumor necrosis factor-{alpha}. J Clin Endocrinol Metab 2010;95:935-42. [PMID: 20089616 DOI: 10.1210/jc.2009-1158] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 2.7] [Reference Citation Analysis]
492 Lee SH, Cho DY, Joo NS, Kim KM, Kim KN. The relationship of alanine aminotransferase to metabolic syndrome in a Korean population. Turk J Gastroenterol 2018;29:52-60. [PMID: 29391308 DOI: 10.5152/tjg.2018.17333] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
493 Bae JC, Cho YK, Lee WY, Seo HI, Rhee EJ, Park SE, Park CY, Oh KW, Sung KC, Kim BI. Impact of nonalcoholic fatty liver disease on insulin resistance in relation to HbA1c levels in nondiabetic subjects. Am J Gastroenterol. 2010;105:2389-2395. [PMID: 20628364 DOI: 10.1038/ajg.2010.275] [Cited by in Crossref: 68] [Cited by in F6Publishing: 52] [Article Influence: 6.2] [Reference Citation Analysis]
494 Ansari A, Bose S, Patra JK, Shin NR, Lim DW, Kim KW, Wang JH, Kim YM, Chin YW, Kim H. A Controlled Fermented Samjunghwan Herbal Formula Ameliorates Non-alcoholic Hepatosteatosis in HepG2 Cells and OLETF Rats. Front Pharmacol 2018;9:596. [PMID: 29971000 DOI: 10.3389/fphar.2018.00596] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
495 Yu H, Yang F, Zhong W, Jiang X, Zhang F, Ji X, Xue M, Qiu Y, Yu J, Hu X, Chen J, Bao Z. Secretory Galectin-3 promotes hepatic steatosis via regulation of the PPARγ/CD36 signaling pathway. Cell Signal 2021;84:110043. [PMID: 33991615 DOI: 10.1016/j.cellsig.2021.110043] [Reference Citation Analysis]
496 Crunkhorn S, Patti ME. Links between thyroid hormone action, oxidative metabolism, and diabetes risk? Thyroid. 2008;18:227-237. [PMID: 18279023 DOI: 10.1089/thy.2007.0249] [Cited by in Crossref: 69] [Cited by in F6Publishing: 67] [Article Influence: 5.3] [Reference Citation Analysis]
497 Amaro A, Fabbrini E, Kars M, Yue P, Schechtman K, Schonfeld G, Klein S. Dissociation between intrahepatic triglyceride content and insulin resistance in familial hypobetalipoproteinemia. Gastroenterology. 2010;139:149-153. [PMID: 20303351 DOI: 10.1053/j.gastro.2010.03.039] [Cited by in Crossref: 103] [Cited by in F6Publishing: 89] [Article Influence: 9.4] [Reference Citation Analysis]
498 Kotronen A, Juurinen L, Tiikkainen M, Vehkavaara S, Yki-Järvinen H. Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. Gastroenterology. 2008;135:122-130. [PMID: 18474251 DOI: 10.1053/j.gastro.2008.03.021] [Cited by in Crossref: 217] [Cited by in F6Publishing: 193] [Article Influence: 16.7] [Reference Citation Analysis]
499 Garg A, Misra A. Hepatic steatosis, insulin resistance, and adipose tissue disorders. J Clin Endocrinol Metab. 2002;87:3019-3022. [PMID: 12107193 DOI: 10.1210/jcem.87.7.8736] [Cited by in Crossref: 50] [Cited by in F6Publishing: 56] [Article Influence: 2.6] [Reference Citation Analysis]
500 Snijder MB, Zimmet PZ, Visser M, Dekker JM, Seidell JC, Shaw JE. Independent and opposite associations of waist and hip circumferences with diabetes, hypertension and dyslipidemia: the AusDiab Study. Int J Obes Relat Metab Disord 2004;28:402-9. [PMID: 14724659 DOI: 10.1038/sj.ijo.0802567] [Cited by in Crossref: 215] [Cited by in F6Publishing: 178] [Article Influence: 12.6] [Reference Citation Analysis]
501 Ke W, Wang P, Wang X, Zhou X, Hu X, Chen F. Dietary Platycodon grandiflorus Attenuates Hepatic Insulin Resistance and Oxidative Stress in High-Fat-Diet Induced Non-Alcoholic Fatty Liver Disease. Nutrients 2020;12:E480. [PMID: 32074961 DOI: 10.3390/nu12020480] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
502 Cai D, Yuan M, Frantz DF, Melendez PA, Hansen L, Lee J, Shoelson SE. Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat Med. 2005;11:183-190. [PMID: 15685173 DOI: 10.1038/nm1166] [Cited by in Crossref: 1513] [Cited by in F6Publishing: 1382] [Article Influence: 94.6] [Reference Citation Analysis]
503 Adami GF, Carbone F, Montecucco F, Camerini G, Cordera R. Adipose Tissue Composition in Obesity and After Bariatric Surgery. Obes Surg 2019;29:3030-8. [PMID: 31190263 DOI: 10.1007/s11695-019-04030-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
504 Lê K, Bortolotti M. Role of dietary carbohydrates and macronutrients in the pathogenesis of nonalcoholic fatty liver disease: . Current Opinion in Clinical Nutrition and Metabolic Care 2008;11:477-82. [DOI: 10.1097/mco.0b013e328302f3ec] [Cited by in Crossref: 35] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
505 Darcy J, Bartke A. From White to Brown - Adipose Tissue Is Critical to the Extended Lifespan and Healthspan of Growth Hormone Mutant Mice. Adv Exp Med Biol 2019;1178:207-25. [PMID: 31493229 DOI: 10.1007/978-3-030-25650-0_11] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
506 Kelley DE, McKolanis TM, Hegazi RA, Kuller LH, Kalhan SC. Fatty liver in type 2 diabetes mellitus: relation to regional adiposity, fatty acids, and insulin resistance. Am J Physiol Endocrinol Metab 2003;285:E906-16. [PMID: 12959938 DOI: 10.1152/ajpendo.00117.2003] [Cited by in Crossref: 242] [Cited by in F6Publishing: 237] [Article Influence: 13.4] [Reference Citation Analysis]
507 Hanifah RA, Majid HA, Jalaludin MY, Al-Sadat N, Murray LJ, Cantwell M, Su TT, Nahar AM. Fitness level and body composition indices: cross-sectional study among Malaysian adolescent. BMC Public Health 2014;14 Suppl 3:S5. [PMID: 25436933 DOI: 10.1186/1471-2458-14-S3-S5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
508 Blaslov K, Bulum T, Zibar K, Duvnjak L. Incretin based therapies: a novel treatment approach for non-alcoholic fatty liver disease. World J Gastroenterol. 2014;20:7356-7365. [PMID: 24966606 DOI: 10.3748/wjg.v20.i23.7356] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 22] [Article Influence: 4.2] [Reference Citation Analysis]
509 Mohammadi F, Qorbani M, Kelishadi R, Baygi F, Ardalan G, Taslimi M, Mahmoudarabi M, Motlagh M, Asayesh H, Larijani B, Heshmat R. Association of Cardiometabolic Risk Factors and Hepatic Enzymes in a National Sample of Iranian Children and Adolescents: The CASPIAN-III Study. Journal of Pediatric Gastroenterology & Nutrition 2014;58:463-8. [DOI: 10.1097/mpg.0000000000000246] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
510 Szczepaniak LS, Nurenberg P, Leonard D, Browning JD, Reingold JS, Grundy S, Hobbs HH, Dobbins RL. Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab. 2005;288:E462-E468. [PMID: 15339742 DOI: 10.1152/ajpendo.00064.2004] [Cited by in Crossref: 1018] [Cited by in F6Publishing: 942] [Article Influence: 59.9] [Reference Citation Analysis]
511 Viljanen AP, Iozzo P, Borra R, Kankaanpää M, Karmi A, Lautamäki R, Järvisalo M, Parkkola R, Rönnemaa T, Guiducci L. Effect of weight loss on liver free fatty acid uptake and hepatic insulin resistance. J Clin Endocrinol Metab. 2009;94:50-55. [PMID: 18957499 DOI: 10.1210/jc.2008-1689] [Cited by in Crossref: 86] [Cited by in F6Publishing: 78] [Article Influence: 6.6] [Reference Citation Analysis]
512 Li M, Campbell S, McDermott R. gamma-Glutamyltransferase, obesity, physical activity, and the metabolic syndrome in indigenous Australian adults. Obesity (Silver Spring). 2009;17:809-813. [PMID: 19148121 DOI: 10.1038/oby.2008.617] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
513 Agius L. Dietary carbohydrate and control of hepatic gene expression: mechanistic links from ATP and phosphate ester homeostasis to the carbohydrate-response element-binding protein. Proc Nutr Soc. 2016;75:10-18. [PMID: 26264689 DOI: 10.1017/s0029665115002451] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
514 Jung TW, Lee YJ, Lee MW, Kim SM, Jung TW. Full-length adiponectin protects hepatocytes from palmitate-induced apoptosis via inhibition of c-Jun NH 2 terminal kinase. FEBS Journal 2009;276:2278-84. [DOI: 10.1111/j.1742-4658.2009.06955.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 2.2] [Reference Citation Analysis]
515 Capell WH, Schlaepfer IR, Wolfe P, Watson PA, Bessesen DH, Pagliassotti MJ, Eckel RH. Fatty acids increase glucose uptake and metabolism in C2C12 myoblasts stably transfected with human lipoprotein lipase. Am J Physiol Endocrinol Metab 2010;299:E576-83. [PMID: 20628023 DOI: 10.1152/ajpendo.00618.2009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
516 Meex RCR, Watt MJ. Hepatokines: linking nonalcoholic fatty liver disease and insulin resistance. Nat Rev Endocrinol. 2017;13:509-520. [PMID: 28621339 DOI: 10.1038/nrendo.2017.56] [Cited by in Crossref: 205] [Cited by in F6Publishing: 172] [Article Influence: 51.3] [Reference Citation Analysis]
517 Birner-gruenberger R, Susani-etzerodt H, Kollroser M, Rechberger GN, Hermetter A. Lipolytic and esterolytic activity-based profiling of murine liver. Proteomics 2008;8:3645-56. [DOI: 10.1002/pmic.200800191] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
518 Graff M, North KE, Franceschini N, Reiner AP, Feitosa M, Carr JJ, Gordon-Larsen P, Wojczynski MK, Borecki IB. PNPLA3 gene-by-visceral adipose tissue volume interaction and the pathogenesis of fatty liver disease: the NHLBI family heart study. Int J Obes (Lond) 2013;37:432-8. [PMID: 22546774 DOI: 10.1038/ijo.2012.65] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 4.1] [Reference Citation Analysis]
519 Niu Z, Hu H, Tang F. High Free Fatty Acid Levels Are Associated with Stroke Recurrence and Poor Functional Outcome in Chinese Patients with Ischemic Stroke. J Nutr Health Aging 2017;21:1102-6. [PMID: 29188867 DOI: 10.1007/s12603-016-0852-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
520 Sato F, Tamura Y, Watada H, Kumashiro N, Igarashi Y, Uchino H, Maehara T, Kyogoku S, Sunayama S, Sato H. Effects of diet-induced moderate weight reduction on intrahepatic and intramyocellular triglycerides and glucose metabolism in obese subjects. J Clin Endocrinol Metab. 2007;92:3326-3329. [PMID: 17519317 DOI: 10.1210/jc.2006-2384] [Cited by in Crossref: 90] [Cited by in F6Publishing: 66] [Article Influence: 6.4] [Reference Citation Analysis]
521 Montesi L, Mazzotti A, Moscatiello S, Forlani G, Marchesini G. Insulin resistance: mechanism and implications for carcinogenesis and hepatocellular carcinoma in NASH. Hepatol Int 2013;7:814-22. [DOI: 10.1007/s12072-013-9451-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
522 Bie J, Zhao B, Marqueen KE, Wang J, Szomju B, Ghosh S. Macrophage-specific transgenic expression of cholesteryl ester hydrolase attenuates hepatic lipid accumulation and also improves glucose tolerance in ob/ob mice. Am J Physiol Endocrinol Metab 2012;302:E1283-91. [PMID: 22395110 DOI: 10.1152/ajpendo.00511.2011] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
523 Macfarlane DP, Raubenheimer PJ, Preston T, Gray CD, Bastin ME, Marshall I, Iredale JP, Andrew R, Walker BR. Effects of acute glucocorticoid blockade on metabolic dysfunction in patients with Type 2 diabetes with and without fatty liver. Am J Physiol Gastrointest Liver Physiol 2014;307:G760-8. [PMID: 25104497 DOI: 10.1152/ajpgi.00030.2014] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
524 Fukuzawa Y, Kapoor MP, Yamasaki K, Okubo T, Hotta Y, Juneja LR. Effects of green tea catechins on nonalcoholic steatohepatitis (NASH) patients. Journal of Functional Foods 2014;9:48-59. [DOI: 10.1016/j.jff.2014.04.010] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]